Document and Entity Information
Document and Entity Information | 12 Months Ended |
Dec. 31, 2022 shares | |
Entity Addresses [Line Items] | |
Document Type | 40-F |
Document Registration Statement | false |
Document Annual Report | true |
Document Period End Date | Dec. 31, 2022 |
Entity Ex Transition Period | false |
Entity File Number | 001-39989 |
Entity Registrant Name | PYROGENESIS CANADA INC. |
Entity Incorporation, State or Country Code | Z4 |
Entity Primary SIC Number | 3599 |
Entity Address, Address Line One | 1744, William St. Suite 200 |
Entity Address, City or Town | Montréal |
Entity Address, State or Province | QC |
Entity Address, Country | CA |
Entity Address, Postal Zip Code | H3J1R4 |
Country Region | 1 |
City Area Code | 514 |
Local Phone Number | 937-0002 |
Title of 12(b) Security | Common Shares, no par value |
Trading Symbol | PYR |
Security Exchange Name | NASDAQ |
Annual Information Form | true |
Audited Annual Financial Statements | true |
Entity Common Stock, Shares Outstanding | 173,580,395 |
Entity Current Reporting Status | Yes |
Entity Interactive Data Current | Yes |
Entity Emerging Growth Company | true |
Entity Central Index Key | 0001743344 |
Current Fiscal Year End Date | --12-31 |
Document Fiscal Year Focus | 2022 |
Document Fiscal Period Focus | FY |
Amendment Flag | false |
ICFR Auditor Attestation Flag | false |
Auditor Firm ID | 1232 |
Auditor Name | Raymond Chabot Grant Thornton LLP |
Auditor Location | Montréal, Canada |
Business Contact [Member] | |
Entity Addresses [Line Items] | |
Entity Address, Address Line One | 1209 Orange St. |
Entity Address, City or Town | Wilmington |
Entity Address, State or Province | DE |
Entity Address, Postal Zip Code | 19801 |
City Area Code | 202 |
Local Phone Number | 572-3133 |
Contact Personnel Name | P. Peter Pascali |
Consolidated Statements of Fina
Consolidated Statements of Financial Position - CAD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Current assets | ||
Cash and cash equivalents [note 8] | $ 3,445,649 | $ 12,202,513 |
Accounts receivable [note 9] | 18,624,631 | 17,639,616 |
Costs and profits in excess of billings on uncompleted contracts [note 10] | 1,051,297 | 4,922,710 |
Inventory [note 24] | 1,876,411 | 887,590 |
Investment tax credits receivable [note 11] | 276,404 | 256,513 |
Income taxes receivable | 14,169 | 117,029 |
Current portion of deposits [note 14] | 432,550 | 1,328,452 |
Current portion of royalties receivable [note 13] | 455,556 | 311,111 |
Contract assets | 499,912 | 375,789 |
Prepaid expenses | 771,603 | 717,661 |
Total current assets | 27,448,182 | 38,758,984 |
Non-current assets | ||
Deposits [note 14] | 46,053 | 248,756 |
Strategic investments [note 12] | 6,242,634 | 14,901,659 |
Property and equipment [note 15] | 3,393,452 | 3,712,937 |
Right-of-use assets [note 16] | 4,818,744 | 5,765,993 |
Royalties receivable [note 13] | 952,230 | 947,543 |
Intangible assets [note 17] | 2,104,848 | 2,774,198 |
Goodwill [note 18] | 2,660,607 | 2,660,607 |
Total assets | 47,666,750 | 69,770,677 |
Current liabilities | ||
Bank indebtedness | 991,902 | 0 |
Accounts payable and accrued liabilities [note 19] | 10,115,870 | 10,069,177 |
Billings in excess of costs and profits on uncompleted contracts [note 20] | 9,670,993 | 9,400,231 |
Current portion of term loans [note 21] | 69,917 | 83,004 |
Current portion of lease liabilities [note 16] | 2,672,212 | 2,934,236 |
Balance due on business combination [note 6] | 2,088,977 | 2,242,503 |
Income taxes payable | 187,602 | 23,048 |
Total current liabilities | 25,797,473 | 24,752,199 |
Non-current liabilities | ||
Lease liabilities [note 16] | 2,861,482 | 2,389,729 |
Term loans [note 21] | 320,070 | 107,901 |
Balance due on business combination [note 6] | 1,818,798 | 1,709,700 |
Deferred income taxes [note 31] | 0 | 42,394 |
Total liabilities | 30,797,823 | 29,001,923 |
Shareholders' equity [note 22] | ||
Common shares | 85,483,223 | 82,104,086 |
Warrants | 223,200 | 0 |
Contributed surplus | 24,546,960 | 19,879,055 |
Accumulated other comprehensive income | 402 | 3,444 |
Deficit | (93,384,858) | (61,217,831) |
Total shareholders' equity | 16,868,927 | 40,768,754 |
Total liabilities and shareholders' equity | $ 47,666,750 | $ 69,770,677 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Loss - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Consolidated Statements of Comprehensive Income (Loss) [Abstract] | ||
Revenues [note 7] | $ 19,013,503 | $ 31,068,350 |
Cost of sales and services [note 24] | 10,869,616 | 18,636,539 |
Gross profit | 8,143,887 | 12,431,811 |
Expenses | ||
Selling, general and administrative [note 24] | 29,025,434 | 27,237,135 |
Research and development, net [note 12] | 2,317,973 | 2,535,987 |
Total Expenses | 31,343,407 | 29,773,122 |
Net loss from operations | (23,199,520) | (17,341,311) |
Changes in fair value of strategic investments [note 12] | (8,340,781) | (21,426,218) |
Finance costs, net [note 25] | (550,742) | (404,370) |
Loss before income taxes | (32,091,043) | (39,171,899) |
Income taxes [note 31] | 75,984 | (739,960) |
Net earnings (loss) | (32,167,027) | (38,431,939) |
Items that will be reclassified subsequently to profit or loss | ||
Foreign currency translation gain (loss) on investments in foreign operations | (3,042) | 3,444 |
Comprehensive income (loss) | $ (32,170,069) | $ (38,428,495) |
Loss per share [note 26] | ||
Basic | $ (0.19) | $ (0.23) |
Diluted | $ (0.19) | $ (0.23) |
Consolidated Statements of Chan
Consolidated Statements of Changes in Shareholder's Equity - CAD ($) | Total | Common Shares [Member] | Warrants [Member] | Contributed Surplus [Member] | Accumulated Other comprehensive Income [Member] | Deficit [Member] |
Beginning balance at Dec. 31, 2020 | $ 59,423,106 | $ 67,950,069 | $ 0 | $ 10,480,310 | $ 0 | $ (19,007,273) |
Beginning balance (in shares) at Dec. 31, 2020 | 159,145,992 | |||||
Shares issued upon exercise of stock options [note 21] | 1,109,818 | $ 1,473,818 | 0 | (364,000) | 0 | 0 |
Shares issued upon exercise of stock options [note 21] (in shares) | 3,482,000 | |||||
Conversion of loan into shares [note 21] | 13,085,197 | $ 13,085,197 | 0 | 0 | 0 | 0 |
Conversion of loan into shares [note 21] (in shares) | 8,337,897 | |||||
Share redemptions for cancellation [note 21] | $ (4,183,617) | $ (404,998) | 0 | 0 | 0 | (3,778,619) |
Share redemptions for cancellation [note 22] (in shares) | (840,094) | (840,094) | ||||
Share-based payments | $ 9,762,745 | $ 0 | 0 | 9,762,745 | 0 | 0 |
Other comprehensive income loss for the year | 3,444 | 0 | 0 | 0 | 3,444 | 0 |
Net loss | (38,431,939) | 0 | 0 | 0 | 0 | (38,431,939) |
Ending balance at Dec. 31, 2021 | 40,768,754 | $ 82,104,086 | 0 | 19,879,055 | 3,444 | (61,217,831) |
Ending balance (in shares) at Dec. 31, 2021 | 170,125,795 | |||||
Shares issued upon exercise of stock options [note 21] | 1,412,799 | $ 2,283,357 | 0 | (870,558) | 0 | 0 |
Shares issued upon exercise of stock options [note 21] (in shares) | 2,440,000 | |||||
Private placement [note 22] | $ 1,318,980 | $ 1,095,780 | 223,200 | 0 | 0 | 0 |
Private placement (in shares) [note 22] | 1,014,600 | |||||
Share redemptions for cancellation [note 22] (in shares) | 0 | |||||
Share-based payments | $ 5,538,463 | $ 0 | 0 | 5,538,463 | 0 | 0 |
Other comprehensive income loss for the year | (3,042) | 0 | 0 | 0 | (3,042) | 0 |
Net loss | (32,167,027) | 0 | 0 | 0 | 0 | (32,167,027) |
Ending balance at Dec. 31, 2022 | $ 16,868,927 | $ 85,483,223 | $ 223,200 | $ 24,546,960 | $ 402 | $ (93,384,858) |
Ending balance (in shares) at Dec. 31, 2022 | 173,580,395 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Cash flows provided by (used in) Operating activities | ||
Net loss | $ (32,167,027) | $ (38,431,939) |
Adjustments for: | ||
Share-based payments | 5,538,463 | 9,762,745 |
Depreciation of property and equipment | 603,894 | 356,103 |
Depreciation of right-of-use assets | 635,828 | 570,411 |
Amortization and write-off of intangible assets | 878,030 | 465,913 |
Amortization of contract assets | 243,626 | 513,572 |
Net finance costs | 550,742 | 404,370 |
Change in fair value of investments | 8,340,781 | 21,426,218 |
Deferred income taxes | (42,394) | (584,246) |
Unrealized foreign exchange | (102,236) | (10,623) |
Cash flows from (used in) operations before changes in balances related to operations | (15,520,293) | (5,527,476) |
Net change to working capital items [note 23] | 4,391,408 | (12,585,956) |
Cash flows provided by (used in) Operating activities | (11,128,885) | (18,113,432) |
Investing activities | ||
Additions to property and equipment | (396,051) | (1,502,231) |
Additions to intangible assets | (290,373) | (246,630) |
Purchase of strategic investments | (3,604,000) | (10,588,857) |
Disposal of strategic investments | 3,922,244 | 14,252,730 |
Business combination, net of cash acquired | 0 | 807,945 |
Cash flows provided by (used in) Investing activities | (368,180) | 2,722,957 |
Financing activities | ||
Increase in bank indebtedness | 991,902 | 0 |
Interest paid | (467,453) | (253,791) |
Repayment of term loans | (33,003) | (20,507) |
Repayment of lease liabilities | (657,381) | (263,078) |
Repayment of balance due on business combination | (217,778) | 0 |
Proceeds from issuance of other term loans | 292,941 | 0 |
Proceeds from issuance of shares upon exercise of warrants | 0 | 13,085,197 |
Proceeds from issuance of shares upon exercise of stock options | 1,412,799 | 1,109,818 |
Proceeds from private placement [note 22] | 1,318,980 | 0 |
Shares repurchased for cancellation | 0 | (4,183,617) |
Cash flows provided by (used in) Financing activities | 2,641,007 | 9,474,022 |
Effect of exchange rate changes on cash denominated in foreign currencies | 99,194 | 14,067 |
Net (decrease) in cash and cash equivalents | (8,756,864) | (5,902,386) |
Cash and cash equivalents - beginning of year | 12,202,513 | 18,104,899 |
Cash and cash equivalents - end of year | 3,445,649 | 12,202,513 |
Non-cash transactions: | ||
Purchase of intangible assets included in accounts payable | 0 | 81,693 |
Purchase of property and equipment included in accounts payable | 0 | 22,557 |
Addition to contract assets included in accounts payable | 0 | 195,060 |
Settlement of accounts receivable on business acquisition | 0 | 1,744,400 |
Accretion interest on balance due on business combination | 173,350 | 110,204 |
Accretion interest on royalties receivable | 118,290 | 132,809 |
Accretion on term loan | 28,236 | 12,185 |
Fair value of HPQ warrants exercised | 0 | 9,181,250 |
Right-of-use assets | (311,421) | 2,157,796 |
Prepaid rent expense | 0 | (36,903) |
Lease liabilities | $ 867,110 | $ 2,120,893 |
Nature of operations
Nature of operations | 12 Months Ended |
Dec. 31, 2022 | |
Nature of operations [Abstract] | |
Nature of operations | 1. PyroGenesis Canada Inc. of the Canada treatment systems technology and designs, sustainable solutions to reduce greenhouse gases. The Company is domiciled at 1744 William Street, Suite 200, Montreal, Quebec. The Company the symbol “PYR” and on the Frankfurt Stock Exchange (FSX) |
Going concern
Going concern | 12 Months Ended |
Dec. 31, 2022 | |
Going concern [abstract] | |
Going concern | 2. These Company will be liabilities in the normal course of business for the foreseeable The Company is the successful signing and delivery of contracts and access The Company the Company has 93,384,858 61,217,831 Furthermore, there have been unexpected delays in the collection of certain accounts receivable from contracts closed in a prior year. This has operations. As 1,650,709 14,006,785 including cash and 3,445,649 12,202,513 an allowance for credit losses amounting to $ 5,023,283 520,000 9 and 10. The Company’s payments from certain contracts as reduction in certain operating expenses. In the absence of this, the Company is dependent upon raising additional funds to finance operations within the past convertible debentures. 1,318,980 also 5,000,000 successful in securing the Company’s will conditions indicate continue operating as a going concern. The consolidated financial to the amounts and to classifications of the assets and liabilities that might be necessary should the Company be unable to achieve its plan and continue in business. If the going concern assumption were not appropriate, adjustments, be material, would be necessary to the carrying value of assets and liabilities, the reported expenses, and the classification of items on the consolidated statement of financial position. |
Basis of preparation
Basis of preparation | 12 Months Ended |
Dec. 31, 2022 | |
Basis of preparation [Abstract] | |
Basis of preparation | 3. (a) These financial statements have been prepared issued by for issuance by the Board of Directors on March 30, 2023. (b) These consolidated financial Drosrite International the functional currency of Airscience Technologies (c) These financial statements have been prepared on the historical (i) (ii) 2, Share-based Payment; and (iii) (d) For financial reporting purposes, subsidiaries are defined as entities controlled by the Company. entity when it entity; and it has the ability to affect those returns through In instances whether or not of the shareholder’s and/or other agreements, it makes most of These consolidated LLC and Pyro Green-Gas Inc. and its subsidiaries. Drosrite International LLC is owned by a member of the Company’s key management personnel and close member of is deemed to be controlled by the Company. Technologies Private Limited were acquired between the Company and its subsidiaries have been eliminated The statements of all years loss from operations in the consolidated statements of |
Significant accounting policies
Significant accounting policies | 12 Months Ended |
Dec. 31, 2022 | |
Significant accounting policies [Abstract] | |
Significant accounting policies | 4. (a) Business combinations are accounted of the consideration transferred over the all measured at the acquisition date. The consideration transferred is measured as the net of the fair values of assets transferred, instruments consideration arrangement, in exchange of the acquiree. The obligation to pay the contingent consideration provision. Changes in fair values that qualify as measurement period adjustments of preliminary purchase price allocations are adjusted in the current period and such changes are Acquisition costs incurred, except for costs associated with the issuance (b) Revenue from depending on which method reflects the transfer of control of the goods and services underlying the particular performance obligation. i) Long-term contracts basis. terminated by the customer, the Company reimbursement of the costs deliverables require the Company to determine whether they contain separately identifiable performance obligations and to allocate the consideration received to each performance Revenue Company’s efforts or inputs of completion and/or hours anticipated performance, transaction price and profit margin, when certain conditions are met. Estimates are required amount of expected loss, if any, Contract modifications are changes in scope and/or price that are approved by the parties to the contract. Approval may written, modifications as a separate stand-alone modifications are accounted for as part of the original contract. Costs and exchange for whether such right is only (costs and profits under the contract. Billings in excess of costs and contractually receivable by the Company that exceeds the right under a given contract. The costs selling expenses over time based on degree of completion ii) Revenue related to sales of goods, which may specified in contracts goods to transferred to the custody transfer point agreed with the customer. iii) Sale of to the sale of intellectual property is recognized to the extent that it uncertainty associated with the variable consideration (c) i) Revenue and expense transactions in foreign using the the functional non-monetary items. Translation gains ii) The assets and end Exchange translation adjustments in other comprehensive income and (d) Cash and significant risk of the date of withdrawal within a three-month period from the date (e) Inventory is composed of spare of estimated selling price in the ordinary course of business, (f) i) Current tax assets and liabilities for the current and prior years are measured at the amount expected to be recovered from or paid substantively enacted by the date of the consolidated statements iii) Deferred tax is provided using the liability method, providing for temporary differences between the tax liabilities and their carrying if it arises from the initial recognition business combination that at the time of the transaction affects neither accounting deferred tax liabilities, using tax is expected over the period in which the deferred tax is extent that it is probable that future taxable profits will Deferred tax assets enforceable right and liabilities entities which intend to settle the liabilities and assets on a net (g) The Company dividing net earnings per share is is increased number of additional shares the Potential shares from loss per share as their inclusion is considered anti-dilutive in (h) Property applicable. Cost includes expenditures that operation. Borrowing effective interest profit and loss. Government assistance equipment useful lives, they are accounted for separately. Property and equipment are depreciated from the acquisition date respective useful life. location and condition necessary for it to be capable of Depreciation is calculated using the following methods Impairment losses recognized in prior that the previously recognized losses may no longer exist or may be decreased. An impairment loss is reversed only to the extent depreciation, had no impairment loss been recognized for the Property and equipment are assessed for impairment Depreciation methods, useful lives and residual if appropriate. (i) Under IFRS 16 Leases, at the contract conveys the right to control the use of an identified The Company recognizes a right-of-use asset and underlying asset is available for use. Right-of-use assets Right-of-use adjusted for any remeasurement of lease liabilities. Cost - - - - restore the underlying asset to the condition required by Right-of-use assets are a lease transfers ownership to exercise a purchase option, on assessed for impairment whenever there is an indication that Lease liabilities Lease liabilities are date over the lease term. The present value of the lease payments is determined rate at rate is the borrowing rate any specified rate, and payments of to terminate the lease. Lease payments also include amounts expected to be exercise price of a purchase option if the Company is reasonably Variable liabilities but occurs. After the reduced to reflect lease payments made. change in future terms and conditions, a change in the estimate of the remeasurement amount of loss statement when the carrying amount of the right- Classification and presentation of lease-related expenses Depreciation charge for right-of-use assets, expenses of lease based on their function within the Company, Cash flow classification Lease payments related while lease from payments not included in the measurement of lease (j) Investment assistance and investment as a reduction of the related expense or cost customary assessments are received. (k) Intangible assets are carried at cost less any accumulated amortization Identifiable intangible assets definition of an intangible their acquisition-date fair value. Subsequent to initial recognition, identifiable intangible assets acquired in a business combination are accumulated impairment losses. The useful lives of intangible assets Intangible assets with finite is consolidated statements of comprehensive loss. Research Development costs unless they meet specific criteria related to technical, market and financial feasibility in order to be recognized as intangible assets which include: - - - - - Costs comprehensive loss in the year they are feasibility. Patent costs Amortization patent impairment. Residual values and useful lives are reviewed Amortization is calculated on a straight-line basis: Goodwill represents the future separately tested for impairment be reversed. (l) The carrying there is an indication of impairment. If any such indication For impairment assessment purposes, assets are inflows (cash cash-generating unit level. Goodwill is allocated to those of goodwill. Cash-generating units to which goodwill assets carrying amount may not be recoverable. The recoverable amount costs to sell. tax discount For the purposes of testing non-financial assets for one An impairment loss is losses are the CGU are allocated first to reduce the carrying amount of goodwill allocated to the units, and then to reduce the carrying amounts on a pro-rata basis of the other assets in the (m) Provisions for legal constructive obligation as a result of a past event, it is probable that an outflow of economic resources will be required from the Company and amounts can be estimated reliably. Provisions are measured at the estimated evidence available at the reporting date, including the risks and uncertainties associated with the there considering the class money is material. No situations are disclosed as contingent liabilities unless (n) Share-based payments The Company applies a fair options are measured Non-employee stock options received if the the services are measured options is presented consideration received Black-Scholes option-pricing model to estimate the fair value Deferred profit-sharing plan The Company and employee to the prosperity and profits of the Company for purposes of eligibility in the DPSP is determined by the Board of Directors of the Company persons to the Company are excluded from participating in For all eligible of the Company’s contribution will be such amount which, in the opinion of its Board of Directors, is and overall financial Nil Nil Obligations for contributions of comprehensive loss in the periods during which services Short-term employee benefits Short-term employee benefit obligations is provided. A liability is legal or constructive obligation can be estimated reliably. (o) Issuance of equity instruments Incremental common allocate the net proceeds between common shares and Extinguishing financial liabilities with equity instruments When Company measured. If the fair be measured to reflect the fair value of the financial liability Contributed surplus Contributed exercised or settled, in which case the amounts are transferred It also includes the unexercised conversion option at the (p) Recognition: The Company the instrument. Purchases regulation or Company commits to purchase or sell the asset. Classification Financial comprehensive contractual cash flow characteristics of these assets. accounting judgment. A financial assets in order to collect contractual cash flows and its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. The Company and cash equivalents, trade accounts receivable, other receivables, A financial asset is measured at fair value through profit or (a) (SPPI) on the principal amount outstanding; or (b) contractual cash flows and sell; or (c) reduces a measurement or recognizing the gains and losses on them on different The Company includes in this category strategic investments All financial liabilities, measured at liabilities and term loans. The balance due on business Initial measurement Financial assets and attributable incremental costs of acquisition or issue. Financial assets value. All transaction costs for such instruments are recognized Subsequent measurement Financial assets (other than financial assets at FVTPL) are measured at amortized less derecognized or impaired, as well as through the amortization Financial liabilities are liabilities designated at well as through own credit risk are to be presented in other comprehensive Fair value measurement principles Fair value is the price that would be received to sell market participants at the measurement date. Where financial assets and market at the reporting date, market if regularly occurring market transactions on an arm’s Securities traded on stock exchanges are stated at market Derecognition A financial asset is derecognized transferred its under the liability is discharged, cancelled, Offsetting of financial instruments Financial assets and financial position if, and only if, there is a currently enforceable to settle on a net basis, or to realize the assets and settle Impairment of financial instruments The Company’s financial costs and profits in excess of billings on uncompleted The trade accounts receivable have no financing component and, receivable. Therefore, the Company recognizes a loss The Company’s supportable conditions, and forecasts of future economic conditions. The Company profits in excess of billings on uncompleted contracts, based on days past due for patterns. Contracts with particular on historical observed loss rates over the expected life of the receivables and are adjusted for forward-looking estimates to reflect differences between economic conditions Impairment receivables and cost in excess of billings on uncompleted Write-off The recovering a financial asset in its entirety or a portion thereof. Failure to engage and communicate with within 90 receivable. Effective Interest Method The allocating estimated effective instrument, or (when appropriate) a shorter period, to the net (q) i) Presentation of Financial Statements - Accounting Policies In accounting policy information rather than their significant accounting policies. Additional amendments to IAS 1 are made to explain how an entity can identify beginning on or after January 1, 2023, with earlier application ii) Presentation of Financial Statements - Classification of Liabilities The guidance in IAS 1 Presentation current amendment is effective iii) The IASB released 12). The amendment relates decommissioning obligations, by recognizing both an asset and a liability. The objective of this amendment is to narrow the initial recognition exemption both taxable and deductible temporary differences, the application permitted. iv) Provisions, Contingent Liabilities and Contingent Assets The IASB which costs an is onerous. costs of fulfilling the contract and an allocation effective for annual reporting periods beginning The Company has determined that the adoption of these standards or amendments will not have a significant impact on its consolidated financial statements as of the date of adoption. Computer equipment Straight line over 3 years Machinery and equipment Straight line over 10 years Automobiles Straight line over 7 years Leasehold improvements Lesser of the lease term or the useful life ( 20 years ) Useful life Production backlog 30 months Patents and development costs 1 21 years |
Significant accounting judgment
Significant accounting judgments, estimates and assumptions | 12 Months Ended |
Dec. 31, 2022 | |
Significant accounting judgments, estimates and assumptions [Abstract] | |
Significant accounting judgments, estimates and assumptions | 5. The preparation of based on liabilities at the reporting period. other factors, including expectations of future events actual uncertainty and the effect of any changes in estimates In the process of applying the Company’s and assumptions which Critical judgments in applying accounting policies (a) may be impaired At each reporting date, intangible assets exists, then the is any indication that an asset may be impaired. (b) The recognition of development costs as intangible recognition are met including management estimates of future (c) The recognition determine consideration is subsequently resolved. (d) The investment tax credits are estimated of various government programs, eligibility and final assessment by taxation authorities of investment technical staff claims. Key sources of estimation uncertainty (e) Revenue recognition for long-term contracts completion requires the use of estimates to determine the recorded amount of revenues, costs in excess of billings and billings in excess The determination of anticipated factors, subcontractors. As risks and incurred will also vary by project. The determination its historical experience. Estimates are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised. Given recognized amount of revenues Agreements that identifiable performance obligations and to allocate the consideration (f) The Company uses the Estimating fair value dependent valuation model including the 22. (g) The Company estimates the assets are expected to be available are reviewed periodically and are updated legal or other and intangible assets are based of above. The circumstances. Useful lives, depreciation and amortization (h) In assessing impairment, expected future cash flows and uses an interest rate to discount them. Estimation uncertainty relates to assumptions about future operating results and the determination of a suitable (i) Where the fair active markets, models are taken from observable markets where possible, but where in establishing the fair values. The judgments allocation of the consideration paid between the fair value of the common shares and warrants inputs to these models or changes in assumptions about investments. (j) In determining non-cancellable term of the lease of the related assets, and incremental borrowing management is reasonably certain to renew. rates and similar property values. The portfolio of leased assets with similar characteristics determines the incremental borrowing rate using the base (k) The Company has unused available tax recognizes deferred income tax assets for these unused tax losses and deductible temporary differences only to the extent that, in losses and temporary differences assurance generate future federal income taxes future taxable profit future sales of future recoverability of these deferred tax in the carrying value of to net loss. (l) Fair value of assets acquired and liabilities assumed in a at assets acquired and liabilities the determination of the and timing of completing the predetermined milestones (m) COVID-19 pandemic The COVID-19 with various cities and has experienced during the impact may be on the Company’s business, |
Business combination
Business combination | 12 Months Ended |
Dec. 31, 2022 | |
Business combination [Abstract] | |
Business combination | $ Total consideration Consideration paid at closing 1 Contingent consideration 3,841,999 Consideration paid at closing and continent consideration 3,842,000 Settlement of pre-existing loan receivable from Pyro Green-Gas 1,744,400 5,586,400 Net assets acquired Current assets 1 5,186,086 ROU asset 477,608 Property and equipment 42,552 Intangible assets and Goodwill 2 4,780,607 Deferred income tax asset 79,360 Current liabilities (4,507,907) Non-current liabilities (471,906) 5,586,400 6. On August 11, 2021, the Company completed the company controls, for 4,355,600 In addition, the Company settled 1,744,000 . The transaction was executed acquisition compared acquisition will provide potential synergies with the Company’s land-based waste will Company’s assessment 30 months the date of the acquisition. The contingent consideration 8 %. The acquisition was accounted for using the purchase 1 Includes $ 807,946 3,255,000 , including an allowance for expected credit losses of $ 512,592 . 2 The goodwill of $ 2,660,607 the expertise of the workforce, and it is not expected to be deductible for tax purposes. During the 6,800,090 related to the operations generated by Pyro Green-Gas In connection with 101,157 , recognized within General and Administrative expenses in the 2021 consolidated The 4,355,600 3,841,999 , accretion expense of $ 173,350 for the year 110,204 December 31, 2021. |
Revenues
Revenues | 12 Months Ended |
Dec. 31, 2022 | |
Revenues [Abstract] | |
Revenues | 2022 2021 $ $ Revenue from contracts with customers by product High purity metallurgical grade silicon & solar grade silicon from (PUREVAP™) 6,272,697 6,138,111 Aluminium and zinc dross recovery (DROSRITE™) 1,912,807 7,940,771 Development and support related to systems supplied to the 1,288,356 7,522,809 Torch 5,558,210 2,084,511 Biogas upgrading and pollution controls 3,347,443 6,800,090 Other sales and services 633,990 582,058 19,013,503 31,068,350 2022 2021 $ $ Revenue from contracts with customers: Sales of goods under long-term contracts recognized over 13,997,163 25,918,594 Sales of goods at a point of time 1,135,498 1,533,910 Other revenue: Sale of intellectual properties (i) 3,600,000 3,300,000 Royalties 280,842 315,846 19,013,503 31,068,350 7. Revenues by product line: The company’s revenues are generated primarily The following is a summary of the Company’s See note 32 for sales by geographic area. (i) During the year, the Company sold for 3,600,000 . transferred intellectual property. In June 2021, the Company for 3,300,000 . transferred intellectual property. on the 10 % of 50,000 100,000 150,000 2025, and $ 200,000 Transaction price As unsatisfied (or partially satisfied) at the reporting 26,741,550 34,258,148 , excluding a contract which was terminated in the fall term contracts, which is expected to occur over the 3 |
Cash and cash equivalents
Cash and cash equivalents | 12 Months Ended |
Dec. 31, 2022 | |
Cash and cash equivalents [Abstract] | |
Cash and cash equivalents | 2022 2021 $ $ Cash 3,445,649 3,568,561 Guaranteed investment certificates — 8,633,952 Cash and cash equivalents 3,445,649 12,202,513 Guaranteed investment certificates were from 0.08 % to 0.86 %, and held to maturity or were redeemed during the 8. As at no include the following components: |
Accounts receivable
Accounts receivable | 12 Months Ended |
Dec. 31, 2022 | |
Accounts receivable [Abstract] | |
Accounts receivable | 9. Details of accounts receivable based on past due terms As 4,693,283 $ 520,000 ), $ 543,283 $ 4,150,000 3,765,000 customer, whereby the carrying amount has been 12,810,231 9,045,231 . The carrying value of all other trade receivables was reduced from $ 9,887,011 8,958,728 . On the basis of the Company’s expected the allowance was determined generally by applying a loss rate of 1 % on balances 1-30 days past the invoice date, 2 % for 31-60 days, 3 % for 10 % for situations where terms. The closing balance of the trade credit loss allowance opening balance as follows: December 31, December 31, 2022 2021 $ $ Current 6,578,269 1,919,786 1 – 30 days 15,959 32,028 31 – 60 days 57,944 7,006,652 61 – 90 days 718,239 788,330 Greater than 90 days 13,790,716 6,317,239 Holdback receivable 1,536,115 974,878 Total 22,697,242 17,038,913 Allowance for expected credit loss (4,693,283) (520,000) Other receivables 240,560 270,536 Sales tax receivable 380,112 850,167 18,624,631 17,639,616 Opening allowance January 1, 2021 — Business combination 512,592 Foreign exchange 7,408 Loss allowance at December 31, 2021 520,000 Loss recognized during the year 4,150,000 Foreign exchange 23,283 Loss allowance at December 31, 2022 4,693,283 |
Costs and profits in excess of
Costs and profits in excess of billings on uncompleted contracts | 12 Months Ended |
Dec. 31, 2022 | |
Costs and profits in excess of billings on uncompleted contracts [Abstract] | |
Costs and profits in excess of billings on uncompleted contracts | 10. As at December 31, 2022, the Company had eighteen 10,475,299 costs 11,856,596 fourteen 16,676,700 revenue of $ 21,599,410 The net amount 1,051,297 330,000 Nil at December 31, by applying a 2 % on all the loss rate varied from 25 % to 50 %. Changes in 4,164,109 (2021 - 983,891 ) 622,696 $ 4,832,968 ) resulting from changes in the measure of progress and the expected credit loss allowance of 330,000 Nil 2021). |
Investment Tax Credits
Investment Tax Credits | 12 Months Ended |
Dec. 31, 2022 | |
Investment tax credits [Abstract] | |
Investment tax credits | 11. An amount recognized 169,434 202,472 ) of investment as $ Nil 706,000 ) of 2021. $ 70,258 148,695 ) of and 69,176 684,709 )) 30,000 32,486 ) against selling general and administrative expenses. Eligible 2,783,450 (2021 – $ 2,000,853 ) less 169,434 ) (2021 684,709 )), less 296,043 (2021 – $ 149,575 ) totalling $ 2,317,973 2,535,987 ). |
Strategic investments
Strategic investments | 12 Months Ended |
Dec. 31, 2022 | |
Strategic investments [Abstract] | |
Strategic investments | December 31, December 31, 2022 2021 $ $ Beauce Gold Fields (“BGF”) shares – level 1 56,419 123,095 HPQ Silicon Inc. (“HPQ”) shares - level 1 5,415,749 12,306,196 HPQ warrants – level 3 770,466 2,472,368 6,242,634 14,901,659 (“BGF”) shares – level 1 (“HPQ”) shares - level 1 HPQ warrants – level 3 Quantity $ Quantity $ Quantity $ Balance, December 31, 2020 1,025,794 123,095 14,990,200 16,489,220 25,844,600 23,379,435 Additions — — 8,268,000 8,070,109 — — Exercised — — 16,250,000 11,700,000 (16,250,000) (9,181,250) Disposed — — (12,755,600) (14,252,732) — — Change in the fair value — — — (9,700,401) — (11,725,817) Balance, December 31, 2021 1,025,794 123,095 26,752,600 12,306,196 9,594,600 2,472,368 Additions — — 6,800,000 3,196,000 6,800,000 408,000 Disposed — — (11,447,500) (3,922,244) — — Change in the fair value — (66,676) — (6,164,203) — (2,109,902) Balance, December 31, 2022 1,025,794 56,419 22,105,100 5,415,749 16,394,600 770,466 Number of Number of warrants warrants Exercise Expiry date Dec 31, 2021 Additions Exercised Dec 31, 2022 price ($) April 29, 2023 1,200,000 — — 1,200,000 0.10 June 2, 2023 4,394,600 — — 4,394,600 0.10 September 3, 2023 4,000,000 — — 4,000,000 0.61 April 20, 2024 — 6,800,000 — 6,800,000 0.60 9,594,600 6,800,000 — 16,394,600 Number of warrants 6,800,000 Date of issuance April 20, 2022 Exercise price ($) 0.60 Assumptions under the Black-Scholes model: Fair value of the shares ($) 0.47 Risk-free interest rate (%) 2.47 Expected volatility (%) 107.60 Expected dividend yield – Contractual remaining life (number of months) 24 2022 2021 Number of warrants 1,200,000 4,394,600 4,000,000 6,800,000 1,200,000 4,394,600 4,000,000 Date of issuance April 29, 2020 June 2, 2020 Sept. 3, 2020 April 20, 2022 April 29, 2020 June 2, 2020 Sept. 3, 2020 Exercise price ($) 0.1 0.1 0.61 0.60 0.1 0.1 0.61 Assumptions under the Black- Scholes model: Fair value of the shares ($) 0.25 0.25 0.25 0.25 0.46 0.46 0.46 Risk-free interest rate (%) 4.03 4.03 4.03 4.03 1.22 1.22 1.22 Expected volatility (%) 80.55 73.74 76.85 74.58 89.88 94.01 110.47 Expected dividend yield – – – – – – – Contractual remaining life (in months) 4 5 8 16 16 17 20 12. The change in the strategic investments is summarized as The Company owns 9.82 % on a 9.64 %) and has transactions with this entity– see notes 7(i) and 13. The following table sets out the details and activity of the HPQ 2022 Transactions 6,800,000 6,800,000 3,604,000 2022. 11,447,500 3,922,244 $ 225,527 . 2021 Transactions 12,755,600 14,252,732 $ 9,893,900 . 16,250,000 2,518,750 . An amount of $ 9,181,250 8,268,000 8,070,109 . At inception, the model using the following assumptions: As pricing model using the following assumptions: As at December 31, 2022, a gain from 280,926 510,573 off balance sheet until realized. |
Royalties receivable
Royalties receivable | 12 Months Ended |
Dec. 31, 2022 | |
Royalties receivable [Abstract] | |
Royalties receivable | December 31 December 31 2022 2021 $ $ Opening balance 1,258,654 1,060,000 Accretion interest 118,290 132,809 Royalties recognized during the year 450,000 450,000 Discounting (169,158) (134,155) Amounts received during the year (250,000) (250,000) Balance at end of the year 1,407,786 1,258,654 Current portion 455,556 311,111 Non-current portion 952,230 947,543 1,407,786 1,258,654 13. The Company subsidiary, contract”) in 2021. The of $ 1,000,000 2,400,000 3,300,000 the form of royalty payments: HPQ 2016 contract: Royalties 10 % 200,000 250,000 thereafter. 250,000 received under this agreement in 2022 ($ 200,000 HPQ Nano contract: Royalties 10 % of 50,000 100,000 150,000 $ 200,000 Powders Inc. An amount of $ Nil 50,000 HPQ Polvere contract: Royalties 10 % 50,000 100,000 150,000 $ 200,000 are due no later than 10 days after the year end of HPQ During the 250,000 200,000 2016 contract 12.5 % discount rate. During the 250,000 200,000 2016 contract 12.5 % discount rate. The Company period(s) consideration collectability of the minimum royalties is probable, which The HPQ Nano contract the future 50 % equity Polvere subsequently remeasured had a fair value of $ Nil Nil |
Deposits
Deposits | 12 Months Ended |
Dec. 31, 2022 | |
Deposits | |
Deposits | December 31 December 31 2022 2021 $ $ Current portion: Suppliers 392,309 1,236,211 Security deposit on leased premises 40,241 92,241 Total 432,550 1,328,452 Non-current portion: Suppliers 7,250 1,952 Security deposit on leased premises 38,803 246,804 Total 46,053 248,756 Total 478,603 1,577,208 14. |
Property and equipment
Property and equipment | 12 Months Ended |
Dec. 31, 2022 | |
Property and equipment. | |
Property and equipment | 15. Property and equipment (1) The adjustment to 89,085 , relates to loan from the Economic Development Agency of Canada, Equipment under new Plasma Powder Production equipment which have been Machinery Equipment Computer and Leasehold under equipment equipment Automobiles improvements construction Total $ $ $ $ $ $ Cost Balance at December 31, 2020 549,659 1,621,899 306,164 180,901 1,940,234 4,598,857 Acquired through business combination 13,585 28,967 — — — 42,552 Additions 245,984 384,092 30,495 752,204 84,143 1,496,918 Balance at December 31, 2021 809,228 2,034,958 336,659 933,105 2,024,377 6,138,327 Additions (1) 164,059 (89,085) — 209,435 — 284,409 Assets under construction put in service — 1,065,672 — 958,705 (2,024,377) — Balance at December 31, 2022 973,287 3,011,545 336,659 2,101,245 — 6,422,736 Accumulated depreciation Balance at December 31, 2020 509,112 1,441,642 21,748 96,785 — 2,069,287 Depreciation 88,410 182,739 59,959 24,995 — 356,103 Balance at December 31, 2021 597,522 1,624,381 81,707 121,780 — 2,425,390 Depreciation 146,550 297,021 57,543 102,780 — 603,894 Balance at December 31, 2022 744,072 1,921,402 139,250 224,560 — 3,029,284 Carrying amounts Balance at December 31, 2021 211,706 410,577 254,952 811,325 2,024,377 3,712,937 Balance at December 31, 2022 229,215 1,090,143 197,409 1,876,685 — 3,393,452 |
Leases
Leases | 12 Months Ended |
Dec. 31, 2022 | |
Leases | |
Leases | 16. Leases The Company has entered into lease contracts mainly for buildings through impose any financial covenants. On January 1, 2022, a lease for rent the $ 1,070,264 1,178,530 2020. At 4 %. As liability was increased by an amount of $ 1,070,264 108,267 . On September option of the property, 275,000 liability was remeasured using a discount rate of 8.6 % and the lease liability and the right-of-use assets were decreased by $ 203,154 . a) Right-of-use assets b) The table below summarizes changes to the lease liabilities: c) Amount recognized in the consolidated statements of comprehensive d) Maturity analysis – contractual undiscounted cash flows Land and Computer building equipment Total $ $ $ Balance at January 1, 2021 3,688,315 12,685 3,701,000 Additions - business combination 477,608 — 477,608 Additions 2,157,796 — 2,157,796 Depreciation (566,182) (4,228) (570,411) Balance at December 31, 2021 5,757,537 8,457 5,765,993 Modification of lease agreements (311,421) — (311,421) Depreciation (631,600) (4,228) (635,828) Balance at December 31, 2022 4,814,516 4,229 4,818,744 $ Balance at January 1, 2021 2,988,542 Addition - business acquisition 477,608 Additions - other 2,120,893 Payments (263,078) Balance at December 31, 2021 5,323,965 Modification of lease agreements 867,110 Payments (657,381) Balance at December 31, 2022 5,533,694 Current portion 2,934,236 Non-current portion 2,389,729 Balance at December 31, 2021 5,323,965 Current portion 2,672,212 Non-current portion 2,861,482 Balance at December 31, 2022 5,533,694 2022 2021 $ $ Depreciation of right-of-use assets 635,828 570,411 Interest on lease liabilities 378,611 307,691 Expense related to lease payments excluded in the measurement liabilities 243,209 178,707 $ 2023 2,984,243 2024 592,719 2025 572,562 2026 474,484 2027 229,332 Thereafter 1,891,989 6,745,329 |
Intangible assets
Intangible assets | 12 Months Ended |
Dec. 31, 2022 | |
Intangible assets. | |
Intangible assets | 17. Intangible assets The Company’s development costs have been incurred to develop plasma-related technologies and the patents protect the design and specification of these technologies. Production Development backlog Patents costs Total $ $ $ $ Cost Balance at December 31, 2020 — 768,392 244,871 1,013,263 Acquired through business combination 2,120,000 — — 2,120,000 Additions — 214,497 — 214,497 Write-off — (85,544) — (85,544) Balance at December 31, 2021 2,120,000 897,345 244,871 3,262,216 Additions — 208,680 — 208,680 Balance at December 31, 2022 2,120,000 1,106,025 244,871 3,470,896 Accumulated amortization Balance at December 31, 2020 — 58,125 49,524 107,649 Amortization 353,333 10,528 16,508 380,369 Balance at December 31, 2021 353,333 68,653 66,032 488,018 Amortization 848,000 13,522 16,508 878,030 Balance at December 31, 2022 1,201,333 82,175 82,540 1,366,048 Carrying amounts Balance at December 31, 2021 1,766,667 828,692 178,839 2,774,198 Balance at December 31, 2022 918,667 1,023,850 162,331 2,104,848 |
Goodwill
Goodwill | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill | |
Goodwill | 18. Goodwill The Goodwill is considered impaired if the recoverable amount The recoverable five-year forecast, followed rate determined by management. The present value of the expected applying a suitable discount rate reflecting current market assessments of the time value of money and risks specific to the segment. For expected recoverable value. At December no impairment was required. pre-tax discount rate of 12.5 % and terminal growth rate of 2 % (2021 - pre-tax discount rate of 8 % and terminal growth rate of 2 %). |
Accounts payable and accrued li
Accounts payable and accrued liabilities | 12 Months Ended |
Dec. 31, 2022 | |
Accounts payable and accrued liabilities | |
Accounts payable and accrued liabilities | December 31 December 31 2022 2021 $ $ Accounts payable 6,065,996 5,457,259 Accrued liabilities 2,891,053 3,730,048 Sale commissions payable 1 904,724 737,364 Accounts payable to the controlling shareholder and CEO 254,097 144,506 10,115,870 10,069,177 19. Accounts payable and accrued liabilities 1 Sale commissions payable relate to the costs to obtain long-term |
Billings in excess of costs and
Billings in excess of costs and profits on uncompleted contracts | 12 Months Ended |
Dec. 31, 2022 | |
Billings in excess of costs and profits on uncompleted contracts | |
Billings in excess of costs and profits on uncompleted contracts | 20. Billings in excess of costs and The amount amounted to $ 37,374,909 21,834,137 ). Payments to date received were $ 47,045,902 31,234,368 ). Changes in 2,416,229 (2021 - $ 6,268,910 ) recognized at 2,686,991 (2021 - $ 9,076,169 ) resulting from cash received excluding amounts |
Term loans
Term loans | 12 Months Ended |
Dec. 31, 2022 | |
Term loans | |
Term loans | Economic Development Agency Other Term Other Term Canada Emergency Business of Canada Loan 1 Loans 2 Loans 3 Account Loan 4 Total $ $ $ $ $ Balance, December 31, 2020 75,800 36,907 — — 112,707 Assumed through business combination — — 36,520 50,000 86,520 Accretion 12,185 — — — 12,185 Payments — (12,207) (8,300) — (20,507) Balance, December 31, 2021 87,985 24,700 28,220 50,000 190,905 Additions 292,941 292,941 Discounting (89,085) — — — (89,085) Accretion 28,229 — — — 28,229 Payments — (13,083) (19,920) — (33,003) Balance, December 31, 2022 320,070 11,617 8,300 50,000 389,987 Less current portion — (11,617) (8,300) (50,000) (69,917) Balance, December 31, 2022 320,070 — — — 320,070 21. Term 1 2 maturing October 23, 2023 6.95 % per 1,200 amount of $ 10,795 3 1,660 , bearing interest at 7.45 % 4 no no Economic Development Agency of Canada Loan On 450,000 Economic contribution is 60 24 months During 292,941 . discounted using the effective 8 % as it is non-interest discounted 89,085 reduction of the property and equipment. Canada Emergency Business Account ("CEBA") Loan The Company's loan. The loan no no by December 31, 24 -month term bearing interest at 5 % and be reimbursed entirely by December 31, 2025. |
Shareholders' equity
Shareholders' equity | 12 Months Ended |
Dec. 31, 2022 | |
Shareholders' equity | |
Shareholders' equity | 22. Shareholders’ equity Common shares and warrants Authorized: The Company is authorized to issue an unlimited number Issuance of units On October 19, 1,014,600 of $ 1.30 1,318,980 . Each unit one of the Company one one additional common 1.75 24 months . The Company of $ 1,095,780 1.08 residual amount of $ 223,200 Shares issued upon exercise of stock options, share During the year 2,440,000 3,482,000 8,146,483 purchase 1,412,799 Nil 1,109,818 12,396,107 respectively. contributed surplus of $ 870,558 364,000 191,414 deal in 2020, were exercised for net proceeds of $ 689,090 . Share redemptions for cancellation In January subject to the 5,000,000 to January 7,500,000 common shares from February 15, 2022, to February 14, 2023. During the year 2022, the no t repurchase any common shares for under no obligation to repurchase its common shares as During the year 840,094 $ 4.96 4,183,617 16,678 . The consideration over the carrying amount of the shares, 3,778,619 The repurchases were made in the normal course of business at market prices through the no obligation to repurchase its common shares as at December Stock options The Company has and consultants to acquire common shares of the Company at a price computed by reference the shares of the The number 5 % ( 2 % for capital over a twelve-month period. The following table sets out the activity in stock options: (1) 1.44 5.48 Grants in 2022 On 150,000 Company, 300,000 $ 3.36 5 ) years. On April 5, 400,000 exercise price of $ 2.96 400,000 10 20 30 and 40 of five ( 5 ) years. On June 2, 2022, 600,000 and 900,000 1,500,000 25 of the day of the grant, 25 25 the date 25 price of $ 3.88 5 ) years. On July 3, 125,000 exercise price of $ 2.14 125,000 10 20 30 and 40 of five ( 5 ) years. Subsequent to 150,000 Company, 500,000 $ 1.03 5 ) years. for an expense amounting to $ 453,204 and there was a shared understanding of the terms and The Company also granted 975,000 of $ 1.03 975,000 10 20 the first anniversary of the 30 40 on the third anniversary of the date 5 ) years. There was no expense accounted for in 2022 relating to Grants in 2021 On 100,000 options have an exercise 3.61 5 ) years. On December 17, 2021, the Company 1,920,000 Company. The stock options have an exercise 3.13 a period of five ( 5 ) years. On October 14, 2021, the 100,000 options have an exercise 5.04 100,000 10 day of the grant, 20 30 of the 40 5 ) years. On June 14, 100,000 exercise price of $ 6.70 100,000 25 25 percent at the 25 25 at the third anniversary of the date of grant and are exercisable 5 ) years. On June 1, 200,000 have an exercise price of 6.59 200,000 25 grant, 25 25 25 5 ) years. On April 6, 2021, the 150,000 100,000 200,000 100,000 the Company. 8.47 250,000 immediately, 200,000 30 35 of the date 35 100,000 will vest 10 20 30 percent at the second anniversary 40 All options mentioned above are exercisable over a period of 5 ) years. The weighted average fair value of stock options granted 2.37 2.99 and $ 2.02 granted was option pricing model based on the following weighted-average The underlying expected volatility was determined by reference to historical features inherent to the stock options granted were incorporated As at December 31, 2022, and consultants for the purchases of one common share (1) 3.96 . As at December 31, 2021, and consultants for the purchases of one common share For 5,538,463 9,762,745 ) recorded in Selling, general and administrative expenses As at December 31, 3,184,866 2,719,354 ) remains to to the grant of stock options. Share purchase warrants The following and outstanding share purchase warrants at December The following and outstanding share purchase warrants at December Weighted Number of average options exercise price $ Balance – December 31, 2020 9,040,000 1.57 Granted 2,970,000 4.55 Exercised (1) (3,482,000) 0.32 Forfeited (125,000) 4.41 Balance, December 31, 2021 8,403,000 3.10 Granted 2,475,000 3.55 Exercised (1) (2,440,000) 0.58 Forfeited (242,500) 4.07 Balance, December 31, 2022 8,195,500 3.96 Years ended December 31, 2022 2021 Number of options granted or recognized 2,475,000 650,000 2,970,000 Exercise price ($) 3.55 3.02 4.55 Fair value of each option under the Black-Scholes pricing ($) 2.37 2.02 2.99 Assumptions under the Black-Scholes model: Fair value of the shares ($) 3.54 3.02 4.52 Risk-free interest rate (%) 2.43 3.38 1.11 Expected volatility (%) 83.17 83.15 83.00 Expected dividend yield — — — Expected life (number of months) 60 60 60 Number of Number of Number of stock stock stock Exercise options options options price Dec 31, 2021 Granted Exercised Forfeitures Dec 31, 2022 vested (1) per option Expiry date $ November 3, 2017 2,400,000 — (2,400,000) — — — 0.58 November 3, 2022 July 3, 2018 300,000 — — — 300,000 300,000 0.51 July 3, 2023 October 29, 2018 40,000 — (40,000) — — — 0.52 October 29, 2023 September 29, 2019 100,000 — — — 100,000 100,000 0.51 September 29, 2024 January 2, 2020 100,000 — — — 100,000 100,000 0.45 January 2, 2025 July 16, 2020 2,243,000 — — (42,500) 2,200,500 1,775,500 4.41 July 16, 2025 October 26, 2020 250,000 — — (200,000) 50,000 37,500 4.00 October 26, 2025 April 6, 2021 550,000 — — — 550,000 410,000 8.47 April 6, 2026 June 1, 2021 200,000 — — — 200,000 100,000 6.59 June 1, 2026 June 14, 2021 100,000 — — — 100,000 50,000 6.70 June 14, 2026 October 14, 2021 100,000 — — — 100,000 30,000 5.04 October 14, 2026 December 17, 2021 1,920,000 — — — 1,920,000 1,920,000 3.13 December 17, 2026 December 30, 2021 100,000 — — — 100,000 30,000 3.61 December 30, 2026 January 3, 2022 — 450,000 — — 450,000 450,000 3.36 January 3, 2027 April 5, 2022 — 400,000 — — 400,000 40,000 2.96 April 5, 2027 June 2, 2022 — 1,500,000 — — 1,500,000 375,000 3.88 June 2, 2027 July 13, 2022 — 125,000 — — 125,000 12,500 2.14 July 13, 2027 8,403,000 2,475,000 (2,440,000) (242,500) 8,195,500 5,730,500 3.96 Number of Number of Number of stock stock stock Exercise options options options price Dec 31, 2020 Granted Exercised Forfeitures Dec 31, 2021 vested per option Expiry date $ November 3, 2017 2,420,000 — (20,000) — 2,400,000 2,400,000 0.58 November 3, 2022 July 3, 2018 300,000 — — — 300,000 300,000 0.51 July 3, 2023 October 29, 2018 70,000 — (30,000) — 40,000 40,000 0.52 October 29, 2023 September 29, 2019 200,000 — (100,000) — 100,000 100,000 0.51 September 29, 2024 January 2, 2020 100,000 — — — 100,000 100,000 0.45 January 2, 2025 July 16, 2020 2,450,000 — (82,000) (125,000) 2,243,000 1,775,500 4.41 July 16, 2025 October 26, 2020 250,000 — — — 250,000 125,000 4.00 October 26, 2025 April 6, 2021 — 550,000 — — 550,000 320,000 8.47 April 6, 2026 June 1, 2021 — 200,000 — — 200,000 50,000 6.59 June 1, 2026 June 14, 2021 — 100,000 — — 100,000 25,000 6.70 June 14, 2026 October 14, 2021 — 100,000 — — 100,000 10,000 5.04 October 14, 2026 December 17, 2021 — 1,920,000 — — 1,920,000 1,920,000 3.13 December 17, 2026 December 30, 2021 — 100,000 — — 100,000 100,000 3.61 December 30, 2026 9,040,000 2,970,000 (3,482,000) (125,000) 8,403,000 7,265,500 3.10 Number of Number of warrants warrants Exercise Dec 31, Dec 31, price per 2021 Issued Exercised Expired 2022 warrant Expiry date Issuance of units – October 19, 2022 — 1,014,600 — — 1,014,600 1.75 Oct 19, 2024 — 1,014,600 — — 1,014,600 1.75 Number of Number of warrants warrants Exercise Dec 31, Dec 31, price per 2020 Issued Exercised Expired 2021 warrant Expiry date $ Issuance of units – September 28, 2018 3,448,276 — (3,448,276) — — 0.58 January 28, 2021 Issuance of units – October 19, 2018 100,000 — (100,000) — — 0.58 February 13, 2021 Issuance of units – May 15, 2019 1,355,500 — (1,355,500) — — 0.85 May 15, 2021 Issuance of units – May 28, 2019 750,000 — (750,000) — — 0.85 May 24, 2021 Issuance of units – June 19, 2019 500,000 — (500,000) — — 0.85 June 19, 2021 Issuance of units – October 25, 2019 225,000 — (225,000) — — 0.75 October 25, 2021 Issuance of units – November 10, 2020 1,677,275 — (1,672,000) (5,275) — 4.5 November 10, 2022 Issuance of warrants – November 10, 2020 — — (95,707) — — 4.5 November 10, 2022 8,056,051 — (8,146,483) (5,275) — |
Supplemental disclosure of cash
Supplemental disclosure of cash flow information | 12 Months Ended |
Dec. 31, 2022 | |
Supplemental disclosure of cash flow information | |
Supplemental disclosure of cash flow information | 23. Supplemental disclosure of 2022 2021 $ $ Accounts receivable (985,015) (12,372,139) Costs and profits in excess of billings on uncompleted 3,871,413 (3,849,077) Inventory (988,821) (839,352) Investment tax credits receivable (19,891) 1,015,862 Royalties receivable (30,842) (65,845) Deposits 2,277,136 145,379 Contract assets (562,809) — Prepaid expenses (53,942) 39,111 Accounts payable and accrued liabilities 346,003 1,953,208 Billings in excess of costs and profits on uncompleted contracts 270,762 1,485,969 Income taxes 267,414 (99,072) 4,391,408 (12,585,956) |
Supplemental disclosure on comp
Supplemental disclosure on comprehensive income statement | 12 Months Ended |
Dec. 31, 2022 | |
Supplemental disclosure on comprehensive income statement | |
Supplemental disclosure on comprehensive income statement | 24. Supplemental disclosure on The amount 844,304 326,279 2021). The aggregate amortization 878,030 (2021 - $ 465,913 ) and was recorded in cost of sales and services. Depreciation 603,894 635,828 December 31, 2022, as 356,103 570,411 administrative. Employee 18,115,284 21,855,957 ) based compensation of $ 5,538,463 9,762,745 ). The Company receivable. The 204,791 226,420 ). An $ Nil 149,575 ) was $ 204,791 76,845 ) was recorded as a reduction to the related expenses |
Net finance costs
Net finance costs | 12 Months Ended |
Dec. 31, 2022 | |
Net finance costs | |
Net finance costs | 25. Net finance costs 2022 2021 $ $ Financial expenses Interest on term loans 3,198 87,775 Interest on lease liabilities 378,611 307,691 Interest accretion on balance due on business combination 173,350 110,204 Interest accretion on long term loans 28,229 12,185 Penalties and other interest expenses 85,644 19,324 669,032 537,179 Financial income Interest accretion on royalty receivable (118,290) (132,809) Net finance costs 550,742 404,370 |
Loss per share
Loss per share | 12 Months Ended |
Dec. 31, 2022 | |
Earnings (loss) per share | |
Earnings (loss) per share | 26. Loss per share The December 31, 2022 and 2021: 2022 2021 $ $ Weighted daily average of Common shares 170,953,374 166,645,546 Dilutive effect of stock options — — Dilutive effect of warrants — — Weighted average number of diluted shares 170,953,374 166,645,546 Number of anti-dilutive stock options and warrants excluded per share calculation 6,745,100 8,403,000 |
Related party transactions
Related party transactions | 12 Months Ended |
Dec. 31, 2022 | |
Related party transactions | |
Related party transactions | 27. Related party transactions During parties: In 2022, rent Company 277,389 274,934 ). On whose beneficiary December 2026. The lessor also reimbursed an amount of $ 1,070,264 of 1,178,530 remeasured using a discount rate of 4 %. As a result, the lease liability 1,070,264 right-of-use assets was decreased by an amount of $ 108,267 . These comprehensive 680,980 $ 799,090 1,107,131 Nil ). A balance due 254,097 144,506 ) is included in accounts payable and accrued liabilities. The key management personnel of the Board of Directors and certain officers. Total 2022 2021 $ $ Salaries – key management 1,204,306 3,049,501 Pension contributions 22,479 59,377 Fees – Board of Directors 157,900 187,600 Share-based compensation – officers 2,017,348 6,182,573 Share-based compensation – Board of Directors 2,293,167 2,338,650 Other benefits – key management 244,621 237,903 Total 5,939,821 12,055,604 |
Financial instruments
Financial instruments | 12 Months Ended |
Dec. 31, 2022 | |
Financial instruments | |
Financial instruments | 28. Financial instruments As Company is otherwise market and seeks use derivative financial instruments to hedge these risks. Foreign currency risk The receivable and accounts payable and accrued liabilities As at December 31, the Company's exposure Foreign currency changes in foreign exchange rates. Sensitivity analysis At December 31, 2022, if the US Dollar changes by 10 % against the Canadian dollar with all other variables held constant, the 1,470,000 (December 31, 2021 - $ 1,516,000 ). Credit concentration During the year two 52 % (December 31, four 79 %) of revenues from operations. Three 56 %, 16 % and 11 %, respectively one 73 %) of accounts receivable with 18,894,727 12,063,636 ), representing the major 10 % revenues and/or total accounts receivable. Credit risk Credit discharge an obligation. the carrying amount excess of billings on uncompleted contracts, deposits and Cash and cash equivalents, by the Company, Management has established before reviewing external ratings, if they are available, some cases bank of each customer. In monitoring customer geographic location, industry, The Company does not generally contract terms may include the no unusual exposure associated with the collection of these The credit risk associated with costs and profits in excess of billings on uncompleted contracts is similar to that of accounts receivable, as these amounts are accumulated and converted to The royalties receivable not have receivable have been discounted to reflect the time value The deposits are not have collateral no loss of these deposits. During the no assets have been written off. The accounts provisioned by the balances due. Interest rate risk Interest rate risk is the risk that the Changes in market interest rates may have an effect on known as cash flow of investments financial instruments bear Price risk Price risk market price (other factors specific to the individual financial instrument or its issuers or factors affecting in the warrants of public 25 % as decreased respectively, 1,841,484 4,042,000 ). Liquidity risk Liquidity risk is the that are settled flows from operations and anticipating any investing and financing The following table summarizes the contractual amounts payable and maturities of financial liabilities and other at December 31, 2022: 1 Accounts payable and accrued liabilities exclude amounts The following table summarizes the contractual amounts payable and maturities of financial liabilities and other at December 31, 2021: 1 Accounts payable and accrued liabilities exclude amounts The Company's 500,000 , and 400,000 576,000 ) line of credit. At December 31, 2022, $ 498,200 341,473 Euros ($ 493,702 ) was drawn on prime rate plus 1% , therefore, 7.45 % for the Canadian facility and 8 % for the Italian facility. There covenants on the credit facilities. Fair value of financial instruments The fair value represents an orderly transaction specific date discount rates. realizable in an immediate settlement of the financial instruments. There instruments: Level 1 — quoted prices (unadjusted) in active markets Level 2 — inputs other than quoted prices included within Level (i.e. as prices) or indirectly (i.e. derived from prices). Level 3 — inputs for the asset or liability that are not based The fair values accounts payable and accrued liabilities approximate their carrying Investments in BGF and HPQ shares are valued at quoted Royalties receivable are discounted according to their corresponding Investments in HPQ warrants are valued using the Black The fair value the Accordingly, as a result 2 and the balance due on business combination as Level 3. 2022 2021 $ $ Cash 2,871,062 1,714,670 Accounts receivable 13,537,912 14,465,011 Accounts payable and accrued liabilities (1,713,717) (1,023,999) Total 14,695,257 15,155,682 2022 2021 % of total % of total Revenues revenues Revenues revenues $ % $ % Customer 1 5,598,653 29 7,308,191 24 Customer 2 4,314,225 23 7,019,953 23 Customer 3 — — 6,417,373 21 Customer 4 — — 3,551,900 11 Total 9,912,878 52 24,297,417 79 Total Carrying contractual Less than value amount one year 2-3 years 4-5 years Over 5 years $ $ $ $ $ $ Bank indebtedness 991,902 991,902 991,902 — — — Accounts payable and accrued liabilities 1 9,620,591 9,620,591 9,620,591 — — — Term 389,987 520,444 59,917 190,587 180,000 89,940 Balance due on business combination 3,907,775 4,137,820 2,177,800 1,960,020 — — Lease liabilities 5,533,694 6,745,329 2,984,243 1,165,281 703,816 1,891,989 20,443,949 22,016,086 15,834,453 3,315,888 883,816 1,981,929 Total Carrying contractual Less than value amount one year 2-3 years 4-5 years Over 5 years $ $ $ $ $ $ Accounts payable and accrued liabilities 1 9,586,423 9,586,423 9,586,423 — — — Term 190,905 263,232 85,731 67,561 62,823 47,117 Balance due on business combination 3,952,203 4,355,600 2,395,580 1,960,020 — — Lease liabilities 5,323,965 6,614,192 3,220,750 710,493 561,628 2,121,321 19,053,496 20,819,447 15,288,484 2,738,074 624,451 2,168,438 |
Contingent liabilities
Contingent liabilities | 12 Months Ended |
Dec. 31, 2022 | |
Contingent liabilities | |
Contingent liabilities | 29. The proceedings is becomes necessary. Based on currently available information, management individually and in in results of operations. The Company had received a government grant in prior years of approximately $ 800,000 a new system of advanced waste treatment systems technology. The grant 3 % of any consideration received received. This repayment and accordingly, no |
Capital management
Capital management | 12 Months Ended |
Dec. 31, 2022 | |
Capital management | |
Capital management | 30. The Company’s objectives in managing capital are: a) b) The Company’s primary objectives when managing capital is to ensure the Company continues as a going concern as well as to maintain optimal returns to shareholders and benefits for The Company third parties and shareholders. The Company is order to 1,650,709 $ 14,006,785 ). The management of capital includes shareholders’ equity for a total amount of $ 16,868,927 40,768,754 ) and term loans of $ 389,987 190,905 ), as well as cash and cash 3,445,649 12,202,513 ). There were order to and periodically purchase its own shares on the open |
Income taxes
Income taxes | 12 Months Ended |
Dec. 31, 2022 | |
Income taxes | |
Income taxes | 31. a) Income tax expenses is comprised of the following: b) Reconciliation of effective tax rate The applicable statutory tax 26.5 % in 2022 26.5 % in 2021. combined rates applicable in the jurisdiction in which the c) Deferred tax assets and liabilities Recognized deferred tax assets and liabilities: As at December 31, 2022 and 2021, recognized deferred Deferred taxes from temporary differences and unused As at December 31, 2022 and 2021, the amounts and expiry dates of tax attributes and temporary differences for which no deferred tax assets were recognized are as follows: Deferred tax assets and that future taxable future taxable profit depends on the successful commercialisation 2022 2021 $ $ Current tax Current year 118,378 (155,714) Deferred tax Origination and reversal of temporary differences (6,219,309) (5,095,595) Change in unrecognized deductible temporary differences 6,176,915 4,511,349 (42,394) (584,246) Income tax expense (recovery) 75,984 (739,960) 2022 2021 $ $ Loss before income taxes (32,091,043) (39,171,899) Income tax rates 26.5 % 26.5 % Income tax recovery at the combined basic Federal and (8,504,126) (10,380,553) Permanent differences 2,165,385 5,079,805 Tax (826) 8,334 Prior year adjustment 115,118 60,533 Change in unrecognized deductible temporary differences 6,176,915 4,511,349 Other 123,518 (19,428) Income tax expense (recovery) 75,984 (739,960) Assets Liabilities Net 2022 2021 2022 2021 2022 2021 $ $ $ $ $ $ Non-capital losses carried forward 772,343 1,705,073 — — 772,343 1,705,073 Strategic investments — — — (656,507) — (656,507) Royalties receivable — — (373,063) (333,543) (373,063) (333,543) Property and equipment — — (155,833) (147,127) (155,833) (147,127) Intangibles — — (243,447) (468,167) (243,447) (468,167) Deferred income — — — (21,000) — (21,000) Right-of-use assets net of liabilities — — — (121,123) — (121,123) Tax 772,343 1,705,073 (772,343) (1,747,467) — (42,394) Set off of tax (772,343) (1,705,073) 772,343 1,705,073 — — Net tax assets (liabilities) — — — (42,394) — (42,394) Recognized Recognized Recognized January 1, on business in profit or December January in profit or December 2021 combination 1, 2022 loss $ $ $ $ $ $ $ Non-capital losses carried forward 4,982,328 642,149 (3,919,404) 1,705,073 1,705,073 (932,730) 772,343 Strategic investments (4,919,499) — 4,262,992 (656,507) (656,507) 656,507 — Investment tax credits (273,854) — 273,854 — — — — Royalties receivable (280,900) — (52,643) (333,543) (333,543) (39,520) (373,063) Property and equipment (25,273) (2,840) (119,014) (147,127) (147,127) (8,706) (155,833) Intangibles — (559,949) 91,782 (468,167) (468,167) 224,720 (243,447) Deferred income — — (21,000) (21,000) (21,000) 21,000 — Right-of-use assets net of liabilities (188,802) — 67,679 (121,123) (121,123) 121,123 — (706,000) 79,360 584,246 (42,394) (42,394) 42,394 — December 31, 2022 December 31, 2021 Federal Provincial Federal Provincial $ $ $ $ Research and development expenses, without time limitation: 11,917,963 12,150,617 11,399,104 11,023,013 Federal research and development investment tax credits: 2029 299,881 — 299,881 — 2030 89,879 — 89,879 — 2031 223,759 — 223,759 — 2032 186,031 — 186,031 — 2033 105,216 — 105,216 — 2034 212,609 — 212,609 — 2035 488,555 — 488,555 — 2036 359,594 — 359,594 — 2037 253,885 — 253,885 — 2038 186,015 — 186,015 — 2039 340,728 — 465,535 — 2040 101,562 — 101,562 — 2041 167,461 — 359,115 — 2042 256,417 — — — 3,271,592 — 3,331,636 — December 31, 2022 December 31, 2021 Federal Provincial Italy Federal Provincial Italy $ $ $ $ $ $ Tax forward: 2032 2,866,759 2,866,759 — 628,948 — — 2033 2,047,643 2,047,643 — 2,047,643 1,490,639 — 2034 589,007 589,007 — 589,007 589,007 — 2035 703,664 416,827 — 703,664 416,827 — 2036 3,579,827 3,440,527 — 3,579,827 3,440,527 — 2037 1,577,876 1,568,739 — 1,577,876 1,568,739 — 2038 5,716,536 5,650,620 — 5,716,536 5,650,620 — 2039 4,772,060 4,079,919 — 4,163,315 4,079,919 — 2040 533,485 533,485 — — — — 2041 3,818,898 3,773,941 — 2,710,255 2,659,255 — 2042 16,135,868 16,140,505 — — — — Indefinite — — 908,073 — — 815,620 42,341,623 41,107,972 908,073 21,717,071 19,895,533 815,620 December 31, 2022 December 31, 2021 Federal Provincial Federal Provincial $ $ $ $ Other deductible temporary differences, Without time limitation: Right-of-use assets net of liabilities 687,896 687,896 — — Strategic investments 3,068,378 3,068,378 — — Financing costs 677,789 677,789 1,100,504 1,100,504 Intangible assets 3,460,822 3,194,890 3,712,181 3,431,133 Capital losses — — 464,768 464,768 7,894,885 7,628,953 5,277,453 4,996,405 |
Segment information
Segment information | 12 Months Ended |
Dec. 31, 2022 | |
Segment information | |
Segment information | 2022 2021 $ $ Brazil 162,797 1,475,608 Canada 11,933,904 7,383,884 England — 634 Germany 11,606 3,867 India 91,699 698,837 Israel 27,360 126,246 Italy 1,309,478 2,514,665 Mexico 371,668 920,818 Netherlands 112,634 — Poland 47,591 60,406 Saudi Arabia 1,511,142 7,019,953 South Africa 29,997 — Spain 22,049 1,178 United States of America 2,661,071 10,567,741 Vietnam 720,507 294,513 19,013,503 31,068,350 2022 2021 $ $ $ $ $ $ Canada India Total Canada India Total Property and equipment 3,372,356 21,096 3,393,452 3,685,974 26,963 3,712,937 Right-of-use assets 4,818,744 — 4,818,744 5,765,993 — 5,765,993 Intangible assets 2,104,848 — 2,104,848 2,774,198 — 2,774,198 Goodwill 2,660,607 — 2,660,607 2,660,607 — 2,660,607 12,956,555 21,096 12,977,651 14,886,772 26,963 14,913,735 32. The Company operates one Board of Directors. The Company’s head office is located in Montreal, Quebec. The operations of in three geographic areas: Canada, Italy and India. The following is a summary of the Company’s Revenue by product line and revenues recognized by The following is a summary of selected asset categories In 2022 and 2021, none of the selected asset categories |
Subsequent events
Subsequent events | 12 Months Ended |
Dec. 31, 2022 | |
Subsequent events | |
Subsequent events | 33. On March 8, 2023, the Company announced it had completed a non-brokered private placement consisting of the issuance and sale of 5,000,000 1.00 5,000,000 . Each unit of one one to purchase one 1.25 shares as the fair value of the common shares on March 1.38 . |
Significant accounting polici_2
Significant accounting policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Significant accounting policies [Abstract] | |
Business combinations | (a) Business combinations are accounted of the consideration transferred over the all measured at the acquisition date. The consideration transferred is measured as the net of the fair values of assets transferred, instruments consideration arrangement, in exchange of the acquiree. The obligation to pay the contingent consideration provision. Changes in fair values that qualify as measurement period adjustments of preliminary purchase price allocations are adjusted in the current period and such changes are Acquisition costs incurred, except for costs associated with the issuance |
Revenue recognition | (b) Revenue from depending on which method reflects the transfer of control of the goods and services underlying the particular performance obligation. i) Long-term contracts basis. terminated by the customer, the Company reimbursement of the costs deliverables require the Company to determine whether they contain separately identifiable performance obligations and to allocate the consideration received to each performance Revenue Company’s efforts or inputs of completion and/or hours anticipated performance, transaction price and profit margin, when certain conditions are met. Estimates are required amount of expected loss, if any, Contract modifications are changes in scope and/or price that are approved by the parties to the contract. Approval may written, modifications as a separate stand-alone modifications are accounted for as part of the original contract. Costs and exchange for whether such right is only (costs and profits under the contract. Billings in excess of costs and contractually receivable by the Company that exceeds the right under a given contract. The costs selling expenses over time based on degree of completion ii) Revenue related to sales of goods, which may specified in contracts goods to transferred to the custody transfer point agreed with the customer. iii) Sale of to the sale of intellectual property is recognized to the extent that it uncertainty associated with the variable consideration |
Foreign currency translation | (c) i) Revenue and expense transactions in foreign using the the functional non-monetary items. Translation gains ii) The assets and end Exchange translation adjustments in other comprehensive income and |
Cash and cash equivalents | (d) Cash and significant risk of the date of withdrawal within a three-month period from the date |
Inventory | (e) Inventory is composed of spare of estimated selling price in the ordinary course of business, |
Deferred income taxes | (f) i) Current tax assets and liabilities for the current and prior years are measured at the amount expected to be recovered from or paid substantively enacted by the date of the consolidated statements iii) Deferred tax is provided using the liability method, providing for temporary differences between the tax liabilities and their carrying if it arises from the initial recognition business combination that at the time of the transaction affects neither accounting deferred tax liabilities, using tax is expected over the period in which the deferred tax is extent that it is probable that future taxable profits will Deferred tax assets enforceable right and liabilities entities which intend to settle the liabilities and assets on a net |
Earnings (loss) per share | (g) The Company dividing net earnings per share is is increased number of additional shares the Potential shares from loss per share as their inclusion is considered anti-dilutive in |
Property and equipment | (h) Property applicable. Cost includes expenditures that operation. Borrowing effective interest profit and loss. Government assistance equipment useful lives, they are accounted for separately. Property and equipment are depreciated from the acquisition date respective useful life. location and condition necessary for it to be capable of Depreciation is calculated using the following methods Impairment losses recognized in prior that the previously recognized losses may no longer exist or may be decreased. An impairment loss is reversed only to the extent depreciation, had no impairment loss been recognized for the Property and equipment are assessed for impairment Depreciation methods, useful lives and residual if appropriate. Computer equipment Straight line over 3 years Machinery and equipment Straight line over 10 years Automobiles Straight line over 7 years Leasehold improvements Lesser of the lease term or the useful life ( 20 years ) |
Leases | (i) Under IFRS 16 Leases, at the contract conveys the right to control the use of an identified The Company recognizes a right-of-use asset and underlying asset is available for use. Right-of-use assets Right-of-use adjusted for any remeasurement of lease liabilities. Cost - - - - restore the underlying asset to the condition required by Right-of-use assets are a lease transfers ownership to exercise a purchase option, on assessed for impairment whenever there is an indication that Lease liabilities Lease liabilities are date over the lease term. The present value of the lease payments is determined rate at rate is the borrowing rate any specified rate, and payments of to terminate the lease. Lease payments also include amounts expected to be exercise price of a purchase option if the Company is reasonably Variable liabilities but occurs. After the reduced to reflect lease payments made. change in future terms and conditions, a change in the estimate of the remeasurement amount of loss statement when the carrying amount of the right- Classification and presentation of lease-related expenses Depreciation charge for right-of-use assets, expenses of lease based on their function within the Company, Cash flow classification Lease payments related while lease from payments not included in the measurement of lease |
Government assistance and investment tax credits | (j) Investment assistance and investment as a reduction of the related expense or cost customary assessments are received. |
Intangible assets and Goodwill | (k) Intangible assets are carried at cost less any accumulated amortization Identifiable intangible assets definition of an intangible their acquisition-date fair value. Subsequent to initial recognition, identifiable intangible assets acquired in a business combination are accumulated impairment losses. The useful lives of intangible assets Intangible assets with finite is consolidated statements of comprehensive loss. Research Development costs unless they meet specific criteria related to technical, market and financial feasibility in order to be recognized as intangible assets which include: - - - - - Costs comprehensive loss in the year they are feasibility. Patent costs Amortization patent impairment. Residual values and useful lives are reviewed Amortization is calculated on a straight-line basis: Goodwill represents the future separately tested for impairment be reversed. (l) The carrying there is an indication of impairment. If any such indication For impairment assessment purposes, assets are inflows (cash cash-generating unit level. Goodwill is allocated to those of goodwill. Cash-generating units to which goodwill assets carrying amount may not be recoverable. The recoverable amount costs to sell. tax discount For the purposes of testing non-financial assets for one An impairment loss is losses are the CGU are allocated first to reduce the carrying amount of goodwill allocated to the units, and then to reduce the carrying amounts on a pro-rata basis of the other assets in the Useful life Production backlog 30 months Patents and development costs 1 21 years |
Provisions and contingent liabilities | (m) Provisions for legal constructive obligation as a result of a past event, it is probable that an outflow of economic resources will be required from the Company and amounts can be estimated reliably. Provisions are measured at the estimated evidence available at the reporting date, including the risks and uncertainties associated with the there considering the class money is material. No situations are disclosed as contingent liabilities unless |
Employee benefits | (n) Share-based payments The Company applies a fair options are measured Non-employee stock options received if the the services are measured options is presented consideration received Black-Scholes option-pricing model to estimate the fair value Deferred profit-sharing plan The Company and employee to the prosperity and profits of the Company for purposes of eligibility in the DPSP is determined by the Board of Directors of the Company persons to the Company are excluded from participating in For all eligible of the Company’s contribution will be such amount which, in the opinion of its Board of Directors, is and overall financial Nil Nil Obligations for contributions of comprehensive loss in the periods during which services Short-term employee benefits Short-term employee benefit obligations is provided. A liability is legal or constructive obligation can be estimated reliably. |
Equity Instruments | (o) Issuance of equity instruments Incremental common allocate the net proceeds between common shares and Extinguishing financial liabilities with equity instruments When Company measured. If the fair be measured to reflect the fair value of the financial liability Contributed surplus Contributed exercised or settled, in which case the amounts are transferred It also includes the unexercised conversion option at the |
Financial Instruments | (p) Recognition: The Company the instrument. Purchases regulation or Company commits to purchase or sell the asset. Classification Financial comprehensive contractual cash flow characteristics of these assets. accounting judgment. A financial assets in order to collect contractual cash flows and its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. The Company and cash equivalents, trade accounts receivable, other receivables, A financial asset is measured at fair value through profit or (a) (SPPI) on the principal amount outstanding; or (b) contractual cash flows and sell; or (c) reduces a measurement or recognizing the gains and losses on them on different The Company includes in this category strategic investments All financial liabilities, measured at liabilities and term loans. The balance due on business Initial measurement Financial assets and attributable incremental costs of acquisition or issue. Financial assets value. All transaction costs for such instruments are recognized Subsequent measurement Financial assets (other than financial assets at FVTPL) are measured at amortized less derecognized or impaired, as well as through the amortization Financial liabilities are liabilities designated at well as through own credit risk are to be presented in other comprehensive Fair value measurement principles Fair value is the price that would be received to sell market participants at the measurement date. Where financial assets and market at the reporting date, market if regularly occurring market transactions on an arm’s Securities traded on stock exchanges are stated at market Derecognition A financial asset is derecognized transferred its under the liability is discharged, cancelled, Offsetting of financial instruments Financial assets and financial position if, and only if, there is a currently enforceable to settle on a net basis, or to realize the assets and settle Impairment of financial instruments The Company’s financial costs and profits in excess of billings on uncompleted The trade accounts receivable have no financing component and, receivable. Therefore, the Company recognizes a loss The Company’s supportable conditions, and forecasts of future economic conditions. The Company profits in excess of billings on uncompleted contracts, based on days past due for patterns. Contracts with particular on historical observed loss rates over the expected life of the receivables and are adjusted for forward-looking estimates to reflect differences between economic conditions Impairment receivables and cost in excess of billings on uncompleted Write-off The recovering a financial asset in its entirety or a portion thereof. Failure to engage and communicate with within 90 receivable. Effective Interest Method The allocating estimated effective instrument, or (when appropriate) a shorter period, to the net |
Future changes and amendments to accounting standards and interpretations | (q) i) Presentation of Financial Statements - Accounting Policies In accounting policy information rather than their significant accounting policies. Additional amendments to IAS 1 are made to explain how an entity can identify beginning on or after January 1, 2023, with earlier application ii) Presentation of Financial Statements - Classification of Liabilities The guidance in IAS 1 Presentation current amendment is effective iii) The IASB released 12). The amendment relates decommissioning obligations, by recognizing both an asset and a liability. The objective of this amendment is to narrow the initial recognition exemption both taxable and deductible temporary differences, the application permitted. iv) Provisions, Contingent Liabilities and Contingent Assets The IASB which costs an is onerous. costs of fulfilling the contract and an allocation effective for annual reporting periods beginning The Company has determined that the adoption of these standards or amendments will not have a significant impact on its consolidated financial statements as of the date of adoption. |
Significant accounting polici_3
Significant accounting policies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Significant accounting policies [Abstract] | |
Schedule of estimated useful lives of property and equipment | Computer equipment Straight line over 3 years Machinery and equipment Straight line over 10 years Automobiles Straight line over 7 years Leasehold improvements Lesser of the lease term or the useful life ( 20 years ) |
Schedule of estimated useful lives of intangible assets | Useful life Production backlog 30 months Patents and development costs 1 21 years |
Business combination (Tables)
Business combination (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Business combination [Abstract] | |
Schedule of final allocation of the purchase price | $ Total consideration Consideration paid at closing 1 Contingent consideration 3,841,999 Consideration paid at closing and continent consideration 3,842,000 Settlement of pre-existing loan receivable from Pyro Green-Gas 1,744,400 5,586,400 Net assets acquired Current assets 1 5,186,086 ROU asset 477,608 Property and equipment 42,552 Intangible assets and Goodwill 2 4,780,607 Deferred income tax asset 79,360 Current liabilities (4,507,907) Non-current liabilities (471,906) 5,586,400 1 Includes $ 807,946 3,255,000 , including an allowance for expected credit losses of $ 512,592 . 2 The goodwill of $ 2,660,607 the expertise of the workforce, and it is not expected to be deductible for tax purposes. |
Revenues (Tables)
Revenues (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Revenues [Abstract] | |
Schedule of revenues by product line | 2022 2021 $ $ Revenue from contracts with customers by product High purity metallurgical grade silicon & solar grade silicon from (PUREVAP™) 6,272,697 6,138,111 Aluminium and zinc dross recovery (DROSRITE™) 1,912,807 7,940,771 Development and support related to systems supplied to the 1,288,356 7,522,809 Torch 5,558,210 2,084,511 Biogas upgrading and pollution controls 3,347,443 6,800,090 Other sales and services 633,990 582,058 19,013,503 31,068,350 |
Schedule of revenues by recognition method | 2022 2021 $ $ Revenue from contracts with customers: Sales of goods under long-term contracts recognized over 13,997,163 25,918,594 Sales of goods at a point of time 1,135,498 1,533,910 Other revenue: Sale of intellectual properties (i) 3,600,000 3,300,000 Royalties 280,842 315,846 19,013,503 31,068,350 |
Cash and cash equivalents (Tabl
Cash and cash equivalents (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Cash and cash equivalents [Abstract] | |
Schedule of cash and cash equivalents | 2022 2021 $ $ Cash 3,445,649 3,568,561 Guaranteed investment certificates — 8,633,952 Cash and cash equivalents 3,445,649 12,202,513 |
Accounts receivable (Tables)
Accounts receivable (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Accounts receivable [Abstract] | |
Schedule of accounts receivables | As 4,693,283 $ 520,000 ), $ 543,283 $ 4,150,000 3,765,000 customer, whereby the carrying amount has been 12,810,231 9,045,231 . The carrying value of all other trade receivables was reduced from $ 9,887,011 8,958,728 . On the basis of the Company’s expected the allowance was determined generally by applying a loss rate of 1 % on balances 1-30 days past the invoice date, 2 % for 31-60 days, 3 % for 10 % for situations where terms. December 31, December 31, 2022 2021 $ $ Current 6,578,269 1,919,786 1 – 30 days 15,959 32,028 31 – 60 days 57,944 7,006,652 61 – 90 days 718,239 788,330 Greater than 90 days 13,790,716 6,317,239 Holdback receivable 1,536,115 974,878 Total 22,697,242 17,038,913 Allowance for expected credit loss (4,693,283) (520,000) Other receivables 240,560 270,536 Sales tax receivable 380,112 850,167 18,624,631 17,639,616 |
Schedule of allowance for credit losses | Opening allowance January 1, 2021 — Business combination 512,592 Foreign exchange 7,408 Loss allowance at December 31, 2021 520,000 Loss recognized during the year 4,150,000 Foreign exchange 23,283 Loss allowance at December 31, 2022 4,693,283 |
Strategic investments (Tables)
Strategic investments (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Strategic investments [Abstract] | |
Schedule of components of strategic investments | December 31, December 31, 2022 2021 $ $ Beauce Gold Fields (“BGF”) shares – level 1 56,419 123,095 HPQ Silicon Inc. (“HPQ”) shares - level 1 5,415,749 12,306,196 HPQ warrants – level 3 770,466 2,472,368 6,242,634 14,901,659 (“BGF”) shares – level 1 (“HPQ”) shares - level 1 HPQ warrants – level 3 Quantity $ Quantity $ Quantity $ Balance, December 31, 2020 1,025,794 123,095 14,990,200 16,489,220 25,844,600 23,379,435 Additions — — 8,268,000 8,070,109 — — Exercised — — 16,250,000 11,700,000 (16,250,000) (9,181,250) Disposed — — (12,755,600) (14,252,732) — — Change in the fair value — — — (9,700,401) — (11,725,817) Balance, December 31, 2021 1,025,794 123,095 26,752,600 12,306,196 9,594,600 2,472,368 Additions — — 6,800,000 3,196,000 6,800,000 408,000 Disposed — — (11,447,500) (3,922,244) — — Change in the fair value — (66,676) — (6,164,203) — (2,109,902) Balance, December 31, 2022 1,025,794 56,419 22,105,100 5,415,749 16,394,600 770,466 |
Schedule of changes in strategic investments | Number of Number of warrants warrants Exercise Expiry date Dec 31, 2021 Additions Exercised Dec 31, 2022 price ($) April 29, 2023 1,200,000 — — 1,200,000 0.10 June 2, 2023 4,394,600 — — 4,394,600 0.10 September 3, 2023 4,000,000 — — 4,000,000 0.61 April 20, 2024 — 6,800,000 — 6,800,000 0.60 9,594,600 6,800,000 — 16,394,600 |
Schedule of assumptions used in estimating fair value of the HPQ warrants | Number of warrants 6,800,000 Date of issuance April 20, 2022 Exercise price ($) 0.60 Assumptions under the Black-Scholes model: Fair value of the shares ($) 0.47 Risk-free interest rate (%) 2.47 Expected volatility (%) 107.60 Expected dividend yield – Contractual remaining life (number of months) 24 2022 2021 Number of warrants 1,200,000 4,394,600 4,000,000 6,800,000 1,200,000 4,394,600 4,000,000 Date of issuance April 29, 2020 June 2, 2020 Sept. 3, 2020 April 20, 2022 April 29, 2020 June 2, 2020 Sept. 3, 2020 Exercise price ($) 0.1 0.1 0.61 0.60 0.1 0.1 0.61 Assumptions under the Black- Scholes model: Fair value of the shares ($) 0.25 0.25 0.25 0.25 0.46 0.46 0.46 Risk-free interest rate (%) 4.03 4.03 4.03 4.03 1.22 1.22 1.22 Expected volatility (%) 80.55 73.74 76.85 74.58 89.88 94.01 110.47 Expected dividend yield – – – – – – – Contractual remaining life (in months) 4 5 8 16 16 17 20 |
Royalties receivable (Tables)
Royalties receivable (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Royalties receivable [Abstract] | |
Schedule of royalties receivable | December 31 December 31 2022 2021 $ $ Opening balance 1,258,654 1,060,000 Accretion interest 118,290 132,809 Royalties recognized during the year 450,000 450,000 Discounting (169,158) (134,155) Amounts received during the year (250,000) (250,000) Balance at end of the year 1,407,786 1,258,654 Current portion 455,556 311,111 Non-current portion 952,230 947,543 1,407,786 1,258,654 |
Deposits (Tables)
Deposits (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Deposits | |
Schedule of components of deposits | December 31 December 31 2022 2021 $ $ Current portion: Suppliers 392,309 1,236,211 Security deposit on leased premises 40,241 92,241 Total 432,550 1,328,452 Non-current portion: Suppliers 7,250 1,952 Security deposit on leased premises 38,803 246,804 Total 46,053 248,756 Total 478,603 1,577,208 |
Property and equipment (Tables)
Property and equipment (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Property and equipment. | |
Schedule of components and movements in property and equipment | (1) The adjustment to 89,085 , relates to loan from the Economic Development Agency of Canada, Machinery Equipment Computer and Leasehold under equipment equipment Automobiles improvements construction Total $ $ $ $ $ $ Cost Balance at December 31, 2020 549,659 1,621,899 306,164 180,901 1,940,234 4,598,857 Acquired through business combination 13,585 28,967 — — — 42,552 Additions 245,984 384,092 30,495 752,204 84,143 1,496,918 Balance at December 31, 2021 809,228 2,034,958 336,659 933,105 2,024,377 6,138,327 Additions (1) 164,059 (89,085) — 209,435 — 284,409 Assets under construction put in service — 1,065,672 — 958,705 (2,024,377) — Balance at December 31, 2022 973,287 3,011,545 336,659 2,101,245 — 6,422,736 Accumulated depreciation Balance at December 31, 2020 509,112 1,441,642 21,748 96,785 — 2,069,287 Depreciation 88,410 182,739 59,959 24,995 — 356,103 Balance at December 31, 2021 597,522 1,624,381 81,707 121,780 — 2,425,390 Depreciation 146,550 297,021 57,543 102,780 — 603,894 Balance at December 31, 2022 744,072 1,921,402 139,250 224,560 — 3,029,284 Carrying amounts Balance at December 31, 2021 211,706 410,577 254,952 811,325 2,024,377 3,712,937 Balance at December 31, 2022 229,215 1,090,143 197,409 1,876,685 — 3,393,452 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Leases | |
Schedule of components and movements in right of use assets | Land and Computer building equipment Total $ $ $ Balance at January 1, 2021 3,688,315 12,685 3,701,000 Additions - business combination 477,608 — 477,608 Additions 2,157,796 — 2,157,796 Depreciation (566,182) (4,228) (570,411) Balance at December 31, 2021 5,757,537 8,457 5,765,993 Modification of lease agreements (311,421) — (311,421) Depreciation (631,600) (4,228) (635,828) Balance at December 31, 2022 4,814,516 4,229 4,818,744 |
Schedule of movements in lease liabilities | $ Balance at January 1, 2021 2,988,542 Addition - business acquisition 477,608 Additions - other 2,120,893 Payments (263,078) Balance at December 31, 2021 5,323,965 Modification of lease agreements 867,110 Payments (657,381) Balance at December 31, 2022 5,533,694 Current portion 2,934,236 Non-current portion 2,389,729 Balance at December 31, 2021 5,323,965 Current portion 2,672,212 Non-current portion 2,861,482 Balance at December 31, 2022 5,533,694 |
Schedule of amount recognized in the statement of comprehensive loss | 2022 2021 $ $ Depreciation of right-of-use assets 635,828 570,411 Interest on lease liabilities 378,611 307,691 Expense related to lease payments excluded in the measurement liabilities 243,209 178,707 |
Schedule of maturity analysis for contractual undiscounted cash flows of lease liabilities | $ 2023 2,984,243 2024 592,719 2025 572,562 2026 474,484 2027 229,332 Thereafter 1,891,989 6,745,329 |
Intangible assets (Tables)
Intangible assets (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Intangible assets. | |
Schedule of components and movements in intangible assets | Production Development backlog Patents costs Total $ $ $ $ Cost Balance at December 31, 2020 — 768,392 244,871 1,013,263 Acquired through business combination 2,120,000 — — 2,120,000 Additions — 214,497 — 214,497 Write-off — (85,544) — (85,544) Balance at December 31, 2021 2,120,000 897,345 244,871 3,262,216 Additions — 208,680 — 208,680 Balance at December 31, 2022 2,120,000 1,106,025 244,871 3,470,896 Accumulated amortization Balance at December 31, 2020 — 58,125 49,524 107,649 Amortization 353,333 10,528 16,508 380,369 Balance at December 31, 2021 353,333 68,653 66,032 488,018 Amortization 848,000 13,522 16,508 878,030 Balance at December 31, 2022 1,201,333 82,175 82,540 1,366,048 Carrying amounts Balance at December 31, 2021 1,766,667 828,692 178,839 2,774,198 Balance at December 31, 2022 918,667 1,023,850 162,331 2,104,848 |
Accounts payable and accrued _2
Accounts payable and accrued liabilities (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Accounts payable and accrued liabilities | |
Schedule of components of accounts payable and accrued liabilities | December 31 December 31 2022 2021 $ $ Accounts payable 6,065,996 5,457,259 Accrued liabilities 2,891,053 3,730,048 Sale commissions payable 1 904,724 737,364 Accounts payable to the controlling shareholder and CEO 254,097 144,506 10,115,870 10,069,177 1 Sale commissions payable relate to the costs to obtain long-term |
Term loans (Tables)
Term loans (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Term loans | |
Schedule of components and movements of term loans | Economic Development Agency Other Term Other Term Canada Emergency Business of Canada Loan 1 Loans 2 Loans 3 Account Loan 4 Total $ $ $ $ $ Balance, December 31, 2020 75,800 36,907 — — 112,707 Assumed through business combination — — 36,520 50,000 86,520 Accretion 12,185 — — — 12,185 Payments — (12,207) (8,300) — (20,507) Balance, December 31, 2021 87,985 24,700 28,220 50,000 190,905 Additions 292,941 292,941 Discounting (89,085) — — — (89,085) Accretion 28,229 — — — 28,229 Payments — (13,083) (19,920) — (33,003) Balance, December 31, 2022 320,070 11,617 8,300 50,000 389,987 Less current portion — (11,617) (8,300) (50,000) (69,917) Balance, December 31, 2022 320,070 — — — 320,070 1 2 maturing October 23, 2023 6.95 % per 1,200 amount of $ 10,795 3 1,660 , bearing interest at 7.45 % 4 no no |
Shareholders' equity (Tables)
Shareholders' equity (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Shareholders' equity | |
Schedule of activity in stock options | (1) 1.44 5.48 Weighted Number of average options exercise price $ Balance – December 31, 2020 9,040,000 1.57 Granted 2,970,000 4.55 Exercised (1) (3,482,000) 0.32 Forfeited (125,000) 4.41 Balance, December 31, 2021 8,403,000 3.10 Granted 2,475,000 3.55 Exercised (1) (2,440,000) 0.58 Forfeited (242,500) 4.07 Balance, December 31, 2022 8,195,500 3.96 |
Schedule of assumptions used in measurement of fair value of stock options | Years ended December 31, 2022 2021 Number of options granted or recognized 2,475,000 650,000 2,970,000 Exercise price ($) 3.55 3.02 4.55 Fair value of each option under the Black-Scholes pricing ($) 2.37 2.02 2.99 Assumptions under the Black-Scholes model: Fair value of the shares ($) 3.54 3.02 4.52 Risk-free interest rate (%) 2.43 3.38 1.11 Expected volatility (%) 83.17 83.15 83.00 Expected dividend yield — — — Expected life (number of months) 60 60 60 |
Schedule of outstanding options | (1) 3.96 . Number of Number of Number of stock stock stock Exercise options options options price Dec 31, 2021 Granted Exercised Forfeitures Dec 31, 2022 vested (1) per option Expiry date $ November 3, 2017 2,400,000 — (2,400,000) — — — 0.58 November 3, 2022 July 3, 2018 300,000 — — — 300,000 300,000 0.51 July 3, 2023 October 29, 2018 40,000 — (40,000) — — — 0.52 October 29, 2023 September 29, 2019 100,000 — — — 100,000 100,000 0.51 September 29, 2024 January 2, 2020 100,000 — — — 100,000 100,000 0.45 January 2, 2025 July 16, 2020 2,243,000 — — (42,500) 2,200,500 1,775,500 4.41 July 16, 2025 October 26, 2020 250,000 — — (200,000) 50,000 37,500 4.00 October 26, 2025 April 6, 2021 550,000 — — — 550,000 410,000 8.47 April 6, 2026 June 1, 2021 200,000 — — — 200,000 100,000 6.59 June 1, 2026 June 14, 2021 100,000 — — — 100,000 50,000 6.70 June 14, 2026 October 14, 2021 100,000 — — — 100,000 30,000 5.04 October 14, 2026 December 17, 2021 1,920,000 — — — 1,920,000 1,920,000 3.13 December 17, 2026 December 30, 2021 100,000 — — — 100,000 30,000 3.61 December 30, 2026 January 3, 2022 — 450,000 — — 450,000 450,000 3.36 January 3, 2027 April 5, 2022 — 400,000 — — 400,000 40,000 2.96 April 5, 2027 June 2, 2022 — 1,500,000 — — 1,500,000 375,000 3.88 June 2, 2027 July 13, 2022 — 125,000 — — 125,000 12,500 2.14 July 13, 2027 8,403,000 2,475,000 (2,440,000) (242,500) 8,195,500 5,730,500 3.96 Number of Number of Number of stock stock stock Exercise options options options price Dec 31, 2020 Granted Exercised Forfeitures Dec 31, 2021 vested per option Expiry date $ November 3, 2017 2,420,000 — (20,000) — 2,400,000 2,400,000 0.58 November 3, 2022 July 3, 2018 300,000 — — — 300,000 300,000 0.51 July 3, 2023 October 29, 2018 70,000 — (30,000) — 40,000 40,000 0.52 October 29, 2023 September 29, 2019 200,000 — (100,000) — 100,000 100,000 0.51 September 29, 2024 January 2, 2020 100,000 — — — 100,000 100,000 0.45 January 2, 2025 July 16, 2020 2,450,000 — (82,000) (125,000) 2,243,000 1,775,500 4.41 July 16, 2025 October 26, 2020 250,000 — — — 250,000 125,000 4.00 October 26, 2025 April 6, 2021 — 550,000 — — 550,000 320,000 8.47 April 6, 2026 June 1, 2021 — 200,000 — — 200,000 50,000 6.59 June 1, 2026 June 14, 2021 — 100,000 — — 100,000 25,000 6.70 June 14, 2026 October 14, 2021 — 100,000 — — 100,000 10,000 5.04 October 14, 2026 December 17, 2021 — 1,920,000 — — 1,920,000 1,920,000 3.13 December 17, 2026 December 30, 2021 — 100,000 — — 100,000 100,000 3.61 December 30, 2026 9,040,000 2,970,000 (3,482,000) (125,000) 8,403,000 7,265,500 3.10 |
Schedule of activity in warrants | Number of Number of warrants warrants Exercise Dec 31, Dec 31, price per 2021 Issued Exercised Expired 2022 warrant Expiry date Issuance of units – October 19, 2022 — 1,014,600 — — 1,014,600 1.75 Oct 19, 2024 — 1,014,600 — — 1,014,600 1.75 Number of Number of warrants warrants Exercise Dec 31, Dec 31, price per 2020 Issued Exercised Expired 2021 warrant Expiry date $ Issuance of units – September 28, 2018 3,448,276 — (3,448,276) — — 0.58 January 28, 2021 Issuance of units – October 19, 2018 100,000 — (100,000) — — 0.58 February 13, 2021 Issuance of units – May 15, 2019 1,355,500 — (1,355,500) — — 0.85 May 15, 2021 Issuance of units – May 28, 2019 750,000 — (750,000) — — 0.85 May 24, 2021 Issuance of units – June 19, 2019 500,000 — (500,000) — — 0.85 June 19, 2021 Issuance of units – October 25, 2019 225,000 — (225,000) — — 0.75 October 25, 2021 Issuance of units – November 10, 2020 1,677,275 — (1,672,000) (5,275) — 4.5 November 10, 2022 Issuance of warrants – November 10, 2020 — — (95,707) — — 4.5 November 10, 2022 8,056,051 — (8,146,483) (5,275) — |
Supplemental disclosure of ca_2
Supplemental disclosure of cash flow information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Supplemental disclosure of cash flow information | |
Summary of supplemental disclosure of cash flow information | 2022 2021 $ $ Accounts receivable (985,015) (12,372,139) Costs and profits in excess of billings on uncompleted 3,871,413 (3,849,077) Inventory (988,821) (839,352) Investment tax credits receivable (19,891) 1,015,862 Royalties receivable (30,842) (65,845) Deposits 2,277,136 145,379 Contract assets (562,809) — Prepaid expenses (53,942) 39,111 Accounts payable and accrued liabilities 346,003 1,953,208 Billings in excess of costs and profits on uncompleted contracts 270,762 1,485,969 Income taxes 267,414 (99,072) 4,391,408 (12,585,956) |
Net finance costs (Tables)
Net finance costs (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Net finance costs | |
Summary of net finance costs | 2022 2021 $ $ Financial expenses Interest on term loans 3,198 87,775 Interest on lease liabilities 378,611 307,691 Interest accretion on balance due on business combination 173,350 110,204 Interest accretion on long term loans 28,229 12,185 Penalties and other interest expenses 85,644 19,324 669,032 537,179 Financial income Interest accretion on royalty receivable (118,290) (132,809) Net finance costs 550,742 404,370 |
Loss per share (Tables)
Loss per share (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Earnings (loss) per share | |
Summary of reconciliation between the number of basic and fully diluted shares outstanding | 2022 2021 $ $ Weighted daily average of Common shares 170,953,374 166,645,546 Dilutive effect of stock options — — Dilutive effect of warrants — — Weighted average number of diluted shares 170,953,374 166,645,546 Number of anti-dilutive stock options and warrants excluded per share calculation 6,745,100 8,403,000 |
Related party transactions (Tab
Related party transactions (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Related party transactions | |
Summary of total compensation to key management | 2022 2021 $ $ Salaries – key management 1,204,306 3,049,501 Pension contributions 22,479 59,377 Fees – Board of Directors 157,900 187,600 Share-based compensation – officers 2,017,348 6,182,573 Share-based compensation – Board of Directors 2,293,167 2,338,650 Other benefits – key management 244,621 237,903 Total 5,939,821 12,055,604 |
Financial instruments (Tables)
Financial instruments (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Financial instruments | |
Summary of amount denominated in foreign currency | 2022 2021 $ $ Cash 2,871,062 1,714,670 Accounts receivable 13,537,912 14,465,011 Accounts payable and accrued liabilities (1,713,717) (1,023,999) Total 14,695,257 15,155,682 |
Summary of credit risk and credit concentration | 2022 2021 % of total % of total Revenues revenues Revenues revenues $ % $ % Customer 1 5,598,653 29 7,308,191 24 Customer 2 4,314,225 23 7,019,953 23 Customer 3 — — 6,417,373 21 Customer 4 — — 3,551,900 11 Total 9,912,878 52 24,297,417 79 |
Summary of contractual amounts payable and maturities of financial liabilities | 1 Accounts payable and accrued liabilities exclude amounts 1 Accounts payable and accrued liabilities exclude amounts Total Carrying contractual Less than value amount one year 2-3 years 4-5 years Over 5 years $ $ $ $ $ $ Bank indebtedness 991,902 991,902 991,902 — — — Accounts payable and accrued liabilities 1 9,620,591 9,620,591 9,620,591 — — — Term 389,987 520,444 59,917 190,587 180,000 89,940 Balance due on business combination 3,907,775 4,137,820 2,177,800 1,960,020 — — Lease liabilities 5,533,694 6,745,329 2,984,243 1,165,281 703,816 1,891,989 20,443,949 22,016,086 15,834,453 3,315,888 883,816 1,981,929 Total Carrying contractual Less than value amount one year 2-3 years 4-5 years Over 5 years $ $ $ $ $ $ Accounts payable and accrued liabilities 1 9,586,423 9,586,423 9,586,423 — — — Term 190,905 263,232 85,731 67,561 62,823 47,117 Balance due on business combination 3,952,203 4,355,600 2,395,580 1,960,020 — — Lease liabilities 5,323,965 6,614,192 3,220,750 710,493 561,628 2,121,321 19,053,496 20,819,447 15,288,484 2,738,074 624,451 2,168,438 |
Income taxes (Tables)
Income taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Income taxes | |
Summary of income tax expenses | 2022 2021 $ $ Current tax Current year 118,378 (155,714) Deferred tax Origination and reversal of temporary differences (6,219,309) (5,095,595) Change in unrecognized deductible temporary differences 6,176,915 4,511,349 (42,394) (584,246) Income tax expense (recovery) 75,984 (739,960) |
Summary of reconciliation of effective tax rate | 2022 2021 $ $ Loss before income taxes (32,091,043) (39,171,899) Income tax rates 26.5 % 26.5 % Income tax recovery at the combined basic Federal and (8,504,126) (10,380,553) Permanent differences 2,165,385 5,079,805 Tax (826) 8,334 Prior year adjustment 115,118 60,533 Change in unrecognized deductible temporary differences 6,176,915 4,511,349 Other 123,518 (19,428) Income tax expense (recovery) 75,984 (739,960) |
Summary of recognized deferred tax assets and liabilities | Recognized Recognized Recognized January 1, on business in profit or December January in profit or December 2021 combination 1, 2022 loss $ $ $ $ $ $ $ Non-capital losses carried forward 4,982,328 642,149 (3,919,404) 1,705,073 1,705,073 (932,730) 772,343 Strategic investments (4,919,499) — 4,262,992 (656,507) (656,507) 656,507 — Investment tax credits (273,854) — 273,854 — — — — Royalties receivable (280,900) — (52,643) (333,543) (333,543) (39,520) (373,063) Property and equipment (25,273) (2,840) (119,014) (147,127) (147,127) (8,706) (155,833) Intangibles — (559,949) 91,782 (468,167) (468,167) 224,720 (243,447) Deferred income — — (21,000) (21,000) (21,000) 21,000 — Right-of-use assets net of liabilities (188,802) — 67,679 (121,123) (121,123) 121,123 — (706,000) 79,360 584,246 (42,394) (42,394) 42,394 — |
Summary of temporary differences and unused tax losses and tax credits | Assets Liabilities Net 2022 2021 2022 2021 2022 2021 $ $ $ $ $ $ Non-capital losses carried forward 772,343 1,705,073 — — 772,343 1,705,073 Strategic investments — — — (656,507) — (656,507) Royalties receivable — — (373,063) (333,543) (373,063) (333,543) Property and equipment — — (155,833) (147,127) (155,833) (147,127) Intangibles — — (243,447) (468,167) (243,447) (468,167) Deferred income — — — (21,000) — (21,000) Right-of-use assets net of liabilities — — — (121,123) — (121,123) Tax 772,343 1,705,073 (772,343) (1,747,467) — (42,394) Set off of tax (772,343) (1,705,073) 772,343 1,705,073 — — Net tax assets (liabilities) — — — (42,394) — (42,394) |
Summary of amounts and expiry dates of tax attributed and temporary difference for which no deferred tax assets was recognized | December 31, 2022 December 31, 2021 Federal Provincial Federal Provincial $ $ $ $ Research and development expenses, without time limitation: 11,917,963 12,150,617 11,399,104 11,023,013 Federal research and development investment tax credits: 2029 299,881 — 299,881 — 2030 89,879 — 89,879 — 2031 223,759 — 223,759 — 2032 186,031 — 186,031 — 2033 105,216 — 105,216 — 2034 212,609 — 212,609 — 2035 488,555 — 488,555 — 2036 359,594 — 359,594 — 2037 253,885 — 253,885 — 2038 186,015 — 186,015 — 2039 340,728 — 465,535 — 2040 101,562 — 101,562 — 2041 167,461 — 359,115 — 2042 256,417 — — — 3,271,592 — 3,331,636 — |
Summary of tax losses carried forward | December 31, 2022 December 31, 2021 Federal Provincial Italy Federal Provincial Italy $ $ $ $ $ $ Tax forward: 2032 2,866,759 2,866,759 — 628,948 — — 2033 2,047,643 2,047,643 — 2,047,643 1,490,639 — 2034 589,007 589,007 — 589,007 589,007 — 2035 703,664 416,827 — 703,664 416,827 — 2036 3,579,827 3,440,527 — 3,579,827 3,440,527 — 2037 1,577,876 1,568,739 — 1,577,876 1,568,739 — 2038 5,716,536 5,650,620 — 5,716,536 5,650,620 — 2039 4,772,060 4,079,919 — 4,163,315 4,079,919 — 2040 533,485 533,485 — — — — 2041 3,818,898 3,773,941 — 2,710,255 2,659,255 — 2042 16,135,868 16,140,505 — — — — Indefinite — — 908,073 — — 815,620 42,341,623 41,107,972 908,073 21,717,071 19,895,533 815,620 |
Summary of other deductible temporary differences, without time limitation | December 31, 2022 December 31, 2021 Federal Provincial Federal Provincial $ $ $ $ Other deductible temporary differences, Without time limitation: Right-of-use assets net of liabilities 687,896 687,896 — — Strategic investments 3,068,378 3,068,378 — — Financing costs 677,789 677,789 1,100,504 1,100,504 Intangible assets 3,460,822 3,194,890 3,712,181 3,431,133 Capital losses — — 464,768 464,768 7,894,885 7,628,953 5,277,453 4,996,405 |
Segment information (Tables)
Segment information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Segment information | |
Summary of total revenues and category of selected assets by geography | 2022 2021 $ $ Brazil 162,797 1,475,608 Canada 11,933,904 7,383,884 England — 634 Germany 11,606 3,867 India 91,699 698,837 Israel 27,360 126,246 Italy 1,309,478 2,514,665 Mexico 371,668 920,818 Netherlands 112,634 — Poland 47,591 60,406 Saudi Arabia 1,511,142 7,019,953 South Africa 29,997 — Spain 22,049 1,178 United States of America 2,661,071 10,567,741 Vietnam 720,507 294,513 19,013,503 31,068,350 2022 2021 $ $ $ $ $ $ Canada India Total Canada India Total Property and equipment 3,372,356 21,096 3,393,452 3,685,974 26,963 3,712,937 Right-of-use assets 4,818,744 — 4,818,744 5,765,993 — 5,765,993 Intangible assets 2,104,848 — 2,104,848 2,774,198 — 2,774,198 Goodwill 2,660,607 — 2,660,607 2,660,607 — 2,660,607 12,956,555 21,096 12,977,651 14,886,772 26,963 14,913,735 |
Going concern (Details)
Going concern (Details) - CAD ($) | 1 Months Ended | 12 Months Ended | |||
Mar. 08, 2023 | Oct. 31, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Going concern [abstract] | |||||
Deficit | $ (93,384,858) | $ (61,217,831) | |||
Working capital | 1,650,709 | 14,006,785 | |||
Cash and cash equivalents. | 3,445,649 | 12,202,513 | $ 18,104,899 | ||
Private Placement | 1,318,980 | ||||
Allowance for credit losses | 5,023,283 | 520,000 | |||
Disclosure of non-adjusting events after reporting period [line items] | |||||
Proceeds from private placement | $ 1,318,980 | $ 1,318,980 | $ 0 | ||
Potential Ordinary Share Transactions [Member] | |||||
Disclosure of non-adjusting events after reporting period [line items] | |||||
Proceeds from private placement | $ 5,000,000 |
Significant accounting polici_4
Significant accounting policies - (Narrative) (Details) | 12 Months Ended | |
Dec. 31, 2022 CAD ($) Item | Dec. 31, 2021 CAD ($) | |
Significant accounting policies [Abstract] | ||
Company's contribution to DPSP | $ | ||
Number of CGUs identified for testing non-financial assets for impairment | Item | 1 |
Significant accounting polici_5
Significant accounting policies (Estimated useful life of property, plant and equipment) (Details) | 12 Months Ended |
Dec. 31, 2022 | |
Computer equipment | |
Disclosure of detailed information about property, plant and equipment [line items] | |
Estimated useful lives | 3 years |
Machinery and equipment | |
Disclosure of detailed information about property, plant and equipment [line items] | |
Estimated useful lives | 10 years |
Automobile | |
Disclosure of detailed information about property, plant and equipment [line items] | |
Estimated useful lives | 7 years |
Leasehold improvements | |
Disclosure of detailed information about property, plant and equipment [line items] | |
Estimated useful lives | 20 years |
Significant accounting polici_6
Significant accounting policies (Estimated useful life of intangible assets) (Details) | 12 Months Ended |
Dec. 31, 2022 | |
Production backlog | |
Disclosure of detailed information about intangible assets [line items] | |
Estimated useful lives | 30 months |
Patents and development costs | Minimum | |
Disclosure of detailed information about intangible assets [line items] | |
Estimated useful lives | 1 year |
Patents and development costs | Maximum | |
Disclosure of detailed information about intangible assets [line items] | |
Estimated useful lives | 21 years |
Business combination (Narrative
Business combination (Narrative) (Details) - CAD ($) | 12 Months Ended | |||
Aug. 11, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure of detailed information about business combination [line items] | ||||
Interest accretion on balance due on business combination | $ 173,350 | $ 110,204 | ||
Allowance for expected credit losses | 4,693,283 | 520,000 | $ 0 | |
Pyro Green-Gas And Subsidiaries | ||||
Disclosure of detailed information about business combination [line items] | ||||
Maximum purchase price consideration in Cash | $ 4,355,600 | |||
Settlement of pre-existing loan receivable from Pyro Green-Gas | $ 1,744,000,000,000 | 1,744,400 | ||
Expected period for completion of specified milestones by Pyro Green-Gas | 30 months | |||
Trade receivables recognized | 807,946 | |||
Allowance for doubtful accounts recognized | 3,255,000,000,000 | |||
Goodwill not expected to be deductible for tax purposes | 2,660,607,000,000 | |||
Recognized revenue of Pyro Green-Gas | 6,800,090,000,000 | |||
Acquisition-related costs | 101,157 | |||
Consideration paid at closing and continent consideration | $ 3,841,999 | 3,842,000 | ||
Interest accretion on balance due on business combination | 173,350 | $ 110,204 | ||
Discount rate | 8% | |||
Allowance for expected credit losses | $ 512,592 |
Business combination (Schedule
Business combination (Schedule of final allocation of the purchase price) (Details) - Pyro Green-Gas And Subsidiaries - CAD ($) | Dec. 31, 2022 | Aug. 11, 2021 |
Total consideration | ||
Consideration paid at closing | $ 1 | |
Contingent consideration | 3,841,999 | |
Consideration paid at closing and continent consideration | 3,842,000 | $ 3,841,999 |
Settlement of pre-existing loan receivable from Pyro Green-Gas | 1,744,400 | $ 1,744,000,000,000 |
Total consideration | 5,586,400 | |
Net assets acquired | ||
Current assets | 5,186,086 | |
ROU asset | 477,608 | |
Property and equipment | 42,552 | |
Intangible assets and Goodwill | 4,780,607 | |
Deferred income tax asset | 79,360 | |
Current liabilities | (4,507,907) | |
Non-current liabilities | (471,906) | |
Net assets acquired | $ 5,586,400 |
Revenues (Narrative) (Details)
Revenues (Narrative) (Details) - CAD ($) | 1 Months Ended | 12 Months Ended | |
Jun. 30, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of performance obligations [line items] | |||
Percentage of royalty on sales | 10% | ||
Intellectual properties [member] | |||
Disclosure of performance obligations [line items] | |||
Non-refundable fee for intellectual property | $ 3,300,000,000,000 | $ 3,600,000,000,000 | |
Transaction price allocated to unsatisfied contracts from sale of intellectual property | $ 26,741,550 | $ 34,258,148 | |
Expected period for revenue to be recognized | 3 years | ||
2023 | |||
Disclosure of performance obligations [line items] | |||
Transaction price allocated to unsatisfied contracts | $ 50,000 | ||
2024 | |||
Disclosure of performance obligations [line items] | |||
Transaction price allocated to unsatisfied contracts | 100,000 | ||
2025 | |||
Disclosure of performance obligations [line items] | |||
Transaction price allocated to unsatisfied contracts | 150,000 | ||
2026 | |||
Disclosure of performance obligations [line items] | |||
Transaction price allocated to unsatisfied contracts | $ 200,000 |
Revenues (Schedule of revenues
Revenues (Schedule of revenues by product line) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items] | ||
Revenue from contracts with customers by product line | $ 19,013,503 | $ 31,068,350 |
High purity metallurgical grade silicon & solar grade silicon from quartz (PUREVAP) | ||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items] | ||
Revenue from contracts with customers by product line | 6,272,697 | 6,138,111 |
Aluminium and zinc dross recovery (DROSRITE) | ||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items] | ||
Revenue from contracts with customers by product line | 1,912,807 | 7,940,771 |
Development and support related to systems supplied to the U.S. Navy | ||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items] | ||
Revenue from contracts with customers by product line | 1,288,356 | 7,522,809 |
Torch related sales | ||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items] | ||
Revenue from contracts with customers by product line | 5,558,210 | 2,084,511 |
Biogas upgrading and pollution controls | ||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items] | ||
Revenue from contracts with customers by product line | 3,347,443 | 6,800,090 |
Other sales and services | ||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items] | ||
Revenue from contracts with customers by product line | $ 633,990 | $ 582,058 |
Revenues (Schedule of revenue_2
Revenues (Schedule of revenues by recognition method) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure Of Disaggregation Of Revenue By Recognition Method [Line Items] | ||
Revenue from contracts with customers | $ 19,013,503 | $ 31,068,350 |
Revenue | 19,013,503 | 31,068,350 |
Intellectual properties [member] | ||
Disclosure Of Disaggregation Of Revenue By Recognition Method [Line Items] | ||
Revenue from contracts with customers | 3,600,000 | 3,300,000 |
Royalty [member] | ||
Disclosure Of Disaggregation Of Revenue By Recognition Method [Line Items] | ||
Revenue from contracts with customers | 280,842 | 315,846 |
Sales of goods under long-term contracts recognized over time [member] | ||
Disclosure Of Disaggregation Of Revenue By Recognition Method [Line Items] | ||
Revenue from contracts with customers | 13,997,163 | 25,918,594 |
Sales of goods at point of time [member] | ||
Disclosure Of Disaggregation Of Revenue By Recognition Method [Line Items] | ||
Revenue from contracts with customers | $ 1,135,498 | $ 1,533,910 |
Cash and cash equivalents (Narr
Cash and cash equivalents (Narrative) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of financial assets [line items] | ||
Proceeds from borrowings | $ 292,941 | $ 0 |
Restricted cash and cash equivalents | $ 0 | $ 0 |
Maximum | ||
Disclosure of financial assets [line items] | ||
Percentage of Interest on Investments | 0.86% | |
Minimum | ||
Disclosure of financial assets [line items] | ||
Percentage of Interest on Investments | 0.08% |
Cash and cash equivalents (Sche
Cash and cash equivalents (Schedule of cash and cash equivalents) (Details) - CAD ($) | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Cash and cash equivalents [Abstract] | |||
Restrictions on cash and cash equivalents | $ 0 | $ 0 | |
Cash | 3,445,649 | 3,568,561 | |
Guaranteed investment certificates | 0 | 8,633,952 | |
Cash and cash equivalents | $ 3,445,649 | $ 12,202,513 | $ 18,104,899 |
Accounts receivable (Narrative)
Accounts receivable (Narrative) (Details) - CAD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure Of Trade And Other Receivables [Line Items] | |||
Allowance for expected credit losses | $ 4,693,283 | $ 520,000 | $ 0 |
Allowance for credit loss, recognized during period | 4,150,000 | 512,592 | |
Carrying amount | 18,624,631 | 17,639,616 | |
Other trade receivables | $ 8,958,728 | 9,887,011 | |
Expected credit loss rate | 2% | ||
One specific customer | |||
Disclosure Of Trade And Other Receivables [Line Items] | |||
Allowance for credit loss, recognized during period | $ 3,765,000,000,000 | ||
Carrying amount | $ 9,045,231,000,000 | 12,810,231,000,000 | |
1 - 30 days | |||
Disclosure Of Trade And Other Receivables [Line Items] | |||
Expected credit loss rate | 1% | ||
31 - 60 days | |||
Disclosure Of Trade And Other Receivables [Line Items] | |||
Expected credit loss rate | 2% | ||
61 - 90 days | |||
Disclosure Of Trade And Other Receivables [Line Items] | |||
Expected credit loss rate | 3% | ||
Greater than 90 days | |||
Disclosure Of Trade And Other Receivables [Line Items] | |||
Allowance for expected credit losses | $ 4,693,283 | $ 520,000 | |
Allowance for expected credit loss included through business combination | $ 543,283 | ||
Expected credit loss rate | 10% |
Accounts receivable (Schedule o
Accounts receivable (Schedule of accounts receivable) (Details) - CAD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure Of Trade And Other Receivables [Line Items] | |||
Total trade accounts receivable | $ 22,697,242 | $ 17,038,913 | |
Holdback Receivable | 1,536,115 | 974,878 | |
Other receivables1 | 240,560 | 270,536 | |
Sales tax receivable | 380,112 | 850,167 | |
Accounts receivable | 18,624,631 | 17,639,616 | |
Allowance for expected credit losses | 4,693,283 | 520,000 | $ 0 |
Utilisation Allowance Account For Credit Losses Of Financial Assets | 4,150,000 | 512,592 | |
Current | |||
Disclosure Of Trade And Other Receivables [Line Items] | |||
Total trade accounts receivable | 6,578,269 | 1,919,786 | |
1 - 30 days | |||
Disclosure Of Trade And Other Receivables [Line Items] | |||
Total trade accounts receivable | 15,959 | 32,028 | |
31 - 60 days | |||
Disclosure Of Trade And Other Receivables [Line Items] | |||
Total trade accounts receivable | 57,944 | 7,006,652 | |
61 - 90 days | |||
Disclosure Of Trade And Other Receivables [Line Items] | |||
Total trade accounts receivable | 718,239 | 788,330 | |
Greater than 90 days | |||
Disclosure Of Trade And Other Receivables [Line Items] | |||
Total trade accounts receivable | 13,790,716 | 6,317,239 | |
Allowance for expected credit losses | 4,693,283 | $ 520,000 | |
Allowance for expected credit loss included through business combination | $ 543,283 |
Accounts receivable (Schedule_2
Accounts receivable (Schedule of allowance for credit losses) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Accounts receivable [Abstract] | ||
Loss allowance | $ 520,000 | $ 0 |
Loss recognized during the year | 4,150,000 | 512,592 |
Foreign exchange | 23,283 | 7,408 |
Loss allowance | $ 4,693,283 | $ 520,000 |
Costs and profits in excess o_2
Costs and profits in excess of billings on uncompleted contracts (Narrative) (Details) | 12 Months Ended | ||
Dec. 31, 2022 CAD ($) Item | Dec. 31, 2021 CAD ($) Item | Dec. 31, 2020 CAD ($) | |
Costs and profits in excess of billings on uncompleted contracts [Abstract] | |||
Number of contracts held | Item | 18 | 14 | |
Amount of billings on contracts | $ 10,475,299 | $ 16,676,700 | |
Cumulative revenue | 11,856,596 | 21,599,410 | |
Changes in the costs and profits in excess of billings on uncompleted contracts | 4,164,109 | 983,891 | |
Changes due to measurement of progress on uncompleted contracts | 622,696 | 4,832,968 | |
Current Costs And Profits In Excess Of Billings On Uncompleted Contracts | 1,051,297 | 4,922,710 | |
Disclosure of financial assets [line items] | |||
Allowance for expected credit losses | $ 4,693,283 | 520,000 | $ 0 |
Expected credit loss rate | 2% | ||
Maximum | |||
Disclosure of financial assets [line items] | |||
Credit loss rate | 50% | ||
Minimum | |||
Disclosure of financial assets [line items] | |||
Credit loss rate | 25% | ||
Uncompleted contracts | |||
Disclosure of financial assets [line items] | |||
Allowance for expected credit losses | $ 330,000 |
Investment tax credits (Narrati
Investment tax credits (Narrative) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of attribution of expenses by nature to their function [line items] | ||
Investment Tax Credits | $ 169,434 | $ 202,472 |
Investment Tax Credits Earned in Prior Years | (706,000) | |
Research and development, net [note 12] | 2,317,973 | 2,535,987 |
Cost of Sales and Services | ||
Disclosure of attribution of expenses by nature to their function [line items] | ||
Investment Tax Credits | 70,258 | 148,695 |
Research and Development Expense | ||
Disclosure of attribution of expenses by nature to their function [line items] | ||
Investment Tax Credits | 69,176 | 684,709 |
Research and Development Expenses Gross | 2,783,450 | 2,000,853 |
Government Grants, Investment Tax Credit | 296,043 | 149,575 |
Research and development, net [note 12] | 2,317,973 | 2,535,987 |
Selling General and Administrative Expenses | ||
Disclosure of attribution of expenses by nature to their function [line items] | ||
Investment Tax Credits | 30,000 | 32,486 |
SR&ED | ||
Disclosure of attribution of expenses by nature to their function [line items] | ||
Investment Tax Credits | $ 169,434 | $ 684,709 |
Strategic investments (Narrativ
Strategic investments (Narrative) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of detailed information about financial instruments [line items] | ||
Payments for purchase of investments | $ 3,604,000 | $ 10,588,857 |
Number of instruments exercised | 0 | |
Proceeds from exercise of warrants | $ 0 | 13,085,197 |
Gain From Initial Recognition Of Warrants Deferred | $ 280,926 | $ 510,573 |
HPQ Silicon Resources Inc. ("HPQ") shares - level 1 | ||
Disclosure of detailed information about financial instruments [line items] | ||
Number of instruments purchased | 6,800,000 | 8,268,000 |
Payments for purchase of investments | $ 3,196,000 | $ 8,070,109 |
Number of instruments disposed | (11,447,500) | (12,755,600) |
Decrease in investments through disposals | $ 3,922,244 | $ 14,252,732 |
Gain on disposal of investments | $ 9,893,900 | |
Number of instruments exercised | 16,250,000 | |
Proceeds from exercise of warrants | $ 2,518,750 | |
HPQ warrants - level 3 | ||
Disclosure of detailed information about financial instruments [line items] | ||
Number of instruments purchased | 6,800,000 | 0 |
Payments for purchase of investments | $ 408,000 | $ 0 |
Number of instruments disposed | 0 | 0 |
Decrease in investments through disposals | $ 0 | $ 0 |
Number of instruments exercised | (16,250,000) | |
Gain From Initial Recognition Of Warrants Deferred | $ 9,181,250 | |
HPQ Silicon Resources Inc. | ||
Disclosure of detailed information about financial instruments [line items] | ||
Percentage of ownership interest held | 9.82% | 9.64% |
Losses on disposals of investments | $ 225,527 |
Strategic investments (Schedule
Strategic investments (Schedule of components of strategic investments) (Details) - CAD ($) | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure of detailed information about financial instruments [line items] | |||
Strategic investments | $ 6,242,634 | $ 14,901,659 | |
Beauce Gold Fields ("BGF") shares - level 1 | |||
Disclosure of detailed information about financial instruments [line items] | |||
Strategic investments | 56,419 | 123,095 | $ 123,095 |
HPQ Silicon Resources Inc. ("HPQ") shares - level 1 | |||
Disclosure of detailed information about financial instruments [line items] | |||
Strategic investments | 5,415,749 | 12,306,196 | 16,489,220 |
HPQ warrants - level 3 | |||
Disclosure of detailed information about financial instruments [line items] | |||
Strategic investments | $ 770,466 | $ 2,472,368 | $ 23,379,435 |
Strategic investments (Schedu_2
Strategic investments (Schedule of changes in strategic investments) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Quantity | ||
Number of warrants, outstanding, beginning balance | 9,594,600 | |
Number of instruments exercised | 0 | |
Number of warrants, outstanding, ending balance | 16,394,600 | 9,594,600 |
Amount | ||
Beginning balance | $ 14,901,659 | |
Additions | 3,604,000 | $ 10,588,857 |
Ending balance | $ 6,242,634 | $ 14,901,659 |
Beauce Gold Fields ("BGF") shares - level 1 | ||
Quantity | ||
Number of warrants, outstanding, beginning balance | 1,025,794 | 1,025,794 |
Additions | 0 | 0 |
Number of instruments exercised | 0 | |
Disposed | 0 | 0 |
Change in the fair value | 0 | 0 |
Number of warrants, outstanding, ending balance | 1,025,794 | 1,025,794 |
Amount | ||
Beginning balance | $ 123,095 | $ 123,095 |
Additions | 0 | 0 |
Exercised | 0 | |
Disposed | 0 | 0 |
Change in the fair value | (66,676) | 0 |
Ending balance | $ 56,419 | $ 123,095 |
HPQ Silicon Resources Inc. ("HPQ") shares - level 1 | ||
Quantity | ||
Number of warrants, outstanding, beginning balance | 26,752,600 | 14,990,200 |
Additions | 6,800,000 | 8,268,000 |
Number of instruments exercised | 16,250,000 | |
Disposed | 11,447,500 | 12,755,600 |
Change in the fair value | 0 | 0 |
Number of warrants, outstanding, ending balance | 22,105,100 | 26,752,600 |
Amount | ||
Beginning balance | $ 12,306,196 | $ 16,489,220 |
Additions | 3,196,000 | 8,070,109 |
Exercised | 11,700,000 | |
Disposed | (3,922,244) | (14,252,732) |
Change in the fair value | (6,164,203) | (9,700,401) |
Ending balance | $ 5,415,749 | $ 12,306,196 |
HPQ warrants - level 3 | ||
Quantity | ||
Number of warrants, outstanding, beginning balance | 9,594,600 | 25,844,600 |
Additions | 6,800,000 | 0 |
Number of instruments exercised | (16,250,000) | |
Disposed | 0 | 0 |
Change in the fair value | 0 | 0 |
Number of warrants, outstanding, ending balance | 16,394,600 | 9,594,600 |
Amount | ||
Beginning balance | $ 2,472,368 | $ 23,379,435 |
Additions | 408,000 | 0 |
Exercised | (9,181,250) | |
Disposed | 0 | 0 |
Change in the fair value | (2,109,902) | (11,725,817) |
Ending balance | $ 770,466 | $ 2,472,368 |
Strategic investments (Details
Strategic investments (Details and activity of the HPQ warrants) (Details) | 12 Months Ended |
Dec. 31, 2022 $ / shares shares | |
Disclosure of detailed information about financial instruments [line items] | |
Number of warrants, outstanding, beginning balance | 9,594,600 |
Addition | 6,800,000 |
Exercised | 0 |
Number of warrants, outstanding, ending balance | 16,394,600 |
April 29, 2023 | |
Disclosure of detailed information about financial instruments [line items] | |
Number of warrants, outstanding, beginning balance | 1,200,000 |
Addition | 0 |
Exercised | 0 |
Number of warrants, outstanding, ending balance | 1,200,000 |
Exercise price ($) | $ / shares | $ 0.10 |
June 2, 2023 | |
Disclosure of detailed information about financial instruments [line items] | |
Number of warrants, outstanding, beginning balance | 4,394,600 |
Addition | 0 |
Exercised | 0 |
Number of warrants, outstanding, ending balance | 4,394,600 |
Exercise price ($) | $ / shares | $ 0.10 |
September 3, 2023 | |
Disclosure of detailed information about financial instruments [line items] | |
Number of warrants, outstanding, beginning balance | 4,000,000 |
Addition | 0 |
Exercised | 0 |
Number of warrants, outstanding, ending balance | 4,000,000 |
Exercise price ($) | $ / shares | $ 0.61 |
August 20, 2024 | |
Disclosure of detailed information about financial instruments [line items] | |
Number of warrants, outstanding, beginning balance | 0 |
Addition | 6,800,000 |
Exercised | 0 |
Number of warrants, outstanding, ending balance | 6,800,000 |
Exercise price ($) | $ / shares | $ 0.60 |
Strategic investments (Schedu_3
Strategic investments (Schedule of assumptions used in estimating fair value of the HPQ warrants) (Details) | Dec. 31, 2022 Item $ / shares shares | Apr. 20, 2022 Item $ / shares shares | Dec. 31, 2021 Item $ / shares shares |
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Number of warrants | shares | 16,394,600 | 9,594,600 | |
HPQ warrants issued on April 29, 2020 | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Number of warrants | shares | 1,200,000 | 1,200,000 | |
Exercise price ($) | $ / shares | $ 0.1 | $ 0.1 | |
HPQ warrants issued on April 29, 2020 | At fair value | Black-Scholes option pricing model | Fair value of the shares ($) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 0.25 | 0.46 | |
HPQ warrants issued on April 29, 2020 | At fair value | Black-Scholes option pricing model | Risk free interest rate (%) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 4.03 | 1.22 | |
HPQ warrants issued on April 29, 2020 | At fair value | Black-Scholes option pricing model | Expected volatility (%) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 80.55 | 89.88 | |
HPQ warrants issued on April 29, 2020 | At fair value | Black-Scholes option pricing model | Contractual remaining life (in months) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 4 | 16 | |
HPQ warrants issued on June 2, 2020 | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Number of warrants | shares | 4,394,600 | 4,394,600 | |
Exercise price ($) | $ / shares | $ 0.1 | $ 0.1 | |
HPQ warrants issued on June 2, 2020 | At fair value | Black-Scholes option pricing model | Fair value of the shares ($) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 0.25 | 0.46 | |
HPQ warrants issued on June 2, 2020 | At fair value | Black-Scholes option pricing model | Risk free interest rate (%) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 4.03 | 1.22 | |
HPQ warrants issued on June 2, 2020 | At fair value | Black-Scholes option pricing model | Expected volatility (%) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 73.74 | 94.01 | |
HPQ warrants issued on June 2, 2020 | At fair value | Black-Scholes option pricing model | Contractual remaining life (in months) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 5 | 17 | |
HPQ warrants issued on Sept. 3, 2020 | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Number of warrants | shares | 4,000,000 | 6,800,000 | 4,000,000 |
Exercise price ($) | $ / shares | $ 0.61 | $ 0.60 | $ 0.61 |
HPQ warrants issued on Sept. 3, 2020 | At fair value | Black-Scholes option pricing model | Fair value of the shares ($) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 0.25 | 0.47 | 0.46 |
HPQ warrants issued on Sept. 3, 2020 | At fair value | Black-Scholes option pricing model | Risk free interest rate (%) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 4.03 | 2.47 | 1.22 |
HPQ warrants issued on Sept. 3, 2020 | At fair value | Black-Scholes option pricing model | Expected volatility (%) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 76.85 | 1.0760 | 110.47 |
HPQ warrants issued on Sept. 3, 2020 | At fair value | Black-Scholes option pricing model | Contractual remaining life (in months) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 8 | 24 | 20 |
HPQ warrants issued on April 20, 2022 | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Number of warrants | shares | 6,800,000 | ||
Exercise price ($) | $ / shares | $ 0.60 | ||
HPQ warrants issued on April 20, 2022 | At fair value | Black-Scholes option pricing model | Fair value of the shares ($) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 0.25 | ||
HPQ warrants issued on April 20, 2022 | At fair value | Black-Scholes option pricing model | Risk free interest rate (%) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 4.03 | ||
HPQ warrants issued on April 20, 2022 | At fair value | Black-Scholes option pricing model | Expected volatility (%) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 74.58 | ||
HPQ warrants issued on April 20, 2022 | At fair value | Black-Scholes option pricing model | Contractual remaining life (in months) | |||
Disclosure of significant unobservable inputs used in fair value measurement of assets [line items] | |||
Significant unobservable input, assets | 16 |
Royalties receivable (Narrative
Royalties receivable (Narrative) (Details) - CAD ($) | 12 Months Ended | ||||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2016 | Nov. 03, 2020 | |
Disclosure of performance obligations [line items] | |||||
Percentage of royalty on net sales | 10% | ||||
Royalties recognized during the year | $ 450,000 | $ 450,000 | |||
Discounting rate for royalties | 12.50% | 12.50% | |||
Derivative, fair value | |||||
Noncurrent Royalties Receivable | 1,407,786 | $ 1,258,654 | $ 1,060,000 | ||
Receipts from royalties, fees, commissions and other revenue | $ 250,000 | 250,000 | |||
HPQ Nano Silicon Powders Inc. | Conversion of future royalties to equity stake | |||||
Disclosure of performance obligations [line items] | |||||
Proportion Of Ownership Interest Held | 50% | ||||
HPQ Silica Polvere Inc. | Conversion of future royalties to equity stake | |||||
Disclosure of performance obligations [line items] | |||||
Proportion Of Ownership Interest Held | 50% | ||||
HPQ 2016 Contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price received | $ 1,000,000 | ||||
Percentage of royalty on net sales | 10% | ||||
Royalties recognized during the year | $ 250,000 | 250,000 | |||
Receipts from royalties, fees, commissions and other revenue | $ 250,000 | 200,000 | |||
HPQ Nano Contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price received | 3,300,000 | $ 2,400,000 | |||
Percentage of royalty on net sales | 10% | ||||
Royalties recognized during the year | $ 200,000 | 200,000 | |||
Receipts from royalties, fees, commissions and other revenue | $ 50,000 | ||||
HPQ Polvere contract | |||||
Disclosure of performance obligations [line items] | |||||
Percentage of royalty on net sales | 10% | ||||
Less than one year | HPQ 2016 Contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price allocated to unsatisfied contracts from sale of intellectual property | $ 200,000 | ||||
Less than one year | HPQ Nano Contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price allocated to unsatisfied contracts from sale of intellectual property | 50,000 | ||||
Less than one year | HPQ Polvere contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price allocated to unsatisfied contracts from sale of intellectual property | 50,000 | ||||
Later Than One Year And Not Later Than Two Years [Member] | HPQ 2016 Contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price allocated to unsatisfied contracts from sale of intellectual property | 250,000 | ||||
Later Than One Year And Not Later Than Two Years [Member] | HPQ Nano Contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price allocated to unsatisfied contracts from sale of intellectual property | 100,000 | ||||
2-3 years | HPQ Nano Contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price allocated to unsatisfied contracts from sale of intellectual property | 150,000 | ||||
Later Than Three Years And Not Later Than Four Years [Member] | HPQ Nano Contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price allocated to unsatisfied contracts from sale of intellectual property | 200,000 | ||||
Later Than Three Years And Not Later Than Four Years [Member] | HPQ Polvere contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price allocated to unsatisfied contracts from sale of intellectual property | 100,000 | ||||
2025 | HPQ Polvere contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price allocated to unsatisfied contracts from sale of intellectual property | 150,000 | ||||
2026 | HPQ Polvere contract | |||||
Disclosure of performance obligations [line items] | |||||
Transaction price allocated to unsatisfied contracts from sale of intellectual property | $ 200,000 |
Royalties receivable (Schedule
Royalties receivable (Schedule of royalties receivable) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Royalties receivable [Abstract] | ||
Opening balance | $ 1,258,654 | $ 1,060,000 |
Accretion interest | 118,290 | 132,809 |
Royalties recognized during the year | 450,000 | 450,000 |
Discounting | (169,158) | (134,155) |
Amounts received during the year | (250,000) | (250,000) |
Balance at end of the year | 1,407,786 | 1,258,654 |
Current portion | 455,556 | 311,111 |
Non Current Portion Of Royalties Receivable | $ 952,230 | $ 947,543 |
Deposits (Schedule of component
Deposits (Schedule of components of deposits) (Details) - CAD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Current portion: | ||
Suppliers | $ 392,309 | $ 1,236,211 |
Security deposit on leased premises | 40,241 | (92,241) |
Total current | 432,550 | 1,328,452 |
Non-current portion: | ||
Suppliers | 7,250 | 1,952 |
Security deposit on leased premises | 38,803 | 246,804 |
Total non-current | 46,053 | 248,756 |
Total Deposits | $ 478,603 | $ 1,577,208 |
Property and equipment (Schedul
Property and equipment (Schedule of components and movements in property and equipment) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | $ 3,712,937 | |
Additions | 867,110 | $ 2,120,893 |
Ending balance | 3,393,452 | 3,712,937 |
Cost | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 6,138,327 | 4,598,857 |
Acquired through business combination | 42,552 | |
Additions | 284,409 | 1,496,918 |
Ending balance | 6,422,736 | 6,138,327 |
Accumulated depreciation and amortisation | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | (2,425,390) | (2,069,287) |
Depreciation | 603,894 | 356,103 |
Ending balance | (3,029,284) | (2,425,390) |
Computer equipment | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 211,706 | |
Ending balance | 229,215 | 211,706 |
Computer equipment | Cost | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 809,228 | 549,659 |
Acquired through business combination | 13,585 | |
Additions | 164,059 | 245,984 |
Ending balance | 973,287 | 809,228 |
Computer equipment | Accumulated depreciation and amortisation | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | (597,522) | (509,112) |
Depreciation | 146,550 | 88,410 |
Ending balance | (744,072) | (597,522) |
Machinery and equipment | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 410,577 | |
Ending balance | 1,090,143 | 410,577 |
Machinery and equipment | Cost | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 2,034,958 | 1,621,899 |
Acquired through business combination | 28,967 | |
Additions | 384,092 | |
Adjustment To Additions | 89,085 | |
Assets under construction put in service | 1,065,672 | |
Ending balance | 3,011,545 | 2,034,958 |
Machinery and equipment | Accumulated depreciation and amortisation | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | (1,624,381) | (1,441,642) |
Depreciation | 297,021 | 182,739 |
Ending balance | (1,921,402) | (1,624,381) |
Automobile | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 254,952 | |
Ending balance | 197,409 | 254,952 |
Automobile | Cost | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 336,659 | 306,164 |
Acquired through business combination | 0 | |
Additions | 0 | 30,495 |
Ending balance | 336,659 | 336,659 |
Automobile | Accumulated depreciation and amortisation | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | (81,707) | (21,748) |
Depreciation | 57,543 | 59,959 |
Ending balance | (139,250) | (81,707) |
Leasehold improvements | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 811,325 | |
Ending balance | 1,876,685 | 811,325 |
Leasehold improvements | Cost | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 933,105 | 180,901 |
Acquired through business combination | 0 | |
Additions | 209,435 | 752,204 |
Assets under construction put in service | 958,705 | |
Ending balance | 2,101,245 | 933,105 |
Leasehold improvements | Accumulated depreciation and amortisation | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | (121,780) | (96,785) |
Depreciation | 102,780 | 24,995 |
Ending balance | (224,560) | (121,780) |
Construction in progress | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 2,024,377 | |
Ending balance | 0 | 2,024,377 |
Construction in progress | Cost | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 2,024,377 | 1,940,234 |
Acquired through business combination | 0 | |
Additions | 0 | 84,143 |
Assets under construction put in service | (2,024,377) | |
Ending balance | 0 | 2,024,377 |
Construction in progress | Accumulated depreciation and amortisation | ||
Disclosure of detailed information about property, plant and equipment [line items] | ||
Beginning balance | 0 | 0 |
Depreciation | 0 | 0 |
Ending balance | $ 0 | $ 0 |
Leases (Narrative) (Details)
Leases (Narrative) (Details) - CAD ($) | 12 Months Ended | ||||
Sep. 01, 2022 | Jan. 01, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure of quantitative information about right-of-use assets [line items] | |||||
Prepayment of rent | $ 1,178,530 | ||||
Remeasurement of lease liabilities | $ (311,421) | ||||
Percentage of discount rate used for remeasurement of lease liabilities. | 8.60% | 4% | |||
Right-of-use assets | 4,818,744 | $ 5,765,993 | 3,701,000 | ||
Lease liabilities | 5,533,694 | 5,323,965 | 2,988,542 | ||
Expense related to lease payments excluded in the measurement of lease liabilities | 243,209 | 178,707 | |||
Lease reimbursement amount | $ 1,070,264 | ||||
Increase (decrease) in lease liability | $ (203,154) | $ 1,070,264 | |||
Decrease in right-of-use assets | (203,154) | $ (108,267) | |||
Lease deposit amount | $ 275,000 | ||||
Trust beneficially owned by the controlling shareholder and CEO | |||||
Disclosure of quantitative information about right-of-use assets [line items] | |||||
Prepayment of rent | $ 1,178,530 | ||||
Percentage of discount rate used for remeasurement of lease liabilities. | 4% | ||||
Right-of-use assets | $ 680,980 | 1,107,131 | |||
Lease liabilities | $ 799,090 |
Leases (Schedule of components
Leases (Schedule of components and movements in right of use assets) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of quantitative information about right-of-use assets [line items] | ||
Beginning balance | $ 5,765,993 | $ 3,701,000 |
Modification of lease agreements | (311,421) | |
Additions - business combination | 477,608 | |
Additions | 2,157,796 | |
Depreciation | (635,828) | (570,411) |
Ending balance | 4,818,744 | 5,765,993 |
Land and building | ||
Disclosure of quantitative information about right-of-use assets [line items] | ||
Beginning balance | 5,757,537 | 3,688,315 |
Modification of lease agreements | (311,421) | |
Additions - business combination | 477,608 | |
Additions | 2,157,796 | |
Depreciation | (631,600) | (566,182) |
Ending balance | 4,814,516 | 5,757,537 |
Computer equipment | ||
Disclosure of quantitative information about right-of-use assets [line items] | ||
Beginning balance | 8,457 | 12,685 |
Modification of lease agreements | 0 | |
Additions - business combination | 0 | |
Additions | 0 | |
Depreciation | (4,228) | (4,228) |
Ending balance | $ 4,229 | $ 8,457 |
Leases (Schedule of movements i
Leases (Schedule of movements in lease liabilities) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Leases | ||
Beginning balance | $ 5,323,965 | $ 2,988,542 |
Addition - business acquisition | 867,110 | 477,608 |
Additions | 867,110 | 2,120,893 |
Payments | (657,381) | (263,078) |
Ending balance | 5,533,694 | 5,323,965 |
Current portion | 2,672,212 | 2,934,236 |
Non-current portion | $ 2,861,482 | $ 2,389,729 |
Leases (Schedule of amount reco
Leases (Schedule of amount recognized in the statement of comprehensive loss) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Leases | ||
Depreciation of right-of-use assets | $ 635,828 | $ 570,411 |
Interest on lease liabilities | 378,611 | 307,691 |
Expense related to lease payments excluded in the measurement of lease liabilities | $ 243,209 | $ 178,707 |
Leases (Schedule of maturity an
Leases (Schedule of maturity analysis for contractual undiscounted cash flows of lease liabilities) (Details) | Dec. 31, 2022 CAD ($) |
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | |
Gross lease liabilities | $ 6,745,329 |
Less than one year | |
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | |
Gross lease liabilities | 2,984,243 |
Later Than One Year And Not Later Than Two Years [Member] | |
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | |
Gross lease liabilities | 592,719 |
2-3 years | |
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | |
Gross lease liabilities | 572,562 |
Later Than Three Years And Not Later Than Four Years [Member] | |
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | |
Gross lease liabilities | 474,484 |
4-5 years | |
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | |
Gross lease liabilities | 229,332 |
Over 5 years | |
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | |
Gross lease liabilities | $ 1,891,989 |
Intangible assets (Schedule of
Intangible assets (Schedule of components and movements in intangible assets) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | $ 2,774,198 | |
Acquired through business combination | 867,110 | $ 477,608 |
Ending balance | 2,104,848 | 2,774,198 |
Cost | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 3,262,216 | 1,013,263 |
Acquired through business combination | 2,120,000 | |
Additions | 208,680 | 214,497 |
Write-off | (85,544) | |
Ending balance | 3,470,896 | 3,262,216 |
Accumulated depreciation and amortisation | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | (488,018) | (107,649) |
Amortization | 878,030 | 380,369 |
Ending balance | (1,366,048) | (488,018) |
Production backlog | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 1,766,667 | |
Ending balance | 918,667 | 1,766,667 |
Production backlog | Cost | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 2,120,000 | 0 |
Acquired through business combination | 2,120,000 | |
Additions | 0 | 0 |
Write-off | 0 | |
Ending balance | 2,120,000 | 2,120,000 |
Production backlog | Accumulated depreciation and amortisation | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | (353,333) | 0 |
Amortization | 848,000 | 353,333 |
Ending balance | (1,201,333) | (353,333) |
Patents | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 828,692 | |
Ending balance | 1,023,850 | 828,692 |
Patents | Cost | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 897,345 | 768,392 |
Acquired through business combination | 0 | |
Additions | 208,680 | 214,497 |
Write-off | (85,544) | |
Ending balance | 1,106,025 | 897,345 |
Patents | Accumulated depreciation and amortisation | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | (68,653) | (58,125) |
Amortization | 13,522 | 10,528 |
Ending balance | (82,175) | (68,653) |
Development costs | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 178,839 | |
Ending balance | 162,331 | 178,839 |
Development costs | Cost | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | 244,871 | 244,871 |
Acquired through business combination | 0 | |
Additions | 0 | 0 |
Write-off | 0 | |
Ending balance | 244,871 | 244,871 |
Development costs | Accumulated depreciation and amortisation | ||
Disclosure of detailed information about intangible assets [line items] | ||
Beginning balance | (66,032) | (49,524) |
Amortization | 16,508 | 16,508 |
Ending balance | $ (82,540) | $ (66,032) |
Goodwill (Narrative) (Details)
Goodwill (Narrative) (Details) - Goodwill [member] - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of impairment loss recognised or reversed for cash-generating unit [line items] | ||
Discount rate | 12.50% | 8% |
Terminal growth rate | 2% | 2% |
Impairment loss | $ 0 |
Accounts payable and accrued _3
Accounts payable and accrued liabilities (Schedule of components of accounts payable and accrued liabilities) (Details) - CAD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Disclosure Of Trade And Other Current Payables [Line Items] | ||
Accounts payable | $ 6,065,996 | $ 5,457,259 |
Accrued liabilities | 2,891,053 | 3,730,048 |
Sale commissions payable | 904,724 | 737,364 |
Accounts payable to the controlling shareholder and CEO | 254,097 | 144,506 |
Accounts payable and accrued liabilities [note 19] | $ 10,115,870 | $ 10,069,177 |
Billings in excess of costs a_2
Billings in excess of costs and profits on uncompleted contracts (Narrative) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Billings in excess of costs and profits on uncompleted contracts | ||
Amounts of payments to date received on contracts in progress. | $ 37,374,909 | $ 21,834,137 |
Payments to date received on contracts in progress | 47,045,902 | 31,234,368 |
Revenue that was included in contract liability balance at beginning of period | 2,416,229 | 6,268,910 |
Increase through cash received excluding amounts recognized as revenue | $ 2,686,991 | $ 9,076,169 |
Term loans (Narrative) (Details
Term loans (Narrative) (Details) | 12 Months Ended | ||
Mar. 05, 2020 CAD ($) Item | Dec. 31, 2023 | Dec. 31, 2022 CAD ($) | |
Disclosure of detailed information about borrowings [line items] | |||
Interest rate per annum (as a percent) | 3% | ||
Machinery and equipment | Cost | |||
Disclosure of detailed information about borrowings [line items] | |||
Reduction of the property and equipment | $ 89,085 | ||
EDC Loan | |||
Disclosure of detailed information about borrowings [line items] | |||
Repayable Contribution Agreement Maximum Amount | $ 450,000 | ||
Notional amount | $ 292,941 | ||
Number of equal monthly instalments for repayment | Item | 60 | ||
Repayment period | 24 months | ||
Effective interest (as a percent) | 8% | ||
Other Term Loans, two | |||
Disclosure of detailed information about borrowings [line items] | |||
Interest rate per annum (as a percent) | 7.45% | ||
Monthly instalment amount | $ 1,660 | ||
Canada Emergency Business Account Loan | |||
Disclosure of detailed information about borrowings [line items] | |||
Interest rate per annum (as a percent) | 0% | ||
Minimum repayment amount, if repaid by December 2023 | $ 0 | ||
Canada Emergency Business Account Loan | Forecast [Member] | |||
Disclosure of detailed information about borrowings [line items] | |||
Repayment period | 24 months | ||
Interest rate per annum (as a percent) | 5% |
Term loans (Schedule of compone
Term loans (Schedule of components and movements of term loans) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of detailed information about borrowings [line items] | ||
Beginning balance | $ 190,905 | $ 112,707 |
Assumed through business combination | 86,520 | |
Additions | 292,941 | |
Discounting | (89,085) | |
Accretion | 28,229 | 12,185 |
Payments | (33,003) | (20,507) |
Ending balance | 389,987 | 190,905 |
Less current portion | (69,917) | (83,004) |
Non-current portion of non-current borrowings | $ 320,070 | 107,901 |
Interest rate | 3% | |
EDC Loan | ||
Disclosure of detailed information about borrowings [line items] | ||
Beginning balance | $ 87,985 | 75,800 |
Assumed through business combination | 0 | |
Additions | 292,941 | |
Discounting | (89,085) | |
Accretion | 28,229 | 12,185 |
Payments | 0 | 0 |
Ending balance | 320,070 | 87,985 |
Less current portion | 0 | |
Non-current portion of non-current borrowings | 320,070 | |
Other Term Loans, one | ||
Disclosure of detailed information about borrowings [line items] | ||
Beginning balance | 24,700 | 36,907 |
Assumed through business combination | 0 | |
Discounting | 0 | |
Accretion | 0 | 0 |
Payments | (13,083) | (12,207) |
Ending balance | 11,617 | 24,700 |
Less current portion | (11,617) | |
Non-current portion of non-current borrowings | $ 0 | |
Interest rate | 6.95% | |
Monthly instalment amount | $ 1,200 | |
Carrying amount of automobile pledged as security | 10,795 | |
Other Term Loans, two | ||
Disclosure of detailed information about borrowings [line items] | ||
Beginning balance | 28,220 | 0 |
Assumed through business combination | 36,520 | |
Discounting | 0 | |
Accretion | 0 | 0 |
Payments | (19,920) | (8,300) |
Ending balance | 8,300 | 28,220 |
Less current portion | (8,300) | |
Non-current portion of non-current borrowings | $ 0 | |
Interest rate | 7.45% | |
Monthly instalment amount | $ 1,660 | |
Canada Emergency Business Account Loan | ||
Disclosure of detailed information about borrowings [line items] | ||
Beginning balance | 50,000 | 0 |
Assumed through business combination | 50,000 | |
Discounting | 0 | |
Accretion | 0 | 0 |
Payments | 0 | 0 |
Ending balance | 50,000 | $ 50,000 |
Less current portion | (50,000) | |
Non-current portion of non-current borrowings | 0 | |
Minimum repayment amount, if repaid by December 2023 | $ 0 | |
Interest rate | 0% |
Shareholders' equity (Narrative
Shareholders' equity (Narrative) (Details) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||||||||
Dec. 31, 2022 CAD ($) shares $ / shares | Oct. 19, 2022 CAD ($) $ / shares shares | Jul. 03, 2022 shares $ / shares | Jun. 02, 2022 shares $ / shares | Apr. 05, 2022 shares $ / shares | Jan. 03, 2022 shares $ / shares | Dec. 30, 2021 shares $ / shares | Dec. 17, 2021 shares $ / shares | Oct. 14, 2021 shares $ / shares | Jun. 14, 2021 shares $ / shares | Jun. 01, 2021 shares $ / shares | Apr. 06, 2021 shares $ / shares | Oct. 31, 2022 CAD ($) | Mar. 30, 2023 $ / shares | Dec. 31, 2022 CAD ($) shares months $ / shares | Dec. 31, 2021 CAD ($) shares $ / shares | Feb. 28, 2022 shares | Jan. 31, 2021 shares | Dec. 31, 2020 shares $ / shares | |
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Gross proceeds | $ 1,318,980 | $ 1,318,980 | $ 0 | ||||||||||||||||
Exercise price of common share purchase warrant | $ / shares | $ 1.75 | $ 1.75 | |||||||||||||||||
Number of options exercised | shares | 2,440,000 | 3,482,000 | |||||||||||||||||
Number of warrants exercised | shares | 0 | 8,146,483 | |||||||||||||||||
Net proceeds from exercise of options | $ 1,412,799 | $ 1,109,818 | |||||||||||||||||
Proceeds from issuance of shares upon exercise of warrants | 0 | 13,085,197 | |||||||||||||||||
Ascribed value from contributed surplus | $ (1,412,799) | (1,109,818) | |||||||||||||||||
Equity component allocated to share capital | $ 13,085,197 | ||||||||||||||||||
Number of Class A common shares authorized to be repurchased | shares | 7,500,000 | 5,000,000 | |||||||||||||||||
Number of Class A common shares repurchased and cancelled | shares | 0 | 840,094 | |||||||||||||||||
Weighted average share price of Class A common shares | $ / shares | $ 4.96 | ||||||||||||||||||
Total cash consideration for repurchase and cancellation of Class A common shares | $ 0 | $ 4,183,617 | |||||||||||||||||
Commission for repurchase and cancellation of Class A common shares | 16,678 | ||||||||||||||||||
Excess of total consideration over the carrying amount of Class A common shares | $ 4,183,617 | ||||||||||||||||||
Percentage of total share capital that can be granted as stock options per person | 5% | ||||||||||||||||||
Number of options granted or recognized | shares | 1,500,000 | 100,000 | 100,000 | 200,000 | 2,475,000 | 2,970,000 | |||||||||||||
Exercise price of stock options granted | $ / shares | $ 1.03 | $ 3.88 | $ 3.36 | $ 3.61 | $ 6.70 | $ 6.59 | $ 8.47 | $ 3.55 | $ 4.55 | ||||||||||
Number of options that will vest | shares | 100,000 | 200,000 | 250,000 | ||||||||||||||||
Fair value of stock options | $ 1,095,780 | ||||||||||||||||||
Share-based compensation | $ 5,538,463 | $ 9,762,745 | |||||||||||||||||
Stock-based compensation expense to be amortized | $ 3,184,866 | 3,184,866 | 2,719,354 | ||||||||||||||||
Term of the stock options granted | 5 years | 5 years | 5 years | ||||||||||||||||
Net proceeds from exercise of warrants | $ 12,396,107 | ||||||||||||||||||
Fair value of stock options per share | $ / shares | $ 1.08 | $ 2.02 | $ 2.37 | $ 2.99 | |||||||||||||||
Weighted average exercise price of share options outstanding in share-based payment arrangement | $ / shares | $ 3.96 | $ 3.96 | $ 3.10 | $ 1.57 | |||||||||||||||
Number of share options outstanding in share-based payment arrangement | shares | 8,195,500 | 8,195,500 | 8,403,000 | 9,040,000 | |||||||||||||||
Warrants | $ 223,200 | $ 223,200 | $ 223,200 | $ 0 | |||||||||||||||
At the date of the grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 25% | 25% | 25% | 30% | |||||||||||||||
At the date of the grant | Vesting of remaining 100,000 stock options | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 10% | ||||||||||||||||||
At the first anniversary of the date of grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 25% | 25% | 25% | 35% | |||||||||||||||
At the first anniversary of the date of grant | Vesting of remaining 100,000 stock options | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 20% | ||||||||||||||||||
At the second anniversary of the date of grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 25% | 25% | 25% | 35% | |||||||||||||||
At the second anniversary of the date of grant | Vesting of remaining 100,000 stock options | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 30% | ||||||||||||||||||
At the third anniversary of the date of grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 25% | 25% | 25% | ||||||||||||||||
At the third anniversary of the date of grant | Vesting of remaining 100,000 stock options | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 40% | ||||||||||||||||||
Consultants | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Percentage of total share capital that can be granted as stock options per person | 2% | ||||||||||||||||||
Employees | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Number of options granted or recognized | shares | 125,000 | 400,000 | 100,000 | 975,000 | |||||||||||||||
Exercise price of stock options granted | $ / shares | $ 2.14 | $ 2.96 | $ 1.03 | ||||||||||||||||
Number of options that will vest | shares | 975,000 | ||||||||||||||||||
Term of the stock options granted | 5 years | 5 years | 5 years | 5 years | |||||||||||||||
Employees | Vesting of remaining 100,000 stock options | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Number of options that will vest | shares | 100,000 | ||||||||||||||||||
Employees | At the date of the grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 10% | 10% | 10% | ||||||||||||||||
Employees | At the first anniversary of the date of grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 20% | 20% | 20% | ||||||||||||||||
Employees | At the second anniversary of the date of grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 30% | 30% | 30% | ||||||||||||||||
Employees | At the third anniversary of the date of grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 40% | 40% | 40% | ||||||||||||||||
Member of Board of Director | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Number of options granted or recognized | shares | 500,000 | 900,000 | 300,000 | 650,000 | |||||||||||||||
Exercise price of stock options granted | $ / shares | $ 3.02 | ||||||||||||||||||
Term of stock options granted | months | 60 | ||||||||||||||||||
Number of options that will vest | shares | 200,000 | ||||||||||||||||||
Term of the stock options granted | 5 years | 5 years | |||||||||||||||||
Member of Board of Director, One | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Number of options granted or recognized | shares | 100,000 | ||||||||||||||||||
Member of Board of Director, Two | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Number of options granted or recognized | shares | 200,000 | ||||||||||||||||||
President & Chief Executive Officer | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Number of options granted or recognized | shares | 150,000 | 600,000 | 150,000 | 1,920,000 | 150,000 | ||||||||||||||
Exercise price of stock options granted | $ / shares | $ 3.13 | ||||||||||||||||||
Term of the stock options granted | 5 years | ||||||||||||||||||
Expenses related to stock options granted | $ 453,204 | ||||||||||||||||||
Chief Financial Officer | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Number of options granted or recognized | shares | 100,000 | ||||||||||||||||||
Exercise price of stock options granted | $ / shares | $ 5.04 | ||||||||||||||||||
Number of options that will vest | shares | 100,000 | ||||||||||||||||||
Term of the stock options granted | 5 years | ||||||||||||||||||
Chief Financial Officer | At the date of the grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 10% | ||||||||||||||||||
Chief Financial Officer | At the first anniversary of the date of grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 20% | ||||||||||||||||||
Chief Financial Officer | At the second anniversary of the date of grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 30% | ||||||||||||||||||
Chief Financial Officer | At the third anniversary of the date of grant | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Vesting percentage | 40% | ||||||||||||||||||
Officer | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Term of the stock options granted | 5 years | ||||||||||||||||||
Contributed Surplus [Member] | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Ascribed value from contributed surplus | 870,558 | 364,000 | |||||||||||||||||
Equity component allocated to share capital | 0 | ||||||||||||||||||
Excess of total consideration over the carrying amount of Class A common shares | 0 | ||||||||||||||||||
Deficit [Member] | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Ascribed value from contributed surplus | $ 0 | 0 | |||||||||||||||||
Equity component allocated to share capital | 0 | ||||||||||||||||||
Excess of total consideration over the carrying amount of Class A common shares | $ 3,778,619 | ||||||||||||||||||
Bought-deal short form prospectus offering | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Number of compensation options | shares | 191,414 | ||||||||||||||||||
Proceeds from exercise of compensation options | $ 689,090 | ||||||||||||||||||
Non-brokered private placement | |||||||||||||||||||
Disclosure of classes of share capital [line items] | |||||||||||||||||||
Number of units issued | shares | 1,014,600 | ||||||||||||||||||
Issuance price per unit | $ / shares | $ 1.30 | ||||||||||||||||||
Gross proceeds | $ 1,318,980 | ||||||||||||||||||
Number of common shares that each unit entitles | shares | 1 | ||||||||||||||||||
Number of common shares that each common share purchase warrant entitles | shares | 1 | ||||||||||||||||||
Exercise price of common share purchase warrant | $ / shares | $ 1.75 | ||||||||||||||||||
Term of common share purchase warrant | 24 months |
Shareholders' equity (Schedule
Shareholders' equity (Schedule of activity in stock options) (Details) | 12 Months Ended | ||||||||
Dec. 31, 2022 shares $ / shares | Jun. 02, 2022 shares $ / shares | Jan. 03, 2022 $ / shares | Dec. 30, 2021 shares $ / shares | Jun. 14, 2021 shares $ / shares | Jun. 01, 2021 shares $ / shares | Apr. 06, 2021 $ / shares | Dec. 31, 2022 shares $ / shares | Dec. 31, 2021 shares $ / shares | |
Number of options | |||||||||
Beginning balance | shares | 8,403,000 | 9,040,000 | |||||||
Granted | shares | 1,500,000 | 100,000 | 100,000 | 200,000 | 2,475,000 | 2,970,000 | |||
Exercised | shares | (2,440,000) | (3,482,000) | |||||||
Forfeited | shares | (242,500) | (125,000) | |||||||
Ending balance | shares | 8,195,500 | 8,195,500 | 8,403,000 | ||||||
Weighted average exercise price | |||||||||
Beginning balance | $ 3.10 | $ 1.57 | |||||||
Granted | $ 1.03 | $ 3.88 | $ 3.36 | $ 3.61 | $ 6.70 | $ 6.59 | $ 8.47 | 3.55 | 4.55 |
Exercised | 0.58 | 0.32 | |||||||
Forfeited | 4.07 | 4.41 | |||||||
Ending balance | 3.96 | 3.96 | 3.10 | ||||||
Fair market value | $ 1.44 | $ 1.44 | $ 5.48 |
Shareholders' equity (Schedul_2
Shareholders' equity (Schedule of assumptions used in measurement of fair value of stock options) (Details) | 12 Months Ended | |||||||||
Dec. 31, 2022 shares $ / shares | Jun. 02, 2022 shares $ / shares | Jan. 03, 2022 shares $ / shares | Dec. 30, 2021 shares $ / shares | Jun. 14, 2021 shares $ / shares | Jun. 01, 2021 shares $ / shares | Apr. 06, 2021 $ / shares | Dec. 31, 2022 shares months $ / shares | Dec. 31, 2021 shares months $ / shares | Oct. 19, 2022 CAD ($) | |
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 1,500,000 | 100,000 | 100,000 | 200,000 | 2,475,000 | 2,970,000 | ||||
Exercise price of stock options granted | $ / shares | $ 1.03 | $ 3.88 | $ 3.36 | $ 3.61 | $ 6.70 | $ 6.59 | $ 8.47 | $ 3.55 | $ 4.55 | |
Fair value of each option under the Black Scholes pricing model ($) | $ | $ 1,095,780 | |||||||||
Employees and officers | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 2,475,000 | 2,970,000 | ||||||||
Exercise price of stock options granted | $ / shares | $ 3.55 | $ 4.55 | ||||||||
Fair value of each option under the Black Scholes pricing model ($) | $ / shares | 2.37 | 2.99 | ||||||||
Assumptions under the Black Scholes model: | ||||||||||
Fair value of the market share ($) | $ / shares | $ 3.54 | $ 4.52 | ||||||||
Risk free interest rate (%) | 2.43% | 1.11% | ||||||||
Expected volatility (%) | 83.17% | 83% | ||||||||
Expected dividend yield | 0% | 0% | ||||||||
Expected life (number of months) | months | 60 | 60 | ||||||||
Member of Board of Director | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 500,000 | 900,000 | 300,000 | 650,000 | ||||||
Exercise price of stock options granted | $ / shares | $ 3.02 | |||||||||
Fair value of each option under the Black Scholes pricing model ($) | $ / shares | 2.02 | |||||||||
Assumptions under the Black Scholes model: | ||||||||||
Fair value of the market share ($) | $ / shares | $ 3.02 | |||||||||
Risk free interest rate (%) | 3.38% | |||||||||
Expected volatility (%) | 83.15% | |||||||||
Expected dividend yield | 0% | |||||||||
Expected life (number of months) | months | 60 | |||||||||
October 26, 2020 | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 0 | |||||||||
July 16, 2020 | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 0 | |||||||||
September 29, 2019 | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 0 | |||||||||
December 30, 2021 | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 100,000 | |||||||||
December 17, 2021 | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 1,920,000 | |||||||||
October 14, 2021 | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 100,000 | |||||||||
June 1, 2021 | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 200,000 | |||||||||
April 6, 2021 | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 550,000 | |||||||||
January 2, 2020 | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 0 | |||||||||
June 14, 2021 | ||||||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | ||||||||||
Number of options granted or recognized | 100,000 |
Shareholders' equity (Schedul_3
Shareholders' equity (Schedule of outstanding options) (Details) | 12 Months Ended | ||||||
Jun. 02, 2022 shares | Dec. 30, 2021 shares | Jun. 14, 2021 shares | Jun. 01, 2021 shares | Dec. 31, 2022 shares $ / shares | Dec. 31, 2021 shares $ / shares | Dec. 31, 2020 $ / shares | |
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 8,403,000 | 9,040,000 | |||||
Granted | 1,500,000 | 100,000 | 100,000 | 200,000 | 2,475,000 | 2,970,000 | |
Exercised | (2,440,000) | (3,482,000) | |||||
Forfeited | 242,500 | 125,000 | |||||
Ending balance | 8,195,500 | 8,403,000 | |||||
Number of stock options vested | 5,730,500 | 7,265,500 | |||||
Exercise price per option | $ / shares | $ 3.96 | $ 3.10 | $ 1.57 | ||||
Share options exercisable | $ / shares | $ 3.96 | ||||||
November 3, 2017 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 2,400,000 | 2,420,000 | |||||
Granted | 0 | ||||||
Exercised | (2,400,000) | (20,000) | |||||
Forfeited | 0 | ||||||
Ending balance | 0 | 2,400,000 | |||||
Number of stock options vested | 0 | 2,400,000 | |||||
Exercise price per option | $ / shares | $ 0.58 | $ 0.58 | |||||
July 3, 2018 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 300,000 | 300,000 | |||||
Granted | 0 | ||||||
Exercised | 0 | ||||||
Forfeited | 0 | ||||||
Ending balance | 300,000 | 300,000 | |||||
Number of stock options vested | 300,000 | 300,000 | |||||
Exercise price per option | $ / shares | $ 0.51 | $ 0.51 | |||||
October 29, 2018 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 40,000 | 70,000 | |||||
Granted | 0 | ||||||
Exercised | (40,000) | (30,000) | |||||
Forfeited | 0 | ||||||
Ending balance | 0 | 40,000 | |||||
Number of stock options vested | 0 | 40,000 | |||||
Exercise price per option | $ / shares | $ 0.52 | $ 0.52 | |||||
September 29, 2019 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 100,000 | 200,000 | |||||
Granted | 0 | ||||||
Exercised | (100,000) | ||||||
Forfeited | 0 | ||||||
Ending balance | 100,000 | 100,000 | |||||
Number of stock options vested | 100,000 | 100,000 | |||||
Exercise price per option | $ / shares | $ 0.51 | $ 0.51 | |||||
January 2, 2020 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 100,000 | 100,000 | |||||
Granted | 0 | ||||||
Exercised | 0 | ||||||
Forfeited | 0 | ||||||
Ending balance | 100,000 | 100,000 | |||||
Number of stock options vested | 100,000 | 100,000 | |||||
Exercise price per option | $ / shares | $ 0.45 | $ 0.45 | |||||
July 16, 2020 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 2,243,000 | 2,450,000 | |||||
Granted | 0 | ||||||
Exercised | (82,000) | ||||||
Forfeited | 42,500 | 125,000 | |||||
Ending balance | 2,200,500 | 2,243,000 | |||||
Number of stock options vested | 1,775,500 | 1,775,500 | |||||
Exercise price per option | $ / shares | $ 4.41 | $ 4.41 | |||||
October 26, 2020 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 250,000 | 250,000 | |||||
Granted | 0 | ||||||
Exercised | 0 | ||||||
Forfeited | 200,000 | 0 | |||||
Ending balance | 50,000 | 250,000 | |||||
Number of stock options vested | 37,500 | 125,000 | |||||
Exercise price per option | $ / shares | $ 4 | $ 4 | |||||
April 6, 2021 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 550,000 | 0 | |||||
Granted | 550,000 | ||||||
Exercised | 0 | ||||||
Forfeited | 0 | ||||||
Ending balance | 550,000 | 550,000 | |||||
Number of stock options vested | 410,000 | 320,000 | |||||
Exercise price per option | $ / shares | $ 8.47 | $ 8.47 | |||||
June 1, 2021 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 200,000 | 0 | |||||
Granted | 200,000 | ||||||
Exercised | 0 | ||||||
Forfeited | 0 | ||||||
Ending balance | 200,000 | 200,000 | |||||
Number of stock options vested | 100,000 | 50,000 | |||||
Exercise price per option | $ / shares | $ 6.59 | $ 6.59 | |||||
June 14, 2021 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 100,000 | 0 | |||||
Granted | 100,000 | ||||||
Exercised | 0 | ||||||
Forfeited | 0 | ||||||
Ending balance | 100,000 | 100,000 | |||||
Number of stock options vested | 50,000 | 25,000 | |||||
Exercise price per option | $ / shares | $ 6.70 | $ 6.70 | |||||
October 14, 2021 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 100,000 | 0 | |||||
Granted | 100,000 | ||||||
Exercised | 0 | ||||||
Forfeited | 0 | ||||||
Ending balance | 100,000 | 100,000 | |||||
Number of stock options vested | 30,000 | 10,000 | |||||
Exercise price per option | $ / shares | $ 5.04 | $ 5.04 | |||||
December 17, 2021 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 1,920,000 | 0 | |||||
Granted | 1,920,000 | ||||||
Exercised | 0 | ||||||
Forfeited | 0 | ||||||
Ending balance | 1,920,000 | 1,920,000 | |||||
Number of stock options vested | 1,920,000 | 1,920,000 | |||||
Exercise price per option | $ / shares | $ 3.13 | $ 3.13 | |||||
December 30, 2021 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 100,000 | 0 | |||||
Granted | 100,000 | ||||||
Exercised | 0 | ||||||
Forfeited | 0 | ||||||
Ending balance | 100,000 | 100,000 | |||||
Number of stock options vested | 30,000 | 100,000 | |||||
Exercise price per option | $ / shares | $ 3.61 | $ 3.61 | |||||
January 3, 2022 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 0 | ||||||
Granted | 450,000 | ||||||
Ending balance | 450,000 | 0 | |||||
Number of stock options vested | 450,000 | ||||||
Exercise price per option | $ / shares | $ 3.36 | ||||||
April 5, 2022 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 0 | ||||||
Granted | 400,000 | ||||||
Ending balance | 400,000 | 0 | |||||
Number of stock options vested | 40,000 | ||||||
Exercise price per option | $ / shares | $ 2.96 | ||||||
June 2, 2022 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 0 | ||||||
Granted | 1,500,000 | ||||||
Ending balance | 1,500,000 | 0 | |||||
Number of stock options vested | 375,000 | ||||||
Exercise price per option | $ / shares | $ 3.88 | ||||||
July 13, 2022 | |||||||
Disclosure of terms and conditions of share-based payment arrangement [line items] | |||||||
Beginning balance | 0 | ||||||
Granted | 125,000 | ||||||
Ending balance | 125,000 | 0 | |||||
Number of stock options vested | 12,500 | ||||||
Exercise price per option | $ / shares | $ 2.14 |
Shareholders' equity (Schedul_4
Shareholders' equity (Schedule of activity in warrants) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of classes of share capital [line items] | ||
Number of warrants outstanding | 0 | 8,056,051 |
Number of warrants issued | 1,014,600 | 0 |
Number of warrants exercised | 0 | (8,146,483) |
Number of warrants expired | 0 | (5,275) |
Number of warrants outstanding | 1,014,600 | 0 |
Price per warrant | $ 1.75 | |
Net proceeds from exercise of warrants | $ 12,396,107 | |
Issuance of units - September 28, 2018 | ||
Disclosure of classes of share capital [line items] | ||
Number of warrants outstanding | 0 | 3,448,276 |
Number of warrants issued | 0 | |
Number of warrants exercised | (3,448,276) | |
Number of warrants expired | 0 | |
Number of warrants outstanding | 0 | |
Price per warrant | $ 0.58 | |
Issuance of units - October 19, 2018 | ||
Disclosure of classes of share capital [line items] | ||
Number of warrants outstanding | 0 | 100,000 |
Number of warrants issued | 0 | |
Number of warrants exercised | (100,000) | |
Number of warrants expired | 0 | |
Number of warrants outstanding | 0 | |
Price per warrant | $ 0.58 | |
Issuance of units - May 15, 2019 | ||
Disclosure of classes of share capital [line items] | ||
Number of warrants outstanding | 0 | 1,355,500 |
Number of warrants issued | 0 | |
Number of warrants exercised | (1,355,500) | |
Number of warrants expired | 0 | |
Number of warrants outstanding | 0 | |
Price per warrant | $ 0.85 | |
Issuance of units - May 28, 2019 | ||
Disclosure of classes of share capital [line items] | ||
Number of warrants outstanding | 0 | 750,000 |
Number of warrants issued | 0 | |
Number of warrants exercised | (750,000) | |
Number of warrants expired | 0 | |
Number of warrants outstanding | 0 | |
Price per warrant | $ 0.85 | |
Issuance of units - June 19, 2019 | ||
Disclosure of classes of share capital [line items] | ||
Number of warrants outstanding | 0 | 500,000 |
Number of warrants issued | 0 | |
Number of warrants exercised | (500,000) | |
Number of warrants expired | 0 | |
Number of warrants outstanding | 0 | |
Price per warrant | $ 0.85 | |
Issuance of units - October 25, 2019 | ||
Disclosure of classes of share capital [line items] | ||
Number of warrants outstanding | 0 | 225,000 |
Number of warrants issued | 0 | |
Number of warrants exercised | (225,000) | |
Number of warrants expired | 0 | |
Number of warrants outstanding | 0 | |
Price per warrant | $ 0.75 | |
Issuance of units - November 10, 2020 | ||
Disclosure of classes of share capital [line items] | ||
Number of warrants outstanding | 0 | 1,677,275 |
Number of warrants issued | 0 | |
Number of warrants exercised | (1,672,000) | |
Number of warrants expired | (5,275) | |
Number of warrants outstanding | 0 | |
Price per warrant | $ 4.5 | |
Issuance of warrants - November 10, 2020 | ||
Disclosure of classes of share capital [line items] | ||
Number of warrants outstanding | 0 | 0 |
Number of warrants issued | 0 | |
Number of warrants exercised | (95,707) | |
Number of warrants expired | 0 | |
Number of warrants outstanding | 0 | |
Price per warrant | $ 4.5 | |
Issuance of units - October 19, 2022 | ||
Disclosure of classes of share capital [line items] | ||
Number of warrants outstanding | 0 | |
Number of warrants issued | 1,014,600 | |
Number of warrants exercised | 0 | |
Number of warrants expired | 0 | |
Number of warrants outstanding | 1,014,600 | 0 |
Price per warrant | $ 1.75 |
Supplemental disclosure of ca_3
Supplemental disclosure of cash flow information (Schedule of supplemental disclosure of cash flow information) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Supplemental disclosure of cash flow information | ||
Accounts receivable | $ (985,015) | $ (12,372,139) |
Costs and profits in excess of billings on uncompleted contracts | 3,871,413 | (3,849,077) |
Inventory | (988,821) | (839,352) |
Investment tax credits receivable | (19,891) | 1,015,862 |
Royalties receivable | (30,842) | (65,845) |
Deposits | 2,277,136 | 145,379 |
Contract assets | (562,809) | 0 |
Prepaid expenses | (53,942) | 39,111 |
Accounts payable and accrued liabilities | 346,003 | 1,953,208 |
Billings in excess of costs and profits on uncompleted contracts | 270,762 | 1,485,969 |
Income taxes | 267,414 | (99,072) |
Net change in balances related to operations | $ 4,391,408 | $ (12,585,956) |
Supplemental disclosure on co_2
Supplemental disclosure on comprehensive income statement (Narrative) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Government Grant [Line Items] | ||
Amortization and write-off of intangible assets | $ 878,030 | $ 465,913 |
Depreciation of property and equipment | 603,894 | 356,103 |
Employee benefits | 18,115,284 | 21,855,957 |
Share-based compensation | 5,538,463 | 9,762,745 |
Grant received | 204,791 | 226,420 |
Grant received recorded in research and development | 149,575 | |
Grant received recorded in selling, general and administrative | 204,791 | 76,845 |
Amount of inventories recognized in cost of sales | 844,304 | 326,279 |
Depreciation of right-of-use assets | $ 635,828 | $ 570,411 |
Net finance costs (Summary of n
Net finance costs (Summary of net finance costs) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Financial expenses | ||
Interest on term loans | $ 3,198 | $ 87,775 |
Interest on lease liabilities | 378,611 | 307,691 |
Interest accretion on balance due on business combination | 173,350 | 110,204 |
Interest accretion on long term loans | 28,229 | 12,185 |
Penalties and other interest expenses | 85,644 | 19,324 |
Finance costs | 669,032 | 537,179 |
Financial income | ||
Interest accretion on royalty receivable | (118,290) | (132,809) |
Net finance costs | $ 550,742 | $ 404,370 |
Loss per share (Summary of reco
Loss per share (Summary of reconciliation between the number of basic and fully diluted shares outstanding) (Details) - shares | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Earnings (loss) per share | ||
Weighted daily average of Common shares | 170,953,374 | 166,645,546 |
Dilutive effect of stock options | 0 | 0 |
Dilutive effect of warrants | 0 | 0 |
Weighted average number of diluted shares | 170,953,374 | 166,645,546 |
Number of anti-dilutive stock options and warrants excluded from fully diluted loss per share calculation | 6,745,100 | 8,403,000 |
Related party transactions (Nar
Related party transactions (Narrative) (Details) - CAD ($) | 12 Months Ended | ||||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Sep. 01, 2022 | Jan. 01, 2022 | |
Disclosure of transactions between related parties [line items] | |||||
Prepayment of rent | $ 1,178,530 | ||||
Percentage of discount rate used for remeasurement of lease liabilities. | 8.60% | 4% | |||
Right-of-use assets | $ 4,818,744 | $ 5,765,993 | 3,701,000 | ||
Lease liabilities | 5,533,694 | 5,323,965 | $ 2,988,542 | ||
Trust beneficially owned by the controlling shareholder and CEO | |||||
Disclosure of transactions between related parties [line items] | |||||
Rent and property taxes | 277,389 | 274,934 | |||
Reimbursement | 1,070,264 | ||||
Prepayment of rent | $ 1,178,530 | ||||
Percentage of discount rate used for remeasurement of lease liabilities. | 4% | ||||
Increase in lease liability from remeasurement | $ 1,070,264 | ||||
Decrease in assets from remeasurement | 108,267 | ||||
Right-of-use assets | 680,980 | 1,107,131 | |||
Lease liabilities | 799,090 | ||||
Amount due to related party for loans | $ 254,097 | $ 144,506 |
Related party transactions (Sum
Related party transactions (Summary of total compensation to key management) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Related party transactions | ||
Salaries - key management | $ 1,204,306 | $ 3,049,501 |
Pension contributions | 22,479 | 59,377 |
Fees - Board of Directors | 157,900 | 187,600 |
Share-based compensation - officers | 2,017,348 | 6,182,573 |
Share-based compensation - Board of Directors | 2,293,167 | 2,338,650 |
Other benefits - key management | 244,621 | 237,903 |
Total compensation | $ 5,939,821 | $ 12,055,604 |
Financial instruments (Summary
Financial instruments (Summary of amount denominated in foreign currency) (Details) - CAD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure of risk management strategy related to hedge accounting [line items] | |||
Cash and cash equivalents [note 8] | $ 3,445,649 | $ 12,202,513 | $ 18,104,899 |
Accounts receivable [note 9] | 18,624,631 | 17,639,616 | |
Accounts payable and accrued liabilities | (10,115,870) | (10,069,177) | |
Total | 1,650,709 | 14,006,785 | |
Currency risk | |||
Disclosure of risk management strategy related to hedge accounting [line items] | |||
Cash and cash equivalents [note 8] | 2,871,062 | 1,714,670 | |
Accounts receivable [note 9] | 13,537,912 | 14,465,011 | |
Accounts payable and accrued liabilities | (1,713,717) | (1,023,999) | |
Total | $ 14,695,257 | 15,155,682 | |
Reasonably possible change in valuation (as a percent) | 10% | ||
Amount of impact on pre-tax gain or loss | $ 1,470,000 | $ 1,516,000 |
Financial instruments (Summar_2
Financial instruments (Summary of credit risk and credit concentration) (Details) | 12 Months Ended | |
Dec. 31, 2022 CAD ($) Item | Dec. 31, 2021 CAD ($) Item | |
IFRS Concentration Risk [Line Items] | ||
Revenues [note 7] | $ 19,013,503 | $ 31,068,350 |
Trade and other current receivables | 18,624,631 | 17,639,616 |
Exposure associated with collection of receivables | 0 | |
Revenues | Customer concentration | ||
IFRS Concentration Risk [Line Items] | ||
Revenues [note 7] | $ 9,912,878 | $ 24,297,417 |
Concentration risk (as a percent) | 52% | 79% |
Trade accounts receivable | Customer concentration | ||
IFRS Concentration Risk [Line Items] | ||
Concentration risk (as a percent) | 10% | |
Decrease Through Writeoff Financial Assets | $ 0 | $ 0 |
Customer 1 | Revenues | Customer concentration | ||
IFRS Concentration Risk [Line Items] | ||
Revenues [note 7] | $ 5,598,653 | $ 7,308,191 |
Concentration risk (as a percent) | 29% | 24% |
Customer 1 | Trade accounts receivable | Customer concentration | ||
IFRS Concentration Risk [Line Items] | ||
Number of major customers | Item | 1 | |
Concentration risk (as a percent) | 56% | 73% |
Trade and other current receivables | $ 18,894,727 | $ 12,063,636 |
Customer 2 | Revenues | Customer concentration | ||
IFRS Concentration Risk [Line Items] | ||
Revenues [note 7] | $ 4,314,225 | $ 7,019,953 |
Concentration risk (as a percent) | 23% | 23% |
Customer 2 | Trade accounts receivable | Customer concentration | ||
IFRS Concentration Risk [Line Items] | ||
Concentration risk (as a percent) | 16% | |
Customer 3 | Revenues | Customer concentration | ||
IFRS Concentration Risk [Line Items] | ||
Revenues [note 7] | $ 0 | $ 6,417,373 |
Concentration risk (as a percent) | 0% | 21% |
Customer 3 | Trade accounts receivable | Customer concentration | ||
IFRS Concentration Risk [Line Items] | ||
Number of major customers | Item | 3 | |
Concentration risk (as a percent) | 11% | |
Customer 4 | Revenues | Customer concentration | ||
IFRS Concentration Risk [Line Items] | ||
Revenues [note 7] | $ 0 | $ 3,551,900 |
Concentration risk (as a percent) | 0% | 11% |
Four Customers [Member] | Revenues | Customer concentration | ||
IFRS Concentration Risk [Line Items] | ||
Number of major customers | Item | 4 | |
Concentration risk (as a percent) | 79% | |
Two Customers [Member] | Revenues | Customer concentration | ||
IFRS Concentration Risk [Line Items] | ||
Number of major customers | Item | 2 | |
Concentration risk (as a percent) | 52% |
Financial instruments (Price ri
Financial instruments (Price risk) (Details) - Price risk - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of risk management strategy related to hedge accounting [line items] | ||
Reasonably possible change in valuation (as a percent) | 25% | |
Amount of impact on investments | $ 1,841,484 | $ 4,042,000 |
Financial instruments (Liquidit
Financial instruments (Liquidity risk) (Details) | 12 Months Ended | |||
Dec. 31, 2022 CAD ($) | Dec. 31, 2022 EUR (€) | Dec. 31, 2022 EUR (€) | Dec. 31, 2021 CAD ($) | |
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Carrying value | $ 20,443,949 | $ 19,053,496 | ||
Total contractual amount | 22,016,086 | 20,819,447 | ||
Accounts payable and accrued liabilities [note 19] | $ 10,115,870 | 10,069,177 | ||
Borrowings, interest rate | 3% | 3% | ||
Less than one year | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | $ 15,834,453 | 15,288,484 | ||
2-3 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 3,315,888 | 2,738,074 | ||
4-5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 883,816 | 624,451 | ||
Over 5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 1,981,929 | 2,168,438 | ||
Accounts Payable and Accrued Liabilities | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Carrying value | 9,620,591 | 9,586,423 | ||
Total contractual amount | 9,620,591 | 9,586,423 | ||
Accounts Payable and Accrued Liabilities | Less than one year | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 9,620,591 | 9,586,423 | ||
Accounts Payable and Accrued Liabilities | 2-3 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 0 | 0 | ||
Accounts Payable and Accrued Liabilities | 4-5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 0 | 0 | ||
Accounts Payable and Accrued Liabilities | Over 5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 0 | 0 | ||
Bank indebtedness | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Carrying value | 991,902 | |||
Total contractual amount | 991,902 | |||
Bank indebtedness | Less than one year | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 991,902 | |||
Bank indebtedness | 2-3 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 0 | |||
Bank indebtedness | 4-5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 0 | |||
Bank indebtedness | Over 5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 0 | |||
Term Loans | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Carrying value | 389,987 | 190,905 | ||
Total contractual amount | 520,444 | 263,232 | ||
Term Loans | Less than one year | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 59,917 | 85,731 | ||
Term Loans | 2-3 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 190,587 | 67,561 | ||
Term Loans | 4-5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 180,000 | 62,823 | ||
Term Loans | Over 5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 89,940 | 47,117 | ||
Balance due on business combination | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Carrying value | 3,907,775 | 3,952,203 | ||
Total contractual amount | 4,137,820 | 4,355,600 | ||
Balance due on business combination | Less than one year | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 2,177,800 | 2,395,580 | ||
Balance due on business combination | 2-3 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 1,960,020 | 1,960,020 | ||
Balance due on business combination | 4-5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 0 | 0 | ||
Balance due on business combination | Over 5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 0 | 0 | ||
Lease labilities | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Carrying value | 5,533,694 | 5,323,965 | ||
Total contractual amount | 6,745,329 | 6,614,192 | ||
Lease labilities | Less than one year | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 2,984,243 | 3,220,750 | ||
Lease labilities | 2-3 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 1,165,281 | 710,493 | ||
Lease labilities | 4-5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 703,816 | 561,628 | ||
Lease labilities | Over 5 years | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Total contractual amount | 1,891,989 | $ 2,121,321 | ||
Line of credit | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Proceeds from borrowings drawn against this facility | 498,200 | |||
Maximum available line of credit | 500,000 | |||
Line of credit | Subsidiaries [Member] | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Proceeds from borrowings drawn against this facility | 493,702 | € 341,473 | ||
Maximum available line of credit | $ 576,000 | € 400,000 | ||
Line of credit | Subsidiaries [Member] | Canadian facility | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Borrowings, interest rate | 7.45% | 7.45% | ||
Borrowings, interest rate basis | prime rate plus 1% | prime rate plus 1% | ||
Spread on variable rate | 1% | 1% | ||
Line of credit | Subsidiaries [Member] | Italian facility | ||||
Disclosure of maturity analysis for non-derivative financial liabilities [line items] | ||||
Borrowings, interest rate | 8% | 8% | ||
Borrowings, interest rate basis | prime rate plus 1% | prime rate plus 1% | ||
Spread on variable rate | 1% | 1% |
Contingent liabilities (Narrati
Contingent liabilities (Narrative) (Details) | 12 Months Ended |
Dec. 31, 2022 CAD ($) | |
Contingent liabilities | |
Government grant received | $ 800,000 |
Interest rate | 3% |
Expected to be repaid | $ 0 |
Capital management (Narrative)
Capital management (Narrative) (Details) - CAD ($) | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Capital management | |||
Working capital | $ 1,650,709 | $ 14,006,785 | |
Shareholders' equity | 16,868,927 | 40,768,754 | $ 59,423,106 |
Debt | 389,987 | 190,905 | |
Cash and cash equivalents [note 8] | $ 3,445,649 | $ 12,202,513 | $ 18,104,899 |
Income taxes (Summary of income
Income taxes (Summary of income tax expenses) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Current tax | ||
Current year | $ 118,378 | $ (155,714) |
Deferred tax | ||
Origination and reversal of temporary differences | (6,219,309) | (5,095,595) |
Change in unrecognized deductible temporary differences | 6,176,915 | 4,511,349 |
Deferred tax | (42,394) | (584,246) |
Income tax expense (recovery) | $ 75,984 | $ (739,960) |
Income taxes (Summary of reconc
Income taxes (Summary of reconciliation of effective tax rate) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Reconciliation of effective tax rate | ||
Income (loss) before income taxes | $ (32,091,043) | $ (39,171,899) |
Income tax rates | 26.50% | 26.50% |
Income tax expense (recovery) at the combined basic Federal and Provincial tax rates | $ (8,504,126) | $ (10,380,553) |
Permanent differences | 2,165,385 | 5,079,805 |
Tax rate changes | (826) | 8,334 |
Prior year adjustment | 115,118 | 60,533 |
Change in unrecognized deductible temporary differences | 6,176,915 | 4,511,349 |
Other | 123,518 | (19,428) |
Income tax expense (recovery) | $ 75,984 | $ (739,960) |
Applicable statutory tax rates | 26.50% | 26.50% |
Income taxes (Summary of recogn
Income taxes (Summary of recognized deferred tax assets and liabilities) (Details) - CAD ($) | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Deferred tax assets and liabilities [abstract] | |||
Tax liabilities | $ 0 | $ (42,394) | |
Tax assets (liabilities) | 0 | (42,394) | $ (706,000) |
Non-capital losses carried forward | |||
Deferred tax assets and liabilities [abstract] | |||
Tax assets | 772,343 | 1,705,073 | |
Tax liabilities | 0 | 0 | |
Tax assets (liabilities) | 772,343 | 1,705,073 | 4,982,328 |
Net tax assets (liabilities) | 772,343 | 1,705,073 | |
Strategic investments | |||
Deferred tax assets and liabilities [abstract] | |||
Tax assets | 0 | 0 | |
Tax liabilities | 0 | (656,507) | |
Tax assets (liabilities) | 0 | (656,507) | (4,919,499) |
Net tax assets (liabilities) | 0 | (656,507) | |
Investment tax credits | |||
Deferred tax assets and liabilities [abstract] | |||
Tax assets (liabilities) | 0 | 0 | (273,854) |
Royalty receivable | |||
Deferred tax assets and liabilities [abstract] | |||
Tax assets | 0 | 0 | |
Tax liabilities | (373,063) | (333,543) | |
Tax assets (liabilities) | (373,063) | (333,543) | (280,900) |
Net tax assets (liabilities) | (373,063) | (333,543) | |
Property and equipment | |||
Deferred tax assets and liabilities [abstract] | |||
Tax assets | 0 | 0 | |
Tax liabilities | (155,833) | (147,127) | |
Tax assets (liabilities) | (155,833) | (147,127) | (25,273) |
Net tax assets (liabilities) | (155,833) | (147,127) | |
Intangibles | |||
Deferred tax assets and liabilities [abstract] | |||
Tax assets | 0 | 0 | |
Tax liabilities | (243,447) | (468,167) | |
Tax assets (liabilities) | (243,447) | (468,167) | 0 |
Net tax assets (liabilities) | (243,447) | (468,167) | |
Deferred income | |||
Deferred tax assets and liabilities [abstract] | |||
Tax assets | 0 | 0 | |
Tax liabilities | 0 | (21,000) | |
Tax assets (liabilities) | 0 | (21,000) | $ 0 |
Net tax assets (liabilities) | 0 | (21,000) | |
Right-of-use assets net of liabilities | |||
Deferred tax assets and liabilities [abstract] | |||
Tax assets | 0 | 0 | |
Tax liabilities | 0 | (121,123) | |
Net tax assets (liabilities) | 0 | (121,123) | |
Set off of tax assets | |||
Deferred tax assets and liabilities [abstract] | |||
Tax assets | 772,343 | 1,705,073 | |
Tax liabilities | (772,343) | (1,705,073) | |
Net tax assets (liabilities) | 0 | (42,394) | |
Set off tax liabilities | |||
Deferred tax assets and liabilities [abstract] | |||
Tax assets | 772,343 | 1,705,073 | |
Tax liabilities | (772,343) | (1,747,467) | |
Net tax assets (liabilities) | 0 | 0 | |
Set off tax net | |||
Deferred tax assets and liabilities [abstract] | |||
Tax assets | 0 | 0 | |
Tax liabilities | 0 | (42,394) | |
Net tax assets (liabilities) | $ 0 | $ (42,394) |
Income taxes (Summary of tempor
Income taxes (Summary of temporary differences and unused tax losses and tax credits) (Details) - CAD ($) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax liability (asset) at beginning of period | $ (42,394) | $ (706,000) |
Recognized in profit or loss | 42,394 | 584,246 |
Recognized in business combination | 79,360 | |
Deferred tax liability (asset) at end of period | 0 | (42,394) |
Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax liability (asset) at beginning of period | 1,705,073 | 4,982,328 |
Recognized in profit or loss | (932,730) | (3,919,404) |
Recognized in business combination | 642,149 | |
Deferred tax liability (asset) at end of period | 772,343 | 1,705,073 |
Strategic investments | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax liability (asset) at beginning of period | (656,507) | (4,919,499) |
Recognized in profit or loss | 656,507 | 4,262,992 |
Recognized in business combination | 0 | |
Deferred tax liability (asset) at end of period | 0 | (656,507) |
Investment tax credits | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax liability (asset) at beginning of period | 0 | (273,854) |
Recognized in profit or loss | 0 | 273,854 |
Recognized in business combination | 0 | |
Deferred tax liability (asset) at end of period | 0 | 0 |
Royalty receivable | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax liability (asset) at beginning of period | (333,543) | (280,900) |
Recognized in profit or loss | (39,520) | (52,643) |
Recognized in business combination | 0 | |
Deferred tax liability (asset) at end of period | (373,063) | (333,543) |
Property and equipment | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax liability (asset) at beginning of period | (147,127) | (25,273) |
Recognized in profit or loss | (8,706) | (119,014) |
Recognized in business combination | (2,840) | |
Deferred tax liability (asset) at end of period | (155,833) | (147,127) |
Intangibles assets | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax liability (asset) at beginning of period | (468,167) | 0 |
Recognized in profit or loss | 224,720 | 91,782 |
Recognized in business combination | (559,949) | |
Deferred tax liability (asset) at end of period | (243,447) | (468,167) |
Deferred income | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax liability (asset) at beginning of period | (21,000) | 0 |
Recognized in profit or loss | 21,000 | (21,000) |
Recognized in business combination | 0 | |
Deferred tax liability (asset) at end of period | 0 | (21,000) |
Right-of-use assets net of liabilities | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Deferred tax liability (asset) at beginning of period | (121,123) | (188,802) |
Recognized in profit or loss | 121,123 | 67,679 |
Recognized in business combination | 0 | |
Deferred tax liability (asset) at end of period | $ 0 | $ (121,123) |
Income taxes (Summary of amount
Income taxes (Summary of amounts and expiry dates of tax attributed and temporary difference for which no deferred tax assets was recognized) (Details) - CAD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Research And Development Expenses, Without Time Limitation | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | $ 11,917,963 | $ 11,399,104 |
Research And Development Expenses, Without Time Limitation | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 12,150,617 | 11,023,013 |
Federal Research And Development Investment Tax Credits | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 3,271,592 | 3,331,636 |
Federal Research And Development Investment Tax Credits | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2029 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 299,881 | 299,881 |
Federal Research And Development Investment Tax Credits | 2029 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2030 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 89,879 | 89,879 |
Federal Research And Development Investment Tax Credits | 2030 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2031 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 223,759 | 223,759 |
Federal Research And Development Investment Tax Credits | 2031 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2032 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 186,031 | 186,031 |
Federal Research And Development Investment Tax Credits | 2032 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2033 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 105,216 | 105,216 |
Federal Research And Development Investment Tax Credits | 2033 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2034 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 212,609 | 212,609 |
Federal Research And Development Investment Tax Credits | 2034 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2035 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 488,555 | 488,555 |
Federal Research And Development Investment Tax Credits | 2035 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2036 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 359,594 | 359,594 |
Federal Research And Development Investment Tax Credits | 2036 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2037 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 253,885 | 253,885 |
Federal Research And Development Investment Tax Credits | 2037 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2038 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 186,015 | 186,015 |
Federal Research And Development Investment Tax Credits | 2038 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2039 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 340,728 | 465,535 |
Federal Research And Development Investment Tax Credits | 2039 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2040 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 101,562 | 101,562 |
Federal Research And Development Investment Tax Credits | 2040 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2041 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 167,461 | 359,115 |
Federal Research And Development Investment Tax Credits | 2041 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 0 | 0 |
Federal Research And Development Investment Tax Credits | 2042 | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | 256,417 | 0 |
Federal Research And Development Investment Tax Credits | 2042 | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Amount of tax attributed and temporary difference for which no deferred tax assets was recognized | $ 0 | $ 0 |
Income taxes (Summary of tax lo
Income taxes (Summary of tax losses carried forward) (Details) - CAD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | $ 7,894,885 | $ 5,277,453 |
Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 42,341,623 | 21,717,071 |
Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 7,628,953 | 4,996,405 |
Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 41,107,972 | 19,895,533 |
Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 908,073 | 815,620 |
2032 | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 2,866,759 | 628,948 |
2032 | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 2,866,759 | 0 |
2032 | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
2033 | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 2,047,643 | 2,047,643 |
2033 | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 2,047,643 | 1,490,639 |
2033 | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
2034 | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 589,007 | 589,007 |
2034 | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 589,007 | 589,007 |
2034 | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
2035 | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 703,664 | 703,664 |
2035 | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 416,827 | 416,827 |
2035 | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
2036 | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 3,579,827 | 3,579,827 |
2036 | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 3,440,527 | 3,440,527 |
2036 | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
2037 | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 1,577,876 | 1,577,876 |
2037 | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 1,568,739 | 1,568,739 |
2037 | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
2038 | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 5,716,536 | 5,716,536 |
2038 | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 5,650,620 | 5,650,620 |
2038 | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
2039 | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 4,772,060 | 4,163,315 |
2039 | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 4,079,919 | 4,079,919 |
2039 | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
2040 | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 533,485 | 0 |
2040 | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 533,485 | 0 |
2040 | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
2041 | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 3,818,898 | 2,710,255 |
2041 | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 3,773,941 | 2,659,255 |
2041 | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
2042 | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 16,135,868 | 0 |
2042 | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 16,140,505 | 0 |
2042 | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
Indefinite | Federal | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
Indefinite | Provincial | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 0 |
Indefinite | Italy | Non-capital losses carried forward | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | $ 908,073 | $ 815,620 |
Income taxes (Summary of other
Income taxes (Summary of other deductible temporary differences, without time limitation) (Details) - CAD ($) | Dec. 31, 2022 | Dec. 31, 2021 |
Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | $ 7,894,885 | $ 5,277,453 |
Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 7,628,953 | 4,996,405 |
Right-of-use assets net of liabilities | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 687,896 | 0 |
Right-of-use assets net of liabilities | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 687,896 | 0 |
Strategic investments | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 3,068,378 | 0 |
Strategic investments | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 3,068,378 | 0 |
Financing costs | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 677,789 | 1,100,504 |
Financing costs | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 677,789 | 1,100,504 |
Intangibles assets | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 3,460,822 | 3,712,181 |
Intangibles assets | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 3,194,890 | 3,431,133 |
Capital losses | Federal | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | 0 | 464,768 |
Capital losses | Provincial | ||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | ||
Tax losses carried forward | $ 0 | $ 464,768 |
Segment information (Narrative)
Segment information (Narrative) (Details) | 12 Months Ended |
Dec. 31, 2022 segment | |
Segment information | |
Number of operating segments | 1 |
Segment information (Summary of
Segment information (Summary of total revenues and category of selected assets by geography) (Details) - CAD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | $ 19,013,503 | $ 31,068,350 | |
Property and equipment [note 15] | 3,393,452 | 3,712,937 | |
Right-of-use assets | 4,818,744 | 5,765,993 | $ 3,701,000 |
Intangible assets [note 17] | 2,104,848 | 2,774,198 | |
Goodwill [note 18] | 2,660,607 | 2,660,607 | |
Total selected asset categories by geographic market | 12,977,651 | 14,913,735 | |
Brazil | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 162,797 | 1,475,608 | |
Canada | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 11,933,904 | 7,383,884 | |
Property and equipment [note 15] | 3,372,356 | 3,685,974 | |
Right-of-use assets | 4,818,744 | 5,765,993 | |
Intangible assets [note 17] | 2,104,848 | 2,774,198 | |
Goodwill [note 18] | 2,660,607 | 2,660,607 | |
Total selected asset categories by geographic market | 12,956,555 | 14,886,772 | |
England | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 0 | 634 | |
Germany | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 11,606 | 3,867 | |
India | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 91,699 | 698,837 | |
Property and equipment [note 15] | 21,096 | 26,963 | |
Right-of-use assets | 0 | 0 | |
Intangible assets [note 17] | 0 | 0 | |
Goodwill [note 18] | 0 | 0 | |
Total selected asset categories by geographic market | 21,096 | 26,963 | |
Israel | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 27,360 | 126,246 | |
Italy | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 1,309,478 | 2,514,665 | |
Mexico | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 371,668 | 920,818 | |
Netherlands | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 112,634 | 0 | |
Poland | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 47,591 | 60,406 | |
Saudi Arabia | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 1,511,142 | 7,019,953 | |
South Africa | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 29,997 | 0 | |
Spain | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 22,049 | 1,178 | |
United States of America | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | 2,661,071 | 10,567,741 | |
Vietnam | |||
Disclosure of geographical areas [line items] | |||
Revenues [note 7] | $ 720,507 | $ 294,513 |
Subsequent events (Narrative) (
Subsequent events (Narrative) (Details) - CAD ($) | 1 Months Ended | 12 Months Ended | |||
Mar. 08, 2023 | Oct. 19, 2022 | Oct. 31, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disclosure of non-adjusting events after reporting period [line items] | |||||
Gross proceeds | $ 1,318,980 | $ 1,318,980 | $ 0 | ||
Price per warrant | $ 1.75 | ||||
Non-brokered private placement | |||||
Disclosure of non-adjusting events after reporting period [line items] | |||||
Number of units issued | 1,014,600 | ||||
Issuance price per unit | $ 1.30 | ||||
Gross proceeds | $ 1,318,980 | ||||
Number of common shares that each unit entitles | 1 | ||||
Number of common shares that each common share purchase warrant entitles | 1 | ||||
Price per warrant | $ 1.75 | ||||
Potential Ordinary Share Transactions [Member] | |||||
Disclosure of non-adjusting events after reporting period [line items] | |||||
Gross proceeds | $ 5,000,000 | ||||
Fair value of common shares | $ 1.38 | ||||
Potential Ordinary Share Transactions [Member] | Non-brokered private placement | |||||
Disclosure of non-adjusting events after reporting period [line items] | |||||
Number of units issued | 5,000,000 | ||||
Issuance price per unit | $ 1 | ||||
Gross proceeds | $ 5,000,000 | ||||
Number of common shares that each unit entitles | 1 | ||||
Number of common share purchase warrant that each unit entitles | 1 | ||||
Number of common shares that each common share purchase warrant entitles | 1 | ||||
Price per warrant | $ 1.25 |